col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


934 Results       Page 1

 [1] 
Oxford University Press: Clinical Infectious Diseases
  original article Date Title Authors   All Authors
1 [GO] 2023―Dec―07 Unlinking time zero from test-negative controls exaggerates risk from COVID-19 Anil N Makam
2 [GO] 2023―Nov―22 Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults Nelson Lee, Lena Nguyen, Peter C Austin, Kevin A Brown, Ramandip Grewal, Sarah A Buchan, et al. (+7)
3 [GO] 2023―Nov―15 Differential Viral Dynamics by Sex and Body Mass Index During Acute SARS-CoV-2 Infection: Results from a Longitudinal Cohort Study Carly Herbert, Yukari C Manabe, Andreas Filippaios, Honghuang Lin, Biqi Wang, Chad Achenbach, et al. (+12)
4 [GO] 2023―Nov―14 Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated individuals Sarah E Smith-Jeffcoat, Jessica E Biddle, H Keipp Talbot, Kerry Grace Morrisey, Melissa S Stockwell, Yvonne Maldonado, et al. (+31)
5 [GO] 2023―Nov―11 Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses Eric A Meyerowitz, Yijia Li
6 [GO] 2023―Nov―06 Coronavirus Disease (COVID) and the Fog of War Michael S Saag
7 [GO] 2023―Oct―27 Letter to the editor: Positive effects of cognitive-behavioral therapy targeting severe fatigue following COVID-19 are sustained up to one year after treatment Tanja A Kuut, Fabiola Müller, Irene Csorba, Annemarie M J Braamse, Pythia Nieuwkerk, Chantal P Rovers, Hans Knoop
8 [GO] 2023―Oct―25 Outcomes of SARS-CoV-2 Omicron Variant Infections Compared with Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicentre Cohort Study Pontus Hedberg, John Karlsson Valik, Lina Abdel Halim, Tobias Alfvén, Pontus Naucler
9 [GO] 2023―Oct―24 The Current Mismatch between COVID-19 Clinical Trial Design and The Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis Rocio Montejano, Alfredo Soler-Carracedo, Alberto M Borobia, Alejandro Martin-Quiros, David Grandioso, Carlos Cañada, et al. (+2)
10 [GO] 2023―Oct―23 A Systematic Review of Predictor Composition, Outcomes, Risk of Bias, and Validation of COVID-19 Prognostic Scores Katharina S Appel, Ramsia Geisler, Daniel Maier, Olga Miljukov, Sina M Hopff, Jörg J Vehreschild
11 [GO] 2023―Oct―05 A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study) Liem B Luong Nguyen, Jeanne Goupil de Bouillé, Lola Menant, Marion Noret, Audrey Dumas, Maud Salmona, et al. (+15)
12 [GO] 2023―Oct―04 SARS-CoV-2 Exposures in a Large Gathering Event and Acquisition of COVID-19 in the Post-Vaccintion Era: A Randomized Trial is Possible During the Pandemic John M Conly, Mark Loeb
13 [GO] 2023―Sep―30 Voices of ID: Dealing with a Pandemic When You’re the Only ID Doctor in Town Abayomi "Yomi" A Agbebi
14 [GO] 2023―Sep―29 Isolated and Lonely in a Nursing Home During the COVID 19 Pandemic: A Deadly Combination for My Mom Debra A Goff
15 [GO] 2023―Sep―27 Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From Coronavirus Disease 2019 in Adults Aged ≥70 Years Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Julia Stowe, Elise Tessier, Ruth Simmons, Mary Ramsay
16 [GO] 2023―Sep―26 The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs Jennifer K Frediani, Richard Parsons, Kaleb B McLendon, Adrianna L Westbrook, Wilbur Lam, Greg Martin, Nira R Pollock
17 [GO] 2023―Sep―12 Description of Cryptococcosis following SARS-CoV-2 infection: A disease survey through the Mycosis Study Group Education and Research Consortium (MSG-19) Jeremey Walker, Todd McCarty, Gerald McGwin, Eloy E Ordaya, Paschalis Vergidis, Luis Ostrosky-Zeichner, et al. (+37)
18 [GO] 2023―Sep―08 High burden of COVID-19-associated pulmonary aspergillosis (CAPA) in severely immunocompromised patients requiring mechanical ventilation Simon Feys, Katrien Lagrou, Hanne Moon Lauwers, Koen Haenen, Cato Jacobs, Marius Brusselmans, et al. (+13)
19 [GO] 2023―Aug―29 The Socio-Economic and Demographic Risk Factors for SARS-CoV-2 Seropositivity Among Healthcare Workers in a UK Hospital: A Prospective Cohort Study Tanya Lam, Anja Saso, Arturo Torres Ortiz, James Hatcher, Marc Woodman, Shruthi Chandran, et al. (+89)
20 [GO] 2023―Aug―23 Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 States, June 2021-March 2023 Eric P Griggs, Patrick K Mitchell, Victoria Lazariu, Manjusha Gaglani, Charlene McEvoy, Nicola P Klein, et al. (+40)
21 [GO] 2023―Aug―23 Characteristics and outcomes of US Veterans with immunocompromised conditions at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents Chris A Gentry, Phoi N Nguyen, Sharanjeet K Thind, George Kurdgelashvili, Riley J Williams
22 [GO] 2023―Aug―10 Impact of SARS-CoV-2 Arrival Surveillance Screening by Nucleic Acid Amplification Versus Rapid Antigen Detection on Subsequent COVID-19 Infections in Military Trainees Daniel J Cybulski, Zachary Matthews, John F Kieffer, Theresa M Casey, Angela B Osuna, Korey Kasper, et al. (+4)
23 [GO] 2023―Aug―09 The cost-effectiveness of universal asymptomatic preoperative SARS-CoV-2 PCR screening: a cost-utility analysis Shunsuke Uno, Rei Goto, Kimiko Honda, Sho Uchida, Yoshifumi Uwamino, Ho Namkoong, et al. (+6)
24 [GO] 2023―Aug―08 Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice. Essy Mozaffari, Aastha Chandak, Robert L Gottlieb, Chidinma Chima-Melton, Stephanie H Read, Heng Jiang, et al. (+5)
25 [GO] 2023―Aug―03 Impact of the COVID-19 Pandemic on Inpatient Antibiotic Use in the United States, January 2019 through July 2022 Erin N O’Leary, Melinda M Neuhauser, Arjun Srinivasan, Heather Dubendris, Amy K Webb, Minn M Soe, et al. (+4)
26 [GO] 2023―Aug―02 Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019 (COVID-19) Gordon Chun Kau Chan, Grace Chung Yan Lui, Candy Ngai Sze Wong, Sindy Sin Ting Yip, Timothy Chun Man Li, Catherine Siu King Cheung, et al. (+3)
27 [GO] 2023―Aug―01 Impact of SARS-CoV-2 Prevention Measures on Non-SARS-CoV-2 Hospital-Onset Respiratory Viral Infections: An Incidence Trend Analysis from 2015-2023 Selina Ehrenzeller, Tom Chen, Vineeta Vaidya, Chanu Rhee, Meghan A Baker, Michael Klompas
28 [GO] 2023―Jul―21 Association between duration of SARS-CoV-2 positivity and long COVID Chiara Pozzi, Riccardo Sarti, Riccardo Levi, Maximiliano Mollura, Elena Azzolini, Riccardo Barbieri, et al. (+2)
29 [GO] 2023―Jul―20 Lack of zoonotic coronavirus species detected among children hospitalized with pneumonia in the Philippines Yusuke Sayama, Michiko Okamoto, Mayuko Saito, Raita Tamaki, Mariko Saito-Obata, Reynaldo Frederick Negosa Quicho, et al. (+3)
30 [GO] 2023―Jul―19 Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial Yanfen Guan, Amy Puenpatom, Matthew G Johnson, Ying Zhang, Yujie Zhao, Joseph Surber, et al. (+12)
31 [GO] 2023―Jul―18 In Support of Universal Admission Testing for SARS-CoV-2 During Significant Community Transmission Chanu Rhee, Michael Klompas, Theodore R Pak, Julia R Köhler
32 [GO] 2023―Jul―14 Asymptomatic testing of hospital admissions for SARS-CoV-2: Is it OK to stop? Karen Brust, Takaaki Kobayashi, Daniel J Diekema
33 [GO] 2023―Jul―12 Lessons from COVID-19 for Pandemic Preparedness: Proceedings from a Multi-Stakeholder Think Tank Shanti Narayanasamy, Lesley H Curtis, Adrian F Hernandez, Christopher W Woods, M Anthony Moody, Mark Sulkowski, et al. (+19)
34 [GO] 2023―Jul―07 SARS-CoV-2 Case-Definitions Must Include Clinical Criteria: Reply to Kojima et al. Lao-Tzu Allan-Blitz, Jeffrey D Klausner
35 [GO] 2023―Jul―05 Trends in Inpatient Antibiotic Use Among Adults Hospitalized During the Coronavirus Disease 2019 Pandemic in Argentina, Brazil, and Chile, 2018-2021 Twisha S Patel, Olivia L McGovern, Garrett Mahon, Hanako Osuka, Icaro Boszczowski, Jose M Munita, et al. (+16)
36 [GO] 2023―Jul―05 A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence Carlos R V Kiffer, Thais F T Rezende, Daniela Testoni Costa-Nobre, Ana Sílvia Scavacini Marinonio, Lucas Hidemitsu Shiguenaga, Debora Nicole Oliveira Kulek, et al. (+9)
37 [GO] 2023―Jul―05 Antibiotic Consumption During the Coronavirus Disease 2019 Pandemic and Emergence of Carbapenemase-Producing Klebsiella pneumoniae Lineages Among Inpatients in a Chilean Hospital: A Time-Series Study and Phylogenomic Analysis Kasim Allel, Anne Peters, José Conejeros, José R W Martínez, Maria Spencer-Sandino, Roberto Riquelme-Neira, et al. (+11)
38 [GO] 2023―Jul―05 Prescribing of Outpatient Antibiotics Commonly Used for Respiratory Infections Among Adults Before and During the Coronavirus Disease 2019 Pandemic in Brazil Dipesh Solanky, Olivia L McGovern, Jonathan R Edwards, Garrett Mahon, Twisha S Patel, Fernanda C Lessa, et al. (+2)
39 [GO] 2023―Jun―30 Active Surveillance and Contact Precautions for Preventing Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections during the COVID-19 Pandemic Martin E Evans, Loretta A Simbartl, Brian P McCauley, Linda K Flarida, Makoto M Jones, Anthony D Harris, et al. (+5)
40 [GO] 2023―Jun―29 A multicenter retrospective cohort study to characterize patients hospitalized with MIS-A and COVID-19 in the United States, 2020-2021 Michael Melgar, Joseph Y Abrams, Shana Godfred-Cato, Ami B Shah, Amit Garg, Andrew Strunk, et al. (+29)
41 [GO] 2023―Jun―29 Correspondence in relation to the recently published paper: Efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19: results of a randomized controlled trial by Kuut and colleagues. Joan S Crawford
42 [GO] 2023―Jun―29 Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years Jeremy Samuel Faust, Ashish Kumar, Jui Shah, Sumanth Khadke, Sourbha S Dani, Sarju Ganatra, Paul E Sax
43 [GO] 2023―Jun―29 Omicron variant-specific serological imprinting following BA.1 or BA.4/5 bivalent vaccination and previous SARS-CoV-2 infection: A cohort study Eva A M Baerends, Joanne Reekie, Signe R Andreasen, Nina B Stærke, Dorthe Raben, Henrik Nielsen, et al. (+19)
44 [GO] 2023―Jun―23 Maintaining the Utility of COVID-19 Pandemic Severity Surveillance: Evaluation of Trends in Attributable Deaths and Development and Validation of a Measurement Tool Caitlin Trottier, Jennifer La, Lucy L Li, Majd Alsoubani, Austin D Vo, Nathanael R Fillmore, et al. (+3)
45 [GO] 2023―Jun―20 SARS-CoV-2 Antibody Replacement Therapy for Immunocompromised Patients Jonathon W Senefeld, Michael J Joyner
46 [GO] 2023―Jun―17 No immunological interference or safety concerns when adjuvanted recombinant zoster vaccine is coadministered with a COVID-19 mRNA-1273 booster vaccine in adults aged 50 years and older: A randomized trial Abdi Naficy, Adrienne Kuxhausen, Paola Pirrotta, Brett Leav, Jacqueline Miller, Kate Anteyi, et al. (+3)
47 [GO] 2023―Jun―17 Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Vinit Upasani, Katie Townsend, Mary Y Wu, Edward J Carr, Agnieszka Hobbs, Giulia Dowgier, et al. (+23)
48 [GO] 2023―Jun―09 One Week of Oral Camostat Versus Placebo in Nonhospitalized Adults With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19): A Randomized Controlled Phase 2 Trial Nikolaus Jilg, Kara W Chew, Mark J Giganti, Eric S Daar, David A Wohl, Arzhang Cyrus Javan, et al. (+32)
49 [GO] 2023―Jun―09 Long-term Real-world Protection Afforded by Third mRNA Doses Against Symptomatic SARS-COV-2 Infections, COVID-19-related Emergency Attendances and Hospitalizations Amongst Older Singaporeans During an Omicron XBB Wave Liang En Wee, Deanette Pang, Calvin Chiew, Janice Tan, Vernon Lee, Benjamin Ong, et al. (+2)
50 [GO] 2023―Jun―08 Glucose-6-phosphate dehydrogenase (G6PD) Deficiency and COVID-19 Ariel Israel, Matitiahu Berkovitch, Eugene Merzon, Avivit Golan-Cohen, Ilan Green, Eytan Ruppin, et al. (+2)
51 [GO] 2023―May―31 Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022 Noah Kojima, Katherine Adams, Wesley H Self, Manjusha Gaglani, Tresa McNeal, Shekhar Ghamande, et al. (+210)
52 [GO] 2023―May―31 Patients Hospitalized With Coronavirus Disease 2019: A Diverse Population Jens Lundgren
53 [GO] 2023―May―30 Correction to: Relative Effectiveness of Coronavirus Disease 2019 Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Period-United States, 1 January 2022 to 31 March 2022
54 [GO] 2023―May―23 A Randomized Controlled Study Assessing Convalescent Immunoglobulins versus Convalescent Plasma for Hospitalized COVID-19 Patients Yasmin Maor, Eilat Shinar, Marina Izak, Galia Rahav, Tal Brosh-Nissimov, Asa Kessler, et al. (+7)
55 [GO] 2023―May―22 Zinc for the treatment of COVID-19: Yet to prove its mettle? Pritheetha Gowthaman, Shawn Vasoo
56 [GO] 2023―May―19 Correction to: Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults
57 [GO] 2023―May―19 Pre-existing autoimmunity is associated with increased severity of COVID-19: A retrospective cohort study using data from the National COVID Cohort Collaborative (N3C) Arjun S Yadaw, David K Sahner, Hythem Sidky, Behdad Afzali, Nathan Hotaling, Emily R Pfaff, et al. (+129)
58 [GO] 2023―May―11 Association of virus variation and vaccination status with post-acute sequelae after SARS-cov-2 infection Guangting Zeng, Yuchi Zhou
59 [GO] 2023―May―10 Increase in False Positive Fourth Generation HIV Tests in Patients with COVID-19 Disease Smitha Gudipati, Anita Shallal, Edward Peterson, Bernard Cook, Norman Markowitz
60 [GO] 2023―May―08 Efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19: results of a randomized controlled trial Tanja A Kuut, Fabiola Müller, Irene Csorba, Annemarie Braamse, Arnoud Aldenkamp, Brent Appelman, et al. (+14)
61 [GO] 2023―May―07 Real-World Effectiveness of Nirmatrelvir/Ritonavir on Covid-19-Associated Hospitalization Prevention: A Population-Based Cohort Study in the Province of Québec, Canada Jean-Luc Kaboré, Benoît Laffont, Mamadou Diop, Melanie R Tardif, Alexis F Turgeon, Jeannot Dumaresq, et al. (+7)
62 [GO] 2023―May―03 Vaccination Status and Trends in Adult COVID-19-Associated Hospitalizations by Race and Ethnicity, March 2020-August 2022 Jean Y Ko, Huong Pham, Onika Anglin, Shua J Chai, Nisha B Alden, James Meek, et al. (+26)
63 [GO] 2023―Apr―27 How Infectious Disease Experts Impacted the Coronavirus Disease 2019 Response: Lessons From the Front Lines Amesh Adalja, Daniel P McQuillen, Diane Meyer
64 [GO] 2023―Apr―20 Therapy with Allogeneic SARS-CoV-2-specific T-cells for Persistent COVID-19 in Immunocompromised Patients Ghady Haidar, Jana L Jacobs, Kailey Hughes Kramer, Asma Naqvi, Amy Heaps, Urvi Parikh, et al. (+23)
65 [GO] 2023―Apr―19 Condition-Dependent and Dynamic Impacts of Indoor Masking Policies for COVID-19 Mitigation: A Nationwide, Interrupted Time-Series Analysis Zeynep Ertem, Richard E Nelson, Elissa M Schechter-Perkins, Amera Al-Amery, Xilin Zhang, Westyn Branch-Elliman
66 [GO] 2023―Apr―19 Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022 Fayette Klaassen, Melanie H Chitwood, Ted Cohen, Virginia E Pitzer, Marcus Russi, Nicole A Swartwood, et al. (+2)
67 [GO] 2023―Apr―12 Undiagnosed pulmonary TB and COVID in adults dying at home in a high TB burden setting, before and during pandemic COVID-19: an autopsy study Nadia Sabet, Tanvier Omar, Minja Milovanovic, Tebogo Magajane, Modiehi Mosala, Tumelo Moloantoa, et al. (+8)
68 [GO] 2023―Apr―11 COVID-19: Shehecheyanu Luis Ostrosky-Zeichner
69 [GO] 2023―Apr―10 Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial Angela R Branche, Nadine G Rouphael, Cecilia Losada, Lindsey R Baden, Evan J Anderson, Anne F Luetkemeyer, et al. (+30)
70 [GO] 2023―Mar―31 Evaluation of acebilustat, a selective inhibitor of leukotriene B4 biosynthesis, for treatment of outpatients with mild-moderate COVID-19 disease: A randomized, double-blind, placebo- controlled Phase 2 trial Joseph E Levitt, Haley Hedlin, Sophie Duong, Di Lu, Justin Lee, Bryan Bunning, et al. (+14)
71 [GO] 2023―Mar―31 COVID-19 Vaccination is Associated with Reduced Outpatient Antibiotic Prescribing In Older Adults with Confirmed SARS-CoV-2: A Population Wide Cohort Study Derek R MacFadden, Colleen Maxwell, Dawn Bowdish, Susan Bronskill, James Brooks, Kevin Brown, et al. (+16)
72 [GO] 2023―Mar―31 Your Outpatient has Coronavirus Disease 2019: What Are the Treatment Options in the Current Severe Acute Respiratory Syndrome Coronavirus 2 Variant Climate? William A Werbel, Ethel D Weld, Sonali D Advani, Payal K Patel, Maria E Sundaram, Varun K Phadke
73 [GO] 2023―Mar―29 Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients Malgorzata Mikulska, Chiara Sepulcri, Chiara Dentone, Federica Magne, Elisa Balletto, Federico Baldi, et al. (+14)
74 [GO] 2023―Mar―29 COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample Evan M Bloch, Ruchika Goel, Xianming Zhu, Eshan U Patel, Shmuel Shoham, David J Sullivan, et al. (+3)
75 [GO] 2023―Mar―22 Isolation and quarantine for COVID-19 in the United States, 2020-2022 John E Oeltmann, Divya Vohra, Holly H Matulewicz, Nickolas DeLuca, Jonathan P Smith, Chandra Couzens, et al. (+12)
76 [GO] 2023―Mar―21 Complexity Interactions Between Nirmatrelvir/Ritonavir and Voriconazole in Patients With Coronavirus Disease 2019 Peile Wang, Han Xing, Xiaojian Zhang, Jing Yang
77 [GO] 2023―Mar―21 Infectious Complications of Lung Transplant for Coronavirus Disease 2019-Associated Lung Injury: A Single-Center Case-Control Cohort Study Rebecca Osborn, Maha Alamri, Rade Tomic, Michael G Ison
78 [GO] 2023―Mar―16 Appropriate outcome settings for the effectiveness of oral zinc treatment for Coronavirus Disease-2019 Nobuaki Mori, Jun Hirai, Nobuhiro Asai, Hiroshige Mikamo
79 [GO] 2023―Mar―15 Correction to: Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada
80 [GO] 2023―Mar―14 Opioid injection-associated bacterial infections in England, 2002-2021: a time series analysis of seasonal variation and the impact of COVID-19 Dan Lewer, Thomas D Brothers, Sara Croxford, Monica Desai, Eva Emanuel, Magdalena Harris, Vivian D Hope
81 [GO] 2023―Mar―11 Post-acute Sequelae After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection by Viral Variant and Vaccination Status: A Multicenter Cross-sectional Study Christian R Kahlert, Carol Strahm, Sabine Güsewell, Alexia Cusini, Angela Brucher, Stephan Goppel, et al. (+45)
82 [GO] 2023―Mar―02 Correction to: Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients
83 [GO] 2023―Mar―02 Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout Alexandra N Lea, Wendy A Leyden, Oleg Sofrygin, Ben J Marafino, Jacek Skarbinski, Sonia Napravnik, et al. (+16)
84 [GO] 2023―Mar―02 Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019 Julia del Amo
85 [GO] 2023―Mar―01 Correction to: Effectiveness of Messenger RNA-based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant
86 [GO] 2023―Feb―21 The COVID-19 Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences in Participants Treated with Nirmatrelvir Plus Ritonavir Versus Untreated Controls Jay A Pandit, Jennifer M Radin, Danielle Chiang, Emily G Spencer, Jeff B Pawelek, Mira Diwan, et al. (+2)
87 [GO] 2023―Feb―21 Coronavirus Disease 2019 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-Analysis of Individual Participant Data From 5 Randomized Trials Adam C Levine, Yuriko Fukuta, Moises A Huaman, Jiangda Ou, Barry R Meisenberg, Bela Patel, et al. (+20)
88 [GO] 2023―Feb―21 Coronavirus Disease 2019 Convalescent Plasma Reaches the Slope of Enlightenment in the Gartner Hype Cycle Shmuel Shoham
89 [GO] 2023―Feb―17 Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda Elizabeth Nalintya, Preethiya Sekar, Paul Kavuma, Joanita Kigozi, Martin Ssuna, Paul Kirumira, et al. (+9)
90 [GO] 2023―Feb―17 Longitudinal whole-genome sequence characterization of a persistent SARS-CoV-2 Omicron BA.5 infection in an immunocompromised patient successfully treated with sotrovimab 1000 mg. Francisco Tejerina, Rosalía Palomino, Pilar Catalan, Amadeo Sanz, Mercedes Marin, Felipe Lopez-Andujar, et al. (+8)
91 [GO] 2023―Feb―14 Successful combination treatment for persistent SARS-CoV-2 infection Ola Blennow, Jan Vesterbacka, Tuullikki Tovatt, Piotr Nowak
92 [GO] 2023―Feb―14 Zinc and Coronavirus Disease 2019 Harri Hemilä, Elizabeth Chalker
93 [GO] 2023―Feb―12 Infection-Induced Immunity Is Associated With Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Decreased Infectivity Aaron M Frutos, Guillermina Kuan, Roger Lopez, Sergio Ojeda, Abigail Shotwell, Nery Sanchez, et al. (+6)
94 [GO] 2023―Feb―10 COVID-19 and Airborne Transmission: Science Rejected, Lives Lost. Can Society Do Better? Lidia Morawska, William Bahnfleth, Philomena M Bluyssen, Atze Boerstra, Giorgio Buonanno, Stephanie J Dancer, et al. (+27)
95 [GO] 2023―Feb―10 It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19)
96 [GO] 2023―Feb―09 One-year Outcomes of Lung Transplantation for COVID-19 Associated End Stage Lung Disease in the United States Kenji Okumura, Soma Jyothula, Thomas Kaleekal, Abhay Dhand
97 [GO] 2023―Feb―08 Relative effectiveness of COVID-19 vaccination and booster dose combinations among 18.9 million vaccinated adults during the early SARS-CoV-2 Omicron period - United States, January 1, 2022-March 31, 2022 Lyudmyla Kompaniyets, Ryan E Wiegand, Adewole C Oyalowo, Lara Bull-Otterson, Heartley Egwuogu, Trevor Thompson, et al. (+11)
98 [GO] 2023―Feb―08 Correction to: Coronavirus Disease 2019 [COVID-19] Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study
99 [GO] 2023―Feb―06 Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19 Evan M Bloch, Daniele Focosi, Shmuel Shoham, Jonathon Senefeld, Aaron A R Tobian, Lindsey R Baden, et al. (+16)
100 [GO] 2023―Feb―03 Correction to: Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial
101 [GO] 2023―Feb―02 Return to travel in the COVID-19 pandemic recovery period and implications for imported malaria: Reinforcing prevention, early diagnosis, and appropriate treatment of malaria Jonathan S Schultz, Kimberly E Mace, Kathrine R Tan
102 [GO] 2023―Jan―31 Research on the Development of Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern in People With Advanced Human Immunodeficiency Virus Disease Should Highlight Structural Conditions and Avoid Harmful Stereotypes Stephen Molldrem
103 [GO] 2023―Jan―31 Coronavirus Disease 2019 Pandemic-Associated Declines and Subsequent Increases in Hepatitis C Virus Treatment Prescriptions in Los Angeles County Cassidy Hernandez-Tamayo, Dima M Qato, Mirna Ponce Jewell, Prabhu Gounder, Jeffrey D Klausner
104 [GO] 2023―Jan―27 The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing Mary K Hayden, Kimberly E Hanson, Janet A Englund, Francesca Lee, Mark J Lee, Mark Loeb, et al. (+13)
105 [GO] 2023―Jan―27 Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study Michael Gottlieb, Ralph Wang, Huihui Yu, Erica S Spatz, Juan Carlos Montoy, Robert Rodriguez, et al. (+103)
106 [GO] 2023―Jan―11 Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort Cecilia Bonazzetti, Beatrice Tazza, Dino Gibertoni, Zeno Pasquini, Natascia Caroccia, Francesca Fanì, et al. (+52)
107 [GO] 2023―Jan―08 Correction to: Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer
108 [GO] 2023―Jan―08 Relationships between social vulnerability and COVID-19 vaccination coverage and vaccine effectiveness Alexandra F Dalton, Zachary A Weber, Katie S Allen, Edward Stenehjem, Stephanie A Irving, Talia L Spark, et al. (+36)
109 [GO] 2023―Jan―08 The Last Mile Problem - COVID-19 Vaccine Coverage Among the Most Socially Vulnerable Boghuma K Titanji
110 [GO] 2023―Jan―03 Three-day icatibant on top of standard care in patients with COVID-19 pneumonia (ICAT·COVID): a randomized, open-label, phase 2, proof-of-concept trial Pierre Malchair, Jordi Giol, Vanesa García, Orlando Rodríguez, José Carlos Ruibal, Alvaro Zarauza, et al. (+48)
111 [GO] 2022―Dec―31 Correction to: Potential Influence of Menstrual Status and Sex Hormones on Female Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Cross-sectional Multicenter Study in Wuhan, China
112 [GO] 2022―Dec―28 SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses Meghan K Herring, James K Romine, Meredith G Wesley, Katherine D Ellingson, Sarang K Yoon, Alberto J Caban-Martinez, et al. (+29)
113 [GO] 2022―Dec―27 Three-month symptom profiles among symptomatic adults with positive and negative SARS-CoV-2 tests: a prospective cohort study from the INSPIRE group Erica S Spatz, Michael Gottlieb, Lauren E Wisk, Jill Anderson, Anna Marie Chang, Nicole L Gentile, et al. (+19)
114 [GO] 2022―Dec―16 Impact of SARS-CoV-2 variants on inpatient clinical outcome Matthew L Robinson, C Paul Morris, Joshua F Betz, Yifan Zhang, Robert Bollinger, Natalie Wang, et al. (+11)
115 [GO] 2022―Dec―12 Epidemiology of human parainfluenza virus type 3 (HPIV-3) and respiratory syncytial virus (RSV) infections in the time of COVID-19: findings from a household cohort in Maryland Marissa K Hetrich, Jennifer Oliva, Kimberli Wanionek, Maria Deloria Knoll, Matthew Lamore, Ignacio Esteban, et al. (+3)
116 [GO] 2022―Dec―09 Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination Jeffrey I Cohen, Lesia Dropulic, Kening Wang, Krista Gangler, Kayla Morgan, Kelly Liepshutz, et al. (+10)
117 [GO] 2022―Dec―09 Developing mucosal vaccines for SARS-CoV-2: What will it take? Kathryn M Edwards, Kathleen M Neuzil
118 [GO] 2022―Dec―07 Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study Hiroshi Mukae, Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, Hiroki Sakaguchi, Takuhiro Sonoyama, et al. (+5)
119 [GO] 2022―Dec―01 Correction to: Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of Coronavirus Disease 2019 in Africa
120 [GO] 2022―Nov―25 Evaluation of the United States definitions for COVID-19 community risk levels Sina Mokhtar, Alyssa S Parpia, Nathan C Lo, Martial L Ndeffo-Mbah
121 [GO] 2022―Nov―25 Impact of vaccination with SCB-2019 COVID-19 vaccine on transmission of SARS-CoV-2 infection: a household contact study in the Philippines Birkneh Tilahun Tadesse, Lulu Bravo, Florian Marks, Asma Binte Aziz, Young Ae You, Jonathan Sugimoto, et al. (+14)
122 [GO] 2022―Nov―25 Predictors of COVID-19 hospitalization after sotrovimab in hematologic malignancy patients during the BA.1 Omicron surge Judy Yan, Samantha N Steiger, Rich Kodama, Jerome Fender, Carrie Tan, Justin Laracy, et al. (+7)
123 [GO] 2022―Nov―22 AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of Symptomatic COVID-19 Myron J Levin, Andrew Ustianowski, Steven Thomas, Alison Templeton, Yuan Yuan, Seth Seegobin, et al. (+15)
124 [GO] 2022―Nov―21 Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)? Marina Caskey, Daniel R Kuritzkes
125 [GO] 2022―Nov―17 Persistence of SARS-CoV-2 to Explain Long COVID Is Not Consistent with the Available Data Armin Alaedini, Gary P Wormser
126 [GO] 2022―Nov―17 Association of upper respiratory Streptococcus pneumoniae colonization with SARS-CoV-2 infection among adults Anna M Parker, Nicole Jackson, Shevya Awasthi, Hanna Kim, Tess Alwan, Anne L Wyllie, et al. (+10)
127 [GO] 2022―Nov―16 Cardiovascular outcomes after tixagevimab and cilgavimab use for pre-exposure prophylaxis against COVID-19: a population-based propensity-matched cohort study Morgan Birabaharan, Eddie Hill, Maedha Begur, David C Kaelber, Thomas CS Martin, Sanjay R Mehta
128 [GO] 2022―Nov―14 Occupations Associated with SARS-CoV-2 Infection and Vaccination, U.S. Blood Donors, July 2021-December 2021 Melisa M Shah, Bryan R Spencer, Leora R Feldstein, James M Haynes, Tina J Benoit, Sharon H Saydah, et al. (+3)
129 [GO] 2022―Nov―11 VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including COVID-19 in the Elderly: a phase III randomised, double-blind, placebo-controlled, multicenter clinical study Alexandra M Blossey, Sina Brückner, Marcus May, Gerald P Parzmair, Hitt Sharma, Umesh Shaligram, et al. (+4)
130 [GO] 2022―Nov―09 The Association Between Pre-Booster Vaccination Antibody Levels and the Risk of SARS-CoV-2 Infection Noam Barda, Michal Canetti, Mayan Gilboa, Keren Asraf, Victoria Indenboim, Yael Weiss-Ottolenghi, et al. (+8)
131 [GO] 2022―Nov―09 Maternal Antibody Response and Transplacental Transfer Following Severe Acute Respiratory Syndrome Coronavirus 2 Infection or Vaccination in Pregnancy Sebastian Otero, Emily S Miller, Ashwin Sunderraj, Elisheva D Shanes, Allie Sakowicz, Jeffery A Goldstein, Leena B Mithal
132 [GO] 2022―Nov―03 Successful treatment of prolonged, severe COVID-19 lower respiratory tract disease in a B-cell ALL patient with an extended course of remdesivir and nirmatrelvir/ritonavir Emily S Ford, William Simmons, Ellora N Karmarkar, Leah H Yoke, Ayodale B Braimah, Johnnie J Orozco, et al. (+14)
133 [GO] 2022―Nov―03 MULTI-PARAMETRIC PREDICTION MODELS FOR COVID-19 VACCINE SELECTION: RESULTS OF A COMPARATIVE POPULATION-BASED COHORT STUDY Daniela Sieghart, Claudia A Hana, Helmuth Haslacher, Thomas Perkmann, Leonhard X Heinz, Clemens Fedrizzi, et al. (+22)
134 [GO] 2022―Nov―03 Real-time whole genome sequencing to guide patient-tailored therapy of SARS-CoV-2 infection Luke B Snell, Adela Medina-Alcolea, Themoula Charalampous, Christopher Alder, Tom G S Williams, Flavia Flaviani, et al. (+10)
135 [GO] 2022―Nov―03 Test 5- versus 10-day remdesivir treatment in immunocompromised patients with COVID-19 Victoria C Yan
136 [GO] 2022―Nov―03 Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial Saoussen Ben Abdallah, Yosra Mhalla, Imen Trabelsi, Adel Sekma, Rim Youssef, Khaoula Bel Haj Ali, et al. (+18)
137 [GO] 2022―Oct―31 Adverse Events Following Immunization with mRNA and Viral Vector Vaccines in Individuals with Previous SARS-CoV-2 Infection from the Canadian National Vaccine Safety Network Julie A Bettinger, Michael A Irvine, Hennady P Shulha, Louis Valiquette, Matthew P Muller, Otto G Vanderkooi, et al. (+8)
138 [GO] 2022―Oct―26 Differential patterns by area-level social determinants of health in COVID-19 related mortality and non-COVID-19 mortality: a population-based study of 11.8 million people in Ontario, Canada Linwei Wang, Andrew Calzavara, Stefan Baral, Janet Smylie, Adrienne K Chan, Beate Sander, et al. (+3)
139 [GO] 2022―Oct―25 Dual antiviral therapy for persistent COVID-19 and associated organizing pneumonia in an immunocompromised host Caitlin A Trottier, Beverly Wong, Rakhi Kohli, Cassidy Boomsma, Francis Magro, Sucharita Kher, et al. (+2)
140 [GO] 2022―Oct―25 A potential role for zinc to enhance treatment for COVID-19? Marco Vinceti, Tommaso Filippini, Susan Fairweather-Tait
141 [GO] 2022―Oct―25 Exhaled Breath Aerosol Shedding by Highly Transmissible Versus Prior SARS-CoV-2 Variants Jianyu Lai, Kristen K Coleman, S -H Sheldon Tai, Jennifer German, Filbert Hong, Barbara Albert, et al. (+12)
142 [GO] 2022―Oct―19 Distinguishing SARS-CoV-2 persistence and reinfection: A retrospective cohort study Sarah E Turbett, Christopher H Tomkins-Tinch, Melis N Anahtar, Caitlin M Dugdale, Emily P Hyle, Erica S Shenoy, et al. (+17)
143 [GO] 2022―Oct―17 Severity of COVID-19 Hospitalization Outcomes and Patient Disposition Differ by Disability Status and Disability Type Kristie E N Clarke, Kai Hong, Megan Schoonveld, Arlene I Greenspan, Martha Montgomery, JoAnn M Thierry
144 [GO] 2022―Oct―10 Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19 Yijia Li, Linda J Harrison, Kara W Chew, Judy S Currier, David A Wohl, Eric S Daar, et al. (+11)
145 [GO] 2022―Oct―10 Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial Paul T Heath, Eva P Galiza, David Neil Baxter, Marta Boffito, Duncan Browne, Fiona Burns, et al. (+39)
146 [GO] 2022―Oct―06 Strategies for using antigen rapid diagnostic tests to reduce transmission of SARS-CoV-2 in low- and middle-income countries: a mathematical modelling study applied to Zambia Alvin X Han, Sarah Girdwood, Shaukat Khan, Jilian A Sacks, Amy Toporowski, Naushin Huq, et al. (+3)
147 [GO] 2022―Oct―03 Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV Sarah Fidler, Julie Fox, Timothy Tipoe, Stephanie Longet, Tom Tipton, Movin Abeywickrema, et al. (+45)
148 [GO] 2022―Sep―30 Rapid selection of sotrovimab escape variants in SARS-CoV-2 Omicron infected immunocompromised patients Smaranda Gliga, Nadine Luebke, Alexander Killer, Henning Gruell, Andreas Walker, Alexander T Dilthey, et al. (+9)
149 [GO] 2022―Sep―29 Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of COVID-19 in Africa Nicole E Kogan, Shae Gantt, David Swerdlow, Cécile Viboud, Muhammed Semakula, Marc Lipsitch, Mauricio Santillana
150 [GO] 2022―Sep―21 The COVID-19 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action Erin M Scherer, Martin Backer, Karen Carvajal, Lara Danziger-Isakov, Sharon Frey, Leigh M Howard, et al. (+11)
151 [GO] 2022―Sep―20 Effectiveness of mRNA-1273 vaccine booster against COVID-19 in immunocompetent adults Ana Florea, Lina S Sy, Lei Qian, Bradley K Ackerson, Yi Luo, Julia E Tubert, et al. (+7)
152 [GO] 2022―Sep―20 Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial David R Boulware, Thomas A Murray, Jennifer L Proper, Christopher J Tignanelli, John B Buse, David M Liebovitz, et al. (+27)
153 [GO] 2022―Sep―19 Associations of Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA-1273 Vaccine in COVE and TeenCOVE Trials Uma Siangphoe, Lindsey R Baden, Hana M El Sahly, Brandon Essink, Kashif Ali, Gary Berman, et al. (+8)
154 [GO] 2022―Sep―15 Dupilumab use is associated with protection from COVID-19 mortality: A retrospective analysis Alexandra N Donlan, Indika Mallawaarachi, Jennifer M Sasson, Robert Preissner, Johanna J Loomba, William A Petri
155 [GO] 2022―Sep―13 Remdesivir resistance in transplant recipients with persistent COVID-19 John I Hogan, Ralf Duerr, Dacia Dimartino, Christian Marier, Sarah E Hochman, Sapna Mehta, et al. (+2)
156 [GO] 2022―Sep―09 Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients with COVID-19: impact on the length of hospital stay and mortality Rodrigo ALONSO-NAVARRO, Genoveva CUESTA, Marta SANTOS, Celia CARDOZO, Verónica RICO, Nicole GARCIA-POUTON, et al. (+15)
157 [GO] 2022―Sep―08 Predictors of Time to COVID-19 Infection in the National Basketball Association: A Retrospective Case-Control Study Raphael E Cuomo, Zhuoran Li, Vidya Purushothaman, Chenna Basavapatna-Shankar, Matthew Nali, Tim K Mackey
158 [GO] 2022―Sep―07 Usage and awareness of antiviral medications for COVID-19 among individuals at risk for severe COVID-19, March 2021 to 1 August 2022 N Kojima, JD Klausner
159 [GO] 2022―Sep―06 Pregnancy status at the time of COVID-19 vaccination and incidence of SARS-CoV-2 infection Maria C Magnus, Siri E Håberg, Ellen Ø Carlsen, Jeffrey C Kwong, Sarah A Buchan, Deshayne B Fell
160 [GO] 2022―Sep―05 Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, Lindsey Baden, Vincent Chi Chung Cheng, Kathryn M Edwards, et al. (+11)
161 [GO] 2022―Sep―02 Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae Zoe Swank, Yasmeen Senussi, Zachary Manickas-Hill, Xu G Yu, Jonathan Z Li, Galit Alter, David R Walt
162 [GO] 2022―Aug―31 Favipiravir in patients with early mild-to-moderate COVID-19: a randomized controlled trial Yoav Golan, Jesus Abraham Simon Campos, Rob Woolson, Donald Cilla, Rodolfo Hanabergh, Yaneicy Gonzales-Rojas, et al. (+3)
163 [GO] 2022―Aug―30 Clinical severity of Omicron SARS-CoV-2 variant relative to Delta in British Columbia, Canada: A retrospective analysis of whole genome sequenced cases Sean P Harrigan, James Wilton, Mei Chong, Younathan Abdia, Hector Velasquez Garcia, Caren Rose, et al. (+9)
164 [GO] 2022―Aug―29 Impact of the use of oral antiviral agents on the risk of hospitalization in community COVID-19 patients Terry Cheuk Fung Yip, Grace Chung Yan Lui, Mandy Sze Man Lai, Vincent Wai Sun Wong, Yee Kit Tse, Bosco Hon Ming Ma, et al. (+5)
165 [GO] 2022―Aug―29 When emulating a trial, do as the trialists do: Missteps in estimating relative effectiveness of a SARS-CoV-2 vaccine booster dose Kathleen E Wirth, Jessie K Edwards, Lydia Feinstein, Alexander Breskin
166 [GO] 2022―Aug―27 Persistence of SARS-CoV-2 omicron variant in children and utility of rapid antigen testing as an indicator of culturable virus Zoe M Lohse, Jerne J Shapiro, John A Lednicky, Melanie N Cash, Inyoung Jun, Carla N Mavian, et al. (+7)
167 [GO] 2022―Aug―23 The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce Sonali D Advani, Emily Sickbert-Bennett, Rebekah Moehring, Andrea Cromer, Yuliya Lokhnygina, Elizabeth Dodds-Ashley, et al. (+4)
168 [GO] 2022―Aug―20 Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19 Sarju Ganatra, Sourbha S Dani, Javaria Ahmad, Ashish Kumar, Jui Shah, George M Abraham, et al. (+3)
169 [GO] 2022―Aug―19 COVID-19 severity and risk of subsequent cardiovascular events Timothy L Wiemken, Leah J McGrath, Kathleen M Andersen, Farid Khan, Deepa Malhotra, Tamuno Alfred, et al. (+5)
170 [GO] 2022―Aug―17 Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study Sharifa Nasreen, Yossi Febriani, Héctor Alexander Velásquez García, Geng Zhang, Mina Tadrous, Sarah A Buchan, et al. (+6)
171 [GO] 2022―Aug―12 Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients Andrew H Karaba, Weiqiang Zhou, Shuai Li, Tihitina Y Aytenfisu, Trevor S Johnston, Olivia Akinde, et al. (+14)
172 [GO] 2022―Aug―12 Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study Elisabeth B Fjelltveit, Bjørn Blomberg, Kanika Kuwelker, Fan Zhou, Therese B Onyango, Karl A Brokstad, et al. (+7)
173 [GO] 2022―Aug―12 Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022 Saba A Qasmieh, McKaylee M Robertson, Chloe A Teasdale, Sarah G Kulkarni, Denis Nash
174 [GO] 2022―Aug―12 SARS-CoV-2 testing and detection during peripartum hospitalizations among a multi-center cohort of pregnant persons, March 2020-February 2021 Miranda J Delahoy, Flor Munoz, De Kun Li, Carmen Sofia Arriola, Nanette Lee Bond, Michael Daugherty, et al. (+16)
175 [GO] 2022―Aug―08 Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19 Kasper S Moestrup, Joanne Reekie, Adrian G Zucco, Tomas Ø Jensen, Jens Ulrik S Jensen, Lothar Wiese, et al. (+5)
176 [GO] 2022―Aug―05 COVID-19 burden among unaccompanied minors in United States custody Carlo Foppiano Palacios, Elizabeth W Tucker, Mark A Travassos
177 [GO] 2022―Aug―04 SARS-CoV-2 hyperimmune intravenous human immunoglobulins neutralizes Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.3 and BA.4/BA.5 for treatment of COVID-19 Mayanka Awasthi, Hana Golding, Surender Khurana
178 [GO] 2022―Aug―04 Measuring work-related risk of COVID-19: comparison of COVID-19 incidence by occupation and industry - Wisconsin, September 2020-May 2021 Ian W Pray, Barbara Grajewski, Collin Morris, Komi Modji, Peter DeJonge, Katherine McCoy, et al. (+4)
179 [GO] 2022―Aug―04 BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years Laura D Zambrano, Margaret M Newhams, Samantha M Olson, Natasha B Halasa, Ashley M Price, Amber O Orzel, et al. (+36)
180 [GO] 2022―Aug―04 Household transmission of SARS-CoV-2 from adult index cases living with and without HIV in South Africa, 2020-2021: a case-ascertained, prospective observational household transmission study Jackie Kleynhans, Sibongile Walaza, Neil A Martinson, Mzimasi Neti, Anne von Gottberg, Jinal N Bhiman, et al. (+13)
181 [GO] 2022―Aug―03 COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study) Takeshi Arashiro, Yuzo Arima, Hirokazu Muraoka, Akihiro Sato, Kunihiro Oba, Yuki Uehara, et al. (+20)
182 [GO] 2022―Aug―02 Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom Karina Doris Vihta1, Koen B Pouwels, Tim EA Peto1, Emma Pritchard, Thomas House, Ruth Studley, et al. (+9)
183 [GO] 2022―Aug―01 Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay Christina J Atchison, Maya Moshe, Jonathan C Brown, Matthew Whitaker, Nathan C K Wong, Anil A Bharath, et al. (+9)
184 [GO] 2022―Jul―30 Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial Rocío Montejano, Fernando de la Calle-Prieto, María Velasco, Carlos Guijarro, Javier Queiruga-Parada, María Jiménez-González, et al. (+25)
185 [GO] 2022―Jul―29 Association between AZD7442 (tixagevimab-cilgavimab) administration and SARS-CoV-2 infection, hospitalization and mortality Jennifer Kertes, Shirley Shapiro Ben David, Noya Engel-Zohar, Keren Rosen, Beatriz Hemo, Avner Kantor, et al. (+4)
186 [GO] 2022―Jul―28 Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer Thomas Lehrnbecher, Ulrich Sack, Carsten Speckmann, Andreas H Groll, Andreas Boldt, Benjamin Siebald, et al. (+7)
187 [GO] 2022―Jul―23 Association of nirmatrelvir/ritonavir treatment on upper respiratory SARS-CoV-2 RT-PCR negative conversion rates among high-risk patients with COVID-19 Hongyan Li, Menghan Gao, Hailong You, Peng Zhang, Yuchen Pan, Nan Li, et al. (+14)
188 [GO] 2022―Jul―23 Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study S Reshwan K Malahe, Rogier A S Hoek, Virgil A S H Dalm, Annoek E C Broers, Caroline M den Hoed, Olivier C Manintveld, et al. (+11)
189 [GO] 2022―Jul―23 Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination Laura Esparcia-Pinedo, Ayla Yarci-Carrión, Gloria Mateo-Jiménez, Noelia Ropero, Laura Gómez-Cabañas, Ángel Lancho-Sánchez, et al. (+8)
190 [GO] 2022―Jul―22 Protection Against the Omicron Variant Offered by Previous SARS-CoV-2 Infection: A Retrospective Cohort Study Michael B Rothberg, Priscilla Kim, Nabin K Shrestha, Lisa Kojima, Larisa G Tereshchenko
191 [GO] 2022―Jul―22 Sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant Sammy Huygens, Bas Oude Munnink, Arvind Gharbharan, Marion Koopmans, Bart Rijnders
192 [GO] 2022―Jul―20 Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021 Kelly M Hatfield, James Baggs, Hannah Wolford, Michael Fang, Ammarah A Sattar, Kelsey S Montgomery, et al. (+3)
193 [GO] 2022―Jul―12 Response to ‘Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome’ Kevin R Viel
194 [GO] 2022―Jul―09 Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study Peter Hunyady, Lea Streller, Darius F Rüther, Sara Reinartz Groba, Dominik Bettinger, Daniel Fitting, et al. (+17)
195 [GO] 2022―Jul―07 Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant Jan Stephan F Sanders, A Lianne Messchendorp, Rory D de Vries, Carla C Baan, Debbie van Baarle, Rob van Binnendijk, et al. (+14)
196 [GO] 2022―Jul―06 Severity of SARS-CoV-2 Infection in Pregnancy in Ontario: A Matched Cohort Analysis Kiera R Murison, Alicia A Grima, Alison E Simmons, Ashleigh R Tuite, David N Fisman
197 [GO] 2022―Jul―06 Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection With accumulation of mutations in a patient with poorly controlled Human Immunodeficiency Virus infection Tongai G Maponga, Montenique Jeffries, Houriiyah Tegally, Andrew Sutherland, Eduan Wilkinson, Richard J Lessells, et al. (+4)
198 [GO] 2022―Jul―05 Lower Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2 Jonathan M Cohen, Michael J Carter, C Ronny Cheung, Shamez Ladhani
199 [GO] 2022―Jul―05 Magnitude and determinants of SARS-CoV-2 household transmission: a longitudinal cohort study J Daniel Kelly, Scott Lu, Khamal Anglin, Miguel Garcia-Knight, Jesus Pineda-Ramirez, Sarah A Goldberg, et al. (+24)
200 [GO] 2022―Jul―02 Antibiotic Resistant Infections among COVID-19 Inpatients in U.S. Hospitals James Baggs, Ashley N Rose, Natalie L McCarthy, Hannah Wolford, Arjun Srinivasan, John A Jernigan, Sujan C Reddy
201 [GO] 2022―Jul―01 Utility of a Test to Return Strategy to Identify Individuals with COVID-19 in the Pre-Kindergarten through Grade 12 School Setting - District of Columbia, January 2022 Marsha E Samson, William L Still, Miguella Mark-Carew, Daniel K Jarris, Areej Idris, André van Zyl, et al. (+6)
202 [GO] 2022―Jun―30 SARS-CoV-2 Infections and Reinfections among Fully Vaccinated and Unvaccinated University Athletes - 15 States, January - November 2021 Mary K Good, Michaila Czarnik, Kimberly G Harmon, Doug Aukerman, Catherine S O’Neal, Carly Day, et al. (+4)
203 [GO] 2022―Jun―29 Increased Mortality among Persons with Symptomatic COVID-19 During the Period of SARS-CoV-2 B.1.617.2 (Delta Variant) Predominance-Alaska, November 2020-October 2021 Eric Q Mooring, Katherine Newell, Louisa Castrodale, Megan Tompkins, Morgan Frank, Joseph McLaughlin
204 [GO] 2022―Jun―28 Early treatment of high-risk hospitalized COVID-19 patients with a combination of interferon beta-1b and remdesivir: a phase 2 open-label randomized controlled trial Anthony Raymond Tam, Ricky Ruiqi Zhang, Kwok Cheung Lung, Raymond Liu, Ka Yi Leung, Danlei Liu, et al. (+20)
205 [GO] 2022―Jun―28 Vaccine coverage associated with ending a SARS-CoV-2 wave: a retrospective longitudinal analysis. Aharona Glatman-Freedman, Sarah F Feldman, Yael Hershkovitz, Zalman Kaufman, Rita Dichtiar, Lital Keinan-Boker, Michal Bromberg
206 [GO] 2022―Jun―27 Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021 Heidi L Moline, Amelia Keaton, Whitney Rice, Jasmine Varghese, Li Deng, Ansley Waters, et al. (+9)
207 [GO] 2022―Jun―24 Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response through Partnerships and Collaborations Preeta K Kutty, Matthew J Stuckey, Emilia H Koumans
208 [GO] 2022―Jun―24 The US COVID-19 surveillance environment: An ecological analysis of the relationship of testing adequacy in the context of vaccination Daesung Choi, Jannie Nielsen, Lance A. Waller, Shivani A. Patel
209 [GO] 2022―Jun―24 Prevalence of SARS-CoV-2 antibodies in the Mozambican population: a cross-sectional Serologic study in three cities, July-August 2020 Paulo Arnaldo, Nédio Mabunda, Peter Wesley Young, Tiffany Tran, Nádia Sitoe, Imelda Chelene, et al. (+7)
210 [GO] 2022―Jun―24 High Community Transmission of SARS-CoV-2 Associated with Decreased Contact Tracing Effectiveness for Identifying Persons at Elevated Risk of Infection - Vermont Brian F Borah, Julia Pringle, Michael Flaherty, John E Oeltmann, Patrick K Moonan, Patsy Kelso
211 [GO] 2022―Jun―24 SARS-CoV-2 in Africa: current considerations and future projections Olubukola T Idoko, Effua Usuf, Uduak Okomo, Chizoba Wonodi, Kondwani Jambo, Beate Kampmann, et al. (+2)
212 [GO] 2022―Jun―24 Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021 Djin-Ye Oh, Martin Hölzer, Sofia Paraskevopoulou, Maria Trofimova, Felix Hartkopf, Matthias Budt, et al. (+25)
213 [GO] 2022―Jun―23 Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for COVID-19 Julie Boucau, Rockib Uddin, Caitlin Marino, James Regan, James P Flynn, Manish C Choudhary, et al. (+15)
214 [GO] 2022―Jun―23 COVID-19 vaccination coverage, intentions, attitudes and barriers by race/ethnicity, language of interview, and nativity, National Immunization Survey Adult COVID Module, April 22, 2021-January 29, 2022 Elizabeth C Ohlsen, David Yankey, Clelia Pezzi, Jennifer L Kriss, Peng Jun Lu, Mei Chuan Hung, et al. (+10)
215 [GO] 2022―Jun―23 Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity Elena Morrocchi, Chiara Pighi, Giuseppe Rubens Pascucci, Nicola Cotugno, Chiara Medri, Donato Amodio, et al. (+11)
216 [GO] 2022―Jun―23 SARS-CoV-2 co-detection with influenza A and other respiratory viruses among school-aged children and their household members- March 12, 2020, to February 22, 2022, Dane County, Wisconsin Jonathan L Temte, Shari Barlow, Emily Temte, Maureen Goss, Allen Bateman, Kelsey Florek, Amra Uzicanin
217 [GO] 2022―Jun―23 Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study Tara C Bouton, Joseph Atarere, Jacquelyn Turcinovic, Scott Seitz, Cole Sher-Jan, Madison Gilbert, et al. (+11)
218 [GO] 2022―Jun―20 Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose Tal Brosh-Nissimov, Khetam Hussein, Yonit Wiener-Well, Efrat Orenbuch-Harroch, Meital Elbaz, Shelly Lipman-Arens, et al. (+8)
219 [GO] 2022―Jun―20 Delayed Recognition of COVID-19 in New York City: A descriptive analysis of COVID-19 illness prior to February 29, 2020 Page Keating, Jessica Sell, Judy Chen, Joel Ackelsberg, Winfred Wu, Benjamin Tsoi, Don Weiss
220 [GO] 2022―Jun―20 A Retrospective Database Analysis of Before and After Social Distancing in Relation to Pediatric Infection Rate and Healthcare Services Usage During the COVID-19 Pandemic Ran Levy, Regev Cohen, Liat Lev-Shalem, Arik Eisenkraft, Tehila Fisher Yosef
221 [GO] 2022―Jun―20 SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021 Mellisa Roskosky, Gwen Moni, Vance Kawakami, Joanie Lambert, Claire Brostrom-Smith, Holly Whitney, et al. (+5)
222 [GO] 2022―Jun―20 Virologic and Immunologic Characterization of COVID-19 Recrudescence after Nirmatrelvir/Ritonavir Treatment Aaron F Carlin, Alex E Clark, Antoine Chaillon, Aaron F Garretson, William Bray, Magali Porrachia, et al. (+3)
223 [GO] 2022―Jun―20 Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine Dien M Vu, Diep T B Vu, Thuy T T Do, Allison E Olmsted, Bach H Dao, Truc T Thai, et al. (+6)
224 [GO] 2022―Jun―20 Modeling the effectiveness of healthcare personnel reactive testing and screening for the SARS-CoV-2 Omicron variant within nursing homes Casey M Zipfel, Prabasaj Paul, Camden D Gowler, Sujan C Reddy, Nimalie D Stone, Kara Jacobs Slifka, Rachel B Slayton
225 [GO] 2022―Jun―19 Life-Threatening Complications of Influenza versus COVID-19 in U.S. Children Natasha B Halasa, Andrew J Spieker, Cameron C Young, Samantha M Olson, Margaret M Newhams, Justin Z Amarin, et al. (+36)
226 [GO] 2022―Jun―19 Increased deaths from fungal infections during the COVID-19 pandemic-National Vital Statistics System, United States, January 2020-December 2021 Jeremy A W Gold, Farida B Ahmad, Jodi A Cisewski, Lauren M Rossen, Alejandro J Montero, Kaitlin Benedict, et al. (+2)
227 [GO] 2022―Jun―19 COVID-19 Severity among Women of Reproductive Age with Symptomatic Laboratory-Confirmed SARS-CoV-2 by Pregnancy Status - United States, Jan 1, 2020 - Dec 25, 2021 Penelope Strid, Lauren B Zapata, Van T Tong, Laura D Zambrano, Kate R Woodworth, Aspen P Riser, et al. (+3)
228 [GO] 2022―Jun―19 Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers - Mexico, March-December 2021 Vesta L Richardson, Martín Alejandro Camacho Franco, Aurora Bautista Márquez, Libny Martínez Valdez, Luis Enrique Castro Ceronio, Vicente Cruz Cruz, et al. (+5)
229 [GO] 2022―Jun―19 Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation to the timing of antenatal vaccination Amihai Rottenstreich, Gila Zarbiv, Esther Oiknine-Djian, Olesya Vorontsov, Roy Zigron, Geffen Kleinstern, et al. (+2)
230 [GO] 2022―Jun―19 Reported exposures among in-person workers with SARS-CoV-2 infection in 6 states, September 2020-June 2021 Hannah Free, Sara E Luckhaupt, Rachael M Billock, Matthew R Groenewold, Sherry Burrer, Marie Haring Sweeney, et al. (+16)
231 [GO] 2022―Jun―19 Integration of sequencing and epidemiological data for surveillance of SARS-CoV-2 infections in a tertiary-care hospital Manja Czech-Sioli, Thomas Günther, Alexis Robitaille, Hannes Roggenkamp, Henning Büttner, Daniela Indenbirken, et al. (+6)
232 [GO] 2022―Jun―19 Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021 Fayette Klaassen, Melanie H Chitwood, Ted Cohen, Virginia E Pitzer, Marcus Russi, Nicole A Swartwood, et al. (+2)
233 [GO] 2022―Jun―14 Rebound Phenomenon after Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease-2019 in High-Risk Persons Nischal Ranganath, John C. O’Horo, Douglas W. Challener, Sidna M. Tulledge-Scheitel, Marsha L. Pike, R. Michael O’Brien, et al. (+2)
234 [GO] 2022―Jun―10 Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services Karina A. Top, Robert T. Chen, Ofer Levy, Al Ozonoff, Bruce Carleton, Nigel Crawford, et al. (+5)
235 [GO] 2022―Jun―10 Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza Zhu-Nan Li, Feng Liu, Stacie Jefferson, Lauren Horner, Paul Carney, Michael D. L. Johnson, et al. (+10)
236 [GO] 2022―Jun―10 Multisystem Inflammatory Syndrome in Children (MIS-C) During SARS-CoV-2 Delta and Omicron Variant Circulation- United States, July 2021 - January 2022 Allison D. Miller, Anna R. Yousaf, Ethan Bornstein, Michael J. Wu, Katherine Lindsey, Michael Melgar, et al. (+3)
237 [GO] 2022―Jun―10 Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021 Michael P. Busch, Susan L. Stramer, Mars Stone, Elaine A. Yu, Eduard Grebe, Edward Notari, et al. (+17)
238 [GO] 2022―Jun―10 Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants Susana Monge, Ayelén Rojas-Benedicto, Carmen Olmedo, Elisa Martín-Merino, Clara Mazagatos, Aurora Limia, et al. (+3)
239 [GO] 2022―Jun―10 Association of Trends in SARS-CoV-2 Seroprevalence and State-Issued Nonpharmaceutical Interventions- United States, August 1, 2020 - March 30, 2021 Maureen J. Miller, Austin Himschoot, Natalie Fitch, Sucheta Jawalkar, Dane Freeman, Charity Hilton, et al. (+15)
240 [GO] 2022―Jun―10 Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021- January 2022 Renee D. Wegrzyn, Grace D. Appiah, Robert Morfino, Scott R. Milford, Allison Taylor Walker, Ezra T. Ernst, et al. (+15)
241 [GO] 2022―Jun―10 Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination So Yun Lim, Soonju Park, Ji Yeun Kim, Seungtaek Kim, Youngmee Jee, Sung-Han Kim
242 [GO] 2022―Jun―10 Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2 Exposure-Minnesota, January-August 2021 Abbey Ruhland, Ashley Fell, Stacy M Holzbauer, Paige D’Heilly, Kris Curtis, Holly Wick, et al. (+6)
243 [GO] 2022―Jun―10 Testing Frequency Matters | An Evaluation of the Diagnostic Performance of a SARS-CoV-2 Rapid Antigen Test in United States Correctional Facilities Margaret L. Lind, Olivia L. Schultes, Alexander J. Robertson, Amy J. Houde, Derek A.T. Cummings, Albert I. Ko, et al. (+2)
244 [GO] 2022―Jun―08 Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States Nathaniel M. Lewis, Wesley H. Self, Manjusha Gaglani, Adit A. Ginde, David J. Douin, H. Keipp Talbot, et al. (+50)
245 [GO] 2022―Jun―08 SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination Coverage-Connecticut, August-September 2021 Stephen M. Bart, Christina C. Curtiss, Rebecca Earnest, Rachel Lobe-Costonis, Hanna Peterson, Caroline McWilliams, et al. (+5)
246 [GO] 2022―Jun―08 mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell’s palsy: a nested case control and self-controlled case series study Eric Yuk Fai Wan, Celine Sze Ling Chui, Vanessa Wai Sei Ng, Yuan Wang, Vincent Ka Chun Yan, Ivan Chun Hang Lam, et al. (+19)
247 [GO] 2022―Jun―08 Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine Nancy H. L. Leung, Samuel M. S. Cheng, Mario Martín-Sánchez, Niki Y. M. Au, Yvonne Y. Ng, Leo L. H. Luk, et al. (+11)
248 [GO] 2022―Jun―08 Maternal and perinatal outcomes associated with SARS-CoV-2 infection during pregnancy, Florida, 2020-2021: A retrospective cohort study Timothy J. Doyle, Gebre-egziabhe Kiros, Emily N. Schmitt-Matzen, Randy Propper, Angela Thompson, Ghasi S. Phillips-Bell
249 [GO] 2022―Jun―08 MERS-CoV Infection Elicits Long-lasting Specific Antibody, T and B Cell Immune Responses in Recovered Individuals Rowa Y Alhabbab, Abdullah Algaissi, Ahmed Bakr Mahmoud, Almohanad A Alkayyal, Sawsan Al-Amri, Mohamed A Alfaleh, et al. (+13)
250 [GO] 2022―Jun―06 Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern (VOCs): A Small-scale Clinical Trial Yao Lin, Shuai Yue, Yang Yang, Sen Yang, Zhiwei Pan, Xiaofan Yang, et al. (+16)
251 [GO] 2022―Jun―06 Durability of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Booster Vaccine Protection Against Omicron Among Healthcare Workers With a Vaccine Mandate Aaron Richterman, Amy Behrman, Patrick J Brennan, Judith A O’Donnell, Christopher K Snider, Krisda H Chaiyachati
252 [GO] 2022―Jun―02 Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients Ronza Najjar-Debbiny, Naomi Gronich, Gabriel Weber, Johad Khoury, Maisam Amar, Nili Stein, et al. (+2)
253 [GO] 2022―May―31 Effectiveness of heterologous COVID-19 vaccine booster dosing in Brazilian healthcare workers, 2021 Alexandre R. Marra, João Luiz Miraglia, Daniel Tavares Malheiros, Yang Guozhang, Vanessa Damazio Teich, Elivane da Silva Victor, et al. (+19)
254 [GO] 2022―May―31 SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults Denis Nash, Madhura S. Rane, McKaylee M. Robertson, Mindy Chang, Sarah Kulkarni Gorrell, Rebecca Zimba, et al. (+9)
255 [GO] 2022―May―31 Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population Min Zhao, Rebecca Slotkin, Amar H. Sheth, Lauren Pischel, Tassos C. Kyriakides, Brinda Emu, et al. (+10)
256 [GO] 2022―May―26 Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2 Alicia A. Grima, Kiera R. Murison, Alison E. Simmons, Ashleigh R. Tuite, David N. Fisman
257 [GO] 2022―May―26 Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations Brittany A. Petros, Jacquelyn Turcinovic, Nicole L. Welch, Laura F. White, Eric D. Kolaczyk, Matthew R. Bauer, et al. (+24)
258 [GO] 2022―May―26 Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease Anna C. Riddell, Beatrix Kele, Kathryn Harris, Jon Bible, Maurice Murphy, Subathira Dakshina, et al. (+8)
259 [GO] 2022―May―24 Understanding ‘hybrid immunity’: comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines Nusrat J. Epsi, Stephanie A. Richard, David A. Lindholm, Katrin Mende, Anuradha Ganesan, Nikhil Huprikar, et al. (+30)
260 [GO] 2022―May―24 Duration of replication-competent SARS-CoV-2 shedding among patients with severe or critical coronavirus disease 2019 (COVID-19) Do Young Kim, Michael Y. Lin, Cheryl Jennings, Haiying Li, Jae Hyung Jung, Nicholas M. Moore, et al. (+5)
261 [GO] 2022―May―24 How drivers of seasonality in respiratory infections may impact vaccine strategy: a case study in how COVID-19 may help us solve one of influenza's biggest challenges Eric Lofgren, Elena N. Naumova, Jack Gorski, Yuri Naumov, Nina H. Fefferman
262 [GO] 2022―May―24 PAVING THE WAY TOWARDS PRECISION VACCINOLOGY: THE PARADIGM OF MYOCARDITIS AFTER COVID-19 VACCINATION Theano Lagousi, Ioanna Papadatou, Petros Strempas, Elena Chatzikalil, Vana Spoulou
263 [GO] 2022―May―24 Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults Janna R. Shapiro, Ioannis Sitaras, Han-Sol Park, Tihitina Y. Aytenfisu, Christopher Caputo, Maggie Li, et al. (+21)
264 [GO] 2022―May―24 Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination Amihai Rottenstreich, Olesya Vorontsov, Or Alfi, Gila Zarbiv, Esther Oiknine-Djian, Roy Zigron, et al. (+4)
265 [GO] 2022―May―24 Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study Paolo Corradini, Chiara Agrati, Giovanni Apolone, Alberto Mantovani, Diana Giannarelli, Vincenzo Marasco, et al. (+21)
266 [GO] 2022―May―20 Comparison of influenza and COVID-19-associated hospitalizations among children < 18 years old in the United States-FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021) Miranda J. Delahoy, Dawud Ujamaa, Christopher A. Taylor, Charisse Cummings, Onika Anglin, Rachel Holstein, et al. (+39)
267 [GO] 2022―May―20 Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, July-November 2021 Alison Levin-Rector, Lauren Firestein, Emily McGibbon, Jessica Sell, Sungwoo Lim, Ellen H. Lee, et al. (+4)
268 [GO] 2022―May―17 Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States Mark W. Tenforde, Wesley H. Self, Yuwei Zhu, Eric A. Naioti, Manjusha Gaglani, Adit A. Ginde, et al. (+54)
269 [GO] 2022―May―17 A Single Dose of BNT162b2 mRNA Vaccine Induces Airway Immunity in SARS-CoV-2 Naive and recovered COVID-19 subjects Emanuela MARTINUZZI, Jonathan BENZAQUEN, Olivier GUERIN, Sylvie LEROY, Thomas SIMON, Marius ILIE, et al. (+12)
270 [GO] 2022―May―17 Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial Shmuel Shoham, Evan M Bloch, Arturo Casadevall, Daniel Hanley, Bryan Lau, Kelly Gebo, et al. (+50)
271 [GO] 2022―May―17 Implications of the SARS-CoV-2 pandemic on the epidemiology of pediatric Respiratory Syncytial Virus (RSV) infection Oludare A. Odumade, Simon D. van Haren, Asimenia Angelidou
272 [GO] 2022―May―10 Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients Juliana de Castilhos, Eli Zamir, Theresa Hippchen, Roman Rohrbach, Sabine Schmidt, Silvana Hengler, et al. (+31)
273 [GO] 2022―May―05 SARS-CoV-2: First Human Challenge Study
274 [GO] 2022―May―05 Alpha variant coronavirus outbreak in a nursing home despite high vaccination coverage: molecular, epidemiological and immunological studies Kathrin Zürcher, Irene A Abela, Madlen Stange, Carole Dupont, Catrina Mugglin, Adrian Egli, et al. (+3)
275 [GO] 2022―May―03 Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection Sudeb C. Dalai, Jennifer N. Dines, Thomas M. Snyder, Rachel M. Gittelman, Tera Eerkes, Pashmi Vaney, et al. (+16)
276 [GO] 2022―Apr―26 Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis Harriet Corvol, Sandra de Miranda, Clémence Dehillotte, Lydie Lemonnier, Raphael Chiron, Isabelle Danner-Boucher, et al. (+10)
277 [GO] 2022―Apr―26 Airflow patterns in double occupancy patient rooms may contribute to roommate-to-roommate transmission of severe acute respiratory syndrome coronavirus 2 Jennifer L. Cadnum, Annette L. Jencson, Heba Alhmidi, Trina F. Zabarsky, Curtis J. Donskey
278 [GO] 2022―Apr―23 Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study Thomas Benfield, Jacob Bodilsen, Christian Brieghel, Zitta Barrella Harboe, Marie Helleberg, Claire Holm, et al. (+25)
279 [GO] 2022―Apr―20 Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis Fatema Tuz Zahra, Gabrielle Grubbs, Kirsten Dummer, Adriana H. Tremoulet, Chisato Shimizu, Jane C. Burns, Surender Khurana
280 [GO] 2022―Apr―20 Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial Marisa Holubar, Aruna Subramanian, Natasha Purington, Haley Hedlin, Bryan Bunning, Katharine S. Walter, et al. (+20)
281 [GO] 2022―Apr―19 Comparison of hospitalized COVID-19 and influenza patients requiring supplemental oxygen in a cohort study: clinical impact and resource consumption Inmaculada López Montesinos, Itziar Arrieta-Aldea, Aitor Dicastillo, Flavio Zuccarino, Luisa Sorli, Roberto Guerri-Fernández, et al. (+20)
282 [GO] 2022―Apr―19 Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave Javier T. Solera, Berta G. Árbol, Abdullah Alshahrani, Ilona Bahinskaya, Nikki Marks, Atul Humar, Deepali Kumar
283 [GO] 2022―Apr―19 Enhanced infection-prevention measures including universal N95 usage and daily testing: the impact on SARS-CoV-2 transmission in cohorted hospital cubicles through successive Delta and Omicron waves Wee Liang En, Karrie Kwan-Ki Ko, Edwin Philip Conceicao, May Kyawt Aung, Aung Myat Oo, Yang Yong, et al. (+2)
284 [GO] 2022―Apr―18 Temporal Dynamics of Nasopharyngeal and Tracheal SARS-CoV-2 Cycle Thresholds in COVID-19 Patients with Tracheostomy Sallie M Long, Alexander Chern, Victoria Cooley, Sei Chung, Noah Z. Feit, Arryn Craney, et al. (+2)
285 [GO] 2022―Apr―18 Observations and perspectives on adaptive immunity to SARS-CoV-2 Jennifer Dan, Ricardo da Silva Antunes, Alba Grifoni, Daniela Weiskopf, Shane Crotty, Alessandro Sette
286 [GO] 2022―Apr―18 Effectiveness of Booster mRNA Vaccines against SARS-CoV-2 Infection in Elderly Population, South Korea, October 2021 - January 2022 Jia Kim, Young June Choe, Eun Jung Jang, Do Sang Lim, Yoo-Yeon Kim, Ryu Kyung Kim, et al. (+3)
287 [GO] 2022―Apr―13 Correction to: Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 Patients: A Case Series and Review of the Literature Jorge A Masso-Silva, Alexander Moshensky, Michael T Y Lam, Mazen Odish, Arjun Patel, Le Xu, et al. (+28)
288 [GO] 2022―Apr―12 Associations between SARS-CoV-2 variants and risk of COVID-19 hospitalization among confirmed cases in Washington State: a retrospective cohort study Miguel I. Paredes, Stephanie M. Lunn, Michael Famulare, Lauren A. Frisbie, Ian Painter, Roy Burstein, et al. (+39)
289 [GO] 2022―Apr―12 Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore M Premikha, Calvin J. Chiew, Wycliffe E. Wei, Yee-Sin Leo, Benjamin Ong, David Chien Lye, et al. (+2)
290 [GO] 2022―Apr―12 Investigation of A SARS-CoV-2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis - Maricopa County, Arizona, June-July 2021 Ariella P Dale, Olivia Almendares, Brandon Howard, Eleanor Burnett, Siru Prasai, Melissa Arons, et al. (+10)
291 [GO] 2022―Apr―11 COVID-19 Disease Severity in Children Infected with the Omicron Variant Adeel A. Butt, Soha R. Dargham, Srusvin Loka, Riyazuddin M. Shaik, Hiam Chemaitelly, Patrick Tang, et al. (+13)
292 [GO] 2022―Apr―11 Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data Jack Skeggs, Aleece MacPhail, Tony Korman, Ian Woolley, Jillian SY Lau
293 [GO] 2022―Apr―06 High SARS-CoV-2 household transmission rates detected by dense saliva sampling L M Kolodziej, S F L van Lelyveld, M E Haverkort, R Mariman, J G C Sluiter-Post, P Badoux, et al. (+11)
294 [GO] 2022―Apr―05 SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study Sivan Gazit, Roei Shlezinger, Galit Perez, Roni Lotan, Asaf Peretz, Amir Ben-Tov, et al. (+6)
295 [GO] 2022―Apr―02 Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count Andrea Antinori, Stefania Cicalini, Silvia Meschi, Veronica Bordoni, Patrizia Lorenzini, Alessandra Vergori, et al. (+26)
296 [GO] 2022―Mar―23 Effects of Confounding Bias in COVID-19 and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors Margaret K Doll, Stacy M Pettigrew, Julia Ma, Aman Verma
297 [GO] 2022―Mar―18 SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty® COVID-19 vaccine Estela Giménez, Eliseo Albert, Joao Zulaica, Ignacio Torres, Luciana Rusu, Alicia Rodríguez Moreno, et al. (+12)
298 [GO] 2022―Mar―11 Incidence and prevalence of COVID-19 within a healthcare worker cohort during the first year of the SARS-CoV-2 pandemic Sarah B Doernberg, Marisa Holubar, Vivek Jain, Yingjie Weng, Di Lu, Jenna B Bollyky, et al. (+6)
299 [GO] 2022―Mar―11 Antibody-mediated Immunogenicity against SARS-CoV-2 following priming, boosting and hybrid immunity: insights from 11 months of follow-up of a healthcare worker cohort in Israel, December 2020-October 2021 Michael Edelstein, Karine Wiegler Beiruti, Hila Ben-Amram, Naor Bar-Zeev, Christian Sussan, Hani Asulin, et al. (+4)
300 [GO] 2022―Mar―11 Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals Kathleen M E Gallagher, Mark B Leick, Rebecca C Larson, Trisha R Berger, Katelin Katsis, Jennifer Y Yam, Marcela V Maus
301 [GO] 2022―Mar―09 Existence of immunological memory response in true sero-negative individuals post COVID-19 molecular diagnosis Yaniv Lustig, Ella Mendelson, Michal Mandelboim, Asaf Biber, Einav G Levin, Carmit Cohen, et al. (+2)
302 [GO] 2022―Mar―09 Seroprevalence of SARS-CoV-2 after the second wave in South Africa in HIV-infected and uninfected persons: a cross-sectional household survey Nicole Wolter, Stefano Tempia, Anne von Gottberg, Jinal N Bhiman, Sibongile Walaza, Jackie Kleynhans, et al. (+15)
303 [GO] 2022―Mar―09 Pharmacokinetics of ß-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in non-plasma compartments of patients with SARS-CoV-2 infection Richard FitzGerald, Laura Dickinson, Laura Else, Thomas Fletcher, Colin Hale, Alieu Amara, et al. (+13)
304 [GO] 2022―Mar―09 Predictive value of isolated symptoms for diagnosis of SARS-CoV-2 infection in children tested during peak circulation of the delta variant Adrianna L Westbrook, Laura C Benedit, Jennifer K Frediani, Mark A Griffiths, Nabeel Y Khan, Joshua M Levy, et al. (+10)
305 [GO] 2022―Mar―08 SARS-CoV-2 in exhaled aerosol particles from covid-19 cases and its association to household transmission Malin Alsved, David Nygren, Sara Thuresson, Patrik Medstrand, Carl-Johan Fraenkel, Jakob Löndahl
306 [GO] 2022―Mar―08 Addressing the Elephant in the Room: Intravenous Injection of COVID-19 mRNA Chun Huan Yau, Yoshio Masuda, Qin Xiang Ng, Seth En Teoh
307 [GO] 2022―Mar―08 COVID-19’s Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission Michael Klompas, Meghan Baker, Chanu Rhee
308 [GO] 2022―Mar―08 SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua County, Florida Brittany Rife Magalis, Shannan Rich, Massimiliano S Tagliamonte, Carla Mavian, Melanie N Cash, Alberto Riva, et al. (+16)
309 [GO] 2022―Mar―08 Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak Vincent Chi-Chung Cheng, Jonathan Daniel Ip, Allen Wing-Ho Chu, Anthony Raymond Tam, Wan-Mui Chan, Syed Muhammad Umer Abdullah, et al. (+12)
310 [GO] 2022―Mar―07 Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile M Elvira Balcells, Nicole Le Corre, Josefina Durán, María Elena Ceballos, Cecilia Vizcaya, Sebastián Mondaca, et al. (+20)
311 [GO] 2022―Mar―03 Long-term health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARS-CoV-2 infection in England: Longitudinal analysis and cross-sectional comparison with controls Frank G Sandmann, Elise Tessier, Joanne Lacy, Meaghan Kall, Edwin Van Leeuwen, Andre Charlett, et al. (+7)
312 [GO] 2022―Mar―03 Real-world incidence of breakthrough COVID-19 hospitalization after vaccination versus natural infection in a large, local, empaneled primary care population using time-to-event analysis Benjamin D Pollock, Curtis B Storlie, Aaron J Tande, Priya Sampathkumar
313 [GO] 2022―Mar―03 Age-related changes in the nasopharyngeal microbiome are associated with SARS-CoV-2 infection and symptoms among children, adolescents, and young adults Jillian H Hurst, Alexander W McCumber, Jhoanna N Aquino, Javier Rodriguez, Sarah M Heston, Debra J Lugo, et al. (+10)
314 [GO] 2022―Mar―03 Vaccine Effectiveness of Three vs. Two Doses of SARS-CoV-2 mRNA Vaccines in a High Risk National Population Adeel A Butt, Victor B Talisa, Peng Yan, Obaid S Shaikh, Saad B Omer, Florian B Mayr
315 [GO] 2022―Mar―02 Efficacy of Bacillus Calmette-Guérin vaccination against respiratory tract infections in the elderly during the Covid-19 pandemic Simone J C F M Moorlag, Esther Taks, Thijs ten Doesschate, Thomas W van der Vaart, Axel B Janssen, Lisa Müller, et al. (+15)
316 [GO] 2022―Mar―02 Impact of Multi-Component Support Strategies on HIV Virologic Suppression Rates during COVID-19: An Interrupted Time Series Analysis Matthew A Spinelli, Noelle Le Tourneau, David V Glidden, Ling Hsu, Matthew D Hickey, Elizabeth Imbert, et al. (+8)
317 [GO] 2022―Mar―01 Probable Animal-to-Human Transmission of SARS-CoV-2 Delta Variant AY.127 Causing a Pet Shop-Related COVID-19 Outbreak in Hong Kong Jasper Fuk-Woo Chan, Gilman Kit-Hang Siu, Shuofeng Yuan, Jonathan Daniel Ip, Jian-Piao Cai, Allen Wing-Ho Chu, et al. (+33)
318 [GO] 2022―Mar―01 SARS-CoV-2 placental infection is associated with massive perivillous fibrin deposition at the maternal-fetal interface: a preliminary study" Esin Kotiloglu-Karaa, Beatrix Kele, Raghavendran Kulasegaran-Shylini, Claire E Broad, Dola Owoyemi, Joanne Martin, et al. (+5)
319 [GO] 2022―Mar―01 Antibody response in immunocompromised patients after the administration of SARS-CoV-2 vaccine BNT162b2 or mRNA-1273: A randomised controlled trial Benjamin Speich, Frédérique Chammartin, Irene A Abela, Patrizia Amico, Marcel P Stoeckle, Anna L Eichenberger, et al. (+14)
320 [GO] 2022―Mar―01 Age-Specific Changes in Virulence Associated with SARS-CoV-2 Variants of Concern David N Fisman, Ashleigh R Tuite
321 [GO] 2022―Mar―01 Sustained impact of the COVID-2019 pandemic on HCV treatment initiations in the United States Martin Hoenigl, Daniela Abramovitz, Ricardo E Flores Ortega, Natasha K Martin, Nancy Reau
322 [GO] 2022―Feb―28 Airborne SARS-CoV-2 in hospitals - effects of aerosol-generating procedures, HEPA-filtration units, patient viral load and physical distance Sara Thuresson, Carl-Johan Fraenkel, Sviataslau Sasinovich, Jonathan Soldemyr, Anders Widell, Patrik Medstrand, et al. (+2)
323 [GO] 2022―Feb―28 Mechanically ventilated patients shed high titre live SARS-CoV2 for extended periods from both the upper and lower respiratory tract Zack Saud, Mark Ponsford, Kirsten Bentley, Jade M Cole, Manish Pandey, Stephen Jolles, et al. (+4)
324 [GO] 2022―Feb―25 Bringing Transmission of SARS-CoV-2 to the Surface: Is there a Role for Fomites? Peter Katona, Ravina Kullar, Kevin Zhang
325 [GO] 2022―Feb―24 Erratum to: Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China Yubo Wang, Yong He, Jin Tong, Yalan Qin, Ting Xie, Jianghua Li, et al. (+5)
326 [GO] 2022―Feb―24 Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay George B Sigal, Tanya Novak, Anu Mathew, Janet Chou, Yubo Zhang, Navaratnam Manjula, et al. (+24)
327 [GO] 2022―Feb―24 Trends in SARS-CoV-2 seroprevalence in Massachusetts estimated from newborn screening specimens Kevin C Ma, Jaime E Hale, Yonatan H Grad, Galit Alter, Katherine Luzuriaga, Roger B Eaton, et al. (+9)
328 [GO] 2022―Feb―23 Delayed mortality among solid organ transplant recipients hospitalized for COVID-19 Madeleine R Heldman, Olivia S Kates, Kassem Safa, Camille N Kotton, Ashrit Multani, Sarah J Georgia, et al. (+34)
329 [GO] 2022―Feb―15 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections by intranasal or testicular inoculation induces testicular damage preventable by vaccination in golden Syrian hamsters Can Li, Zhanhong Ye, Anna Jin-Xia Zhang, Jasper Fuk-Woo Chan, Wenchen Song, Feifei Liu, et al. (+13)
330 [GO] 2022―Feb―14 The effect of gestational age at BNT162b2 mRNA vaccination on maternal and neonatal SARS-CoV-2 antibody levels Amihai Rottenstreich, Gila Zarbiv, Esther Oiknine-Djian, Olesya Vorontsov, Roy Zigron, Geffen Kleinstern, et al. (+2)
331 [GO] 2022―Feb―14 Reproduction Numbers of SARS-CoV-2 Variants: A Systematic Review and Meta-analysis Zhanwei Du, Caifen Liu, Chunyu Wang, Lingfeng Xu, Mingda Xu, Lin Wang, et al. (+5)
332 [GO] 2022―Feb―11 Self-Assessed Severity as a Determinant of COVID-19 Symptom Specificity: A Longitudinal Cohort Study Anna Bershteyn, Angela M Dahl, Tracy Q Dong, Meagan E Deming, Connie L Celum, Helen Y Chu, et al. (+20)
333 [GO] 2022―Feb―11 Inequities in COVID-19 vaccination rates among adolescents in Massachusetts: a cross-sectional study David X Gao, Lloyd D Fisher, Donald R Miller, Alan C Geller
334 [GO] 2022―Feb―08 Comparing Covid-19 pandemic waves in hospitalized patients - a retrospective, multicenter, cohort study Yaron Niv, Noa Eliakim-Raz, Yaron Bar-Lavi, Manfred Green, Jacob Dreiher, Amit Hupert, et al. (+10)
335 [GO] 2022―Feb―08 Household transmission of SARS-CoV-2 Alpha variant - United States, 2021 Marisa A P Donnelly, Meagan R Chuey, Raymond Soto, Noah G Schwartz, Victoria T Chu, Stacey L Konkle, et al. (+34)
336 [GO] 2022―Jan―29 A Link Between Obesity and Coronavirus Disease 2019
337 [GO] 2022―Jan―26 Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants Inga Holmdahl, Rebecca Kahn, Kara Jacobs Slifka, Kathleen Dooling, Rachel B Slayton
338 [GO] 2022―Jan―26 Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection - results of a prospective multicenter cohort Carol Strahm, Marco Seneghini, Sabine Güsewell, Thomas Egger, Onicio Leal, Angela Brucher, et al. (+20)
339 [GO] 2022―Jan―25 The direct and indirect effects of the COVID-19 pandemic on private healthcare utilization in South Africa, March 2020 - September 2021 Amanda C Perofsky, Stefano Tempia, Jeremy Bingham, Caroline Maslo, Mande Toubkin, Anchen Laubscher, et al. (+4)
340 [GO] 2022―Jan―24 SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses Jan Lawrenz, Qinya Xie, Fabian Zech, Tatjana Weil, Alina Seidel, Daniela Krnavek, et al. (+4)
341 [GO] 2022―Jan―24 Long Term Accuracy of SARS-CoV-2 Interferon-γ Release Assay and its Application in Household Investigation Kanagavel Murugesan, Prasanna Jagannathan, Jonathan Altamirano, Yvonne A Maldonado, Hector F Bonilla, Karen B Jacobson, et al. (+7)
342 [GO] 2022―Jan―15 Impact of COVID-19 on HIV Preexposure Prophylaxis Prescriptions in the United States - A Time Series Analysis Ya-Lin A Huang, Weiming Zhu, Jeffrey Wiener, Athena P Kourtis, H Irene Hall, Karen W Hoover
343 [GO] 2022―Jan―15 Lower Prevalence of SARS-CoV-2 Infection Among People Experiencing Homelessness Tested in Outdoor Encampments Compared with Overnight Shelters - Denver, Colorado, June - July 2020 Sarah E Rowan, David W McCormick, Karen A Wendel, Tracy Scott, Jesse Chavez-van de Hey, Kay Wilcox, et al. (+4)
344 [GO] 2022―Jan―14 Rapid detection and characterization of SARS-CoV-2 omicron variant in a returning traveler Mary Elizabeth Sexton, Jesse J Waggoner, Ludy R Carmola, Phuong-Vi Nguyen, Ethan Wang, Dara Khosravi, et al. (+14)
345 [GO] 2022―Jan―14 Contributions to the mitigation of the COVID-19 pandemic Stefan Pilz
346 [GO] 2022―Jan―13 Clinical characteristics and outcomes of COVID-19 in pregnant women: a propensity score matched analysis of the data from the COVID-19 Registry Japan Kensuke Shoji, Shinya Tsuzuki, Takayuki Akiyama, Nobuaki Matsunaga, Yusuke Asai, Setsuko Suzuki, et al. (+7)
347 [GO] 2022―Jan―13 Seroprevalence and risk factors for SARS-CoV-2 among incarcerated adult men in Q, Canada (2021) Nadine Kronfli, Camille Dussault, Mathieu Maheu-Giroux, Alexandros Halavrezos, Sylvie Chalifoux, Jessica Sherman, et al. (+5)
348 [GO] 2022―Jan―13 SARS-CoV-2 transmission dynamics and immune responses in a household of vaccinated persons Jamin Liu, Matthew T Laurie, Luis Rubio, Sara E Vazquez, Sara Sunshine, Anthea M Mitchell, et al. (+13)
349 [GO] 2022―Jan―12 Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19 Nabin K Shrestha, Patrick C Burke, Amy S Nowacki, Paul Terpeluk, Steven M Gordon
350 [GO] 2022―Jan―12 Trend in sensitivity of SARS-CoV-2 serology one year after mild and asymptomatic COVID-19: unpacking potential bias in seroprevalence studies Christopher R Bailie, Yeu-Yang Tseng, Louise Carolan, Martyn D Kirk, Suellen Nicholson, Annette Fox, Sheena G Sullivan
351 [GO] 2022―Jan―11 SARS-CoV-2 Environmental contamination in hospital rooms is uncommon using viral culture techniques Bobby G Warren, Alicia Nelson, Aaron Barrett, Bechtler Addison, Amanda Graves, Raquel Binder, et al. (+6)
352 [GO] 2022―Jan―05 Quantifying environmental mitigation of aerosol viral load in a controlled chamber with participants diagnosed with COVID-19 Hooman Parhizkar, Leslie Dietz, Andreas Olsen-Martinez, Patrick F Horve, Liliana Barnatan, Dale Northcutt, Kevin G Van Den Wymelenberg
353 [GO] 2022―Jan―03 COVID-19 mRNA vaccines delay the onset of breakthrough infections with less radiographic abnormalities Xin Li, Jacky Man-Chun Chan, Bosco Lam, David Christopher Lung, Kwok-Cheung Lung, Christina Kin-Yi Chow, et al. (+7)
354 [GO] 2022―Jan―01 Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B.1.1.529 lineage) in international travelers to Japan Taketomo Maruki, Noriko Iwamoto, Kohei Kanda, Nobumasa Okumura, Gen Yamada, Masahiro Ishikane, et al. (+8)
355 [GO] 2021―Dec―31 Compassionate Use of REGEN-COV ® in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders David Stein, Ernesto Oviedo-Orta, Wendy A Kampman, Jennifer McGinniss, George Betts, Margaret McDermott, et al. (+5)
356 [GO] 2021―Dec―22 COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study Shohei Yamamoto, Kenji Maeda, Kouki Matsuda, Akihito Tanaka, Kumi Horii, Kaori Okudera, et al. (+9)
357 [GO] 2021―Dec―20 Predictors of SARS-CoV-2 infection following high-risk exposure Kristin L Andrejko, Jake Pry, Jennifer F Myers, John Openshaw, James Watt, Nozomi Birkett, et al. (+12)
358 [GO] 2021―Dec―18 Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection Harmony L Tyner, Jefferey L Burgess, Lauren Grant, Manjusha Gaglani, Jennifer L Kuntz, Allison L Naleway, et al. (+22)
359 [GO] 2021―Dec―15 Fair Allocation of Scarce Therapies for COVID-19 Govind Persad, Monica E Peek, Seema K Shah
360 [GO] 2021―Dec―15 Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients Lu Lu, Bobo Wing-Yee Mok, Lin-Lei Chen, Jacky Man-Chun Chan, Owen Tak-Yin Tsang, Bosco Hoi-Shiu Lam, et al. (+14)
361 [GO] 2021―Dec―13 Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study Dana Danino, Shalom Ben-Shimol, Bart Adriaan Van Der Beek, Noga Givon-Lavi, Yonat Shemer Avni, David Greenberg, et al. (+2)
362 [GO] 2021―Dec―13 Real-World Effectiveness Of Remdesivir In Adults Hospitalized With Covid-19: A Retrospective, Multicenter Comparative Effectiveness Study Brian T Garibaldi, Kunbo Wang, Matthew L Robinson, Joshua Betz, G Caleb Alexander, Kathleen M Andersen, et al. (+7)
363 [GO] 2021―Dec―09 SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member - Connecticut, July-August 2021 Stephen M Bart, Adora Harizaj, Claire L Pearson, Tiara Conteh, Erin Grogan, Randy Downing, et al. (+4)
364 [GO] 2021―Dec―09 Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV Khadija Khan, Gila Lustig, Mallory Bernstein, Derseree Archary, Sandile Cele, Farina Karim, et al. (+18)
365 [GO] 2021―Dec―09 Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons with Breakthrough SARS-CoV-2 Infection in a High-risk National Population Adeel A Butt, Peng Yan, Obaid S Shaikh, Florian B Mayr, Saad B Omer
366 [GO] 2021―Dec―09 Clinical performance of a standardized SARS-CoV-2 interferon-γ release assay for simple detection of T-cell responses after infection or vaccination Marta Fernández-González, Vanesa Agulló, Sergio Padilla, José Alberto García, Javier García-Abellán, Ángela Botella, et al. (+4)
367 [GO] 2021―Dec―09 Hyperinflammatory syndromes after SARS-CoV-2 mRNA vaccination in individuals with underlying immune dysregulation Joseph M Rocco, Christina Mallarino-Haeger, Attiya H Randolph, Susan M Ray, Marcos C Schechter, Christa S Zerbe, et al. (+2)
368 [GO] 2021―Dec―09 Longitudinal Analysis of Memory T cell Responses in Survivors of Middle East respiratory syndrome Hyoung-Shik Shin, Yeonjae Kim, Jihye Kang, Jihye Um, Jun-Sun Park, Wan Beom Park, et al. (+8)
369 [GO] 2021―Dec―06 Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in COVID-19 Patients Elana R Shaw, Lindsey B Rosen, Aristine Cheng, Kerry Dobbs, Ottavia M Delmonte, Elise M N Ferré, et al. (+7)
370 [GO] 2021―Dec―03 Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study Matthew A Spinelli, Michael J Peluso, Kara L Lynch, Cassandra Yun, David V Glidden, Timothy J Henrich, et al. (+2)
371 [GO] 2021―Dec―01 Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naïve residents of nursing homes Pieter Pannus, Kristof Y Neven, Stéphane De Craeye, Leo Heyndrickx, Sara Vande Kerckhove, Daphnée Georges, et al. (+17)
372 [GO] 2021―Dec―01 Duration of SARS-CoV-2 Natural Immunity and Protection against the Delta Variant: A Retrospective Cohort Study Priscilla Kim, Steven M Gordon, Megan M Sheehan, Michael B Rothberg
373 [GO] 2021―Nov―15 Universal SARS-CoV-2 testing for obstetric inpatient units across the United States Jennifer Gilner, Namita Kansal, Joseph R Biggio, Shani Delaney, Chad A Grotegut, Erica Hardy, et al. (+14)
374 [GO] 2021―Nov―15 Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study Natacha Madelon, Kim Lauper, Gautier Breville, Irène Sabater Royo, Rachel Goldstein, Diego O Andrey, et al. (+8)
375 [GO] 2021―Nov―09 SARS-CoV-2 reinfection associates with unstable housing and occurs in the presence of antibodies David J Bean, Janet Monroe, Jacquelyn Turcinovic, Yvetane Moreau, John H Connor, Manish Sagar
376 [GO] 2021―Nov―01 Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination Yalile Perez, Emily R Levy, Avni Y Joshi, Abinash Virk, Martin Rodriguez-Porcel, Matthew Johnson, et al. (+4)
377 [GO] 2021―Oct―28 The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units Andrew Conway Morris, Katherine Sharrocks, Rachel Bousfield, Leanne Kermack, Mailis Maes, Ellen Higginson, et al. (+15)
378 [GO] 2021―Oct―26 Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study Khitam Muhsen, Nimrod Maimon, Ami Mizrahi, Omri Bodenneimer, Dani Cohen, Michal Maimon, et al. (+2)
379 [GO] 2021―Oct―23 Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare Sarah E Waldman, Tara Buehring, Daniel J Escobar, Shruti K Gohil, Ralph Gonzales, Susan S Huang, et al. (+6)
380 [GO] 2021―Oct―07 Lack of Antinuclear Antibodies in Convalescent COVID-19 Patients with Persistent Symptoms Michael J Peluso, Isaac J Thomas, Sadie E Munter, Steven G Deeks, Timothy J Henrich
381 [GO] 2021―Sep―30 Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2-specific monoclonal antibodies Benoit Bailly, Helene Péré, David Veyer, Ana Berceanu,  Etienne Daguindau, Pauline Roux, et al. (+17)
382 [GO] 2021―Sep―30 Changing patterns of bloodstream infections in the community and acute care across two COVID-19 epidemic waves: a retrospective analysis using data linkage Nina Zhu, Timothy M Rawson, Siddharth Mookerjee, James R Price, Frances Davies, Jonathan Otter, et al. (+5)
383 [GO] 2021―Sep―30 Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort Essy Mozaffari, Aastha Chandak, Zhiji Zhang, Shuting Liang, Mark Thrun, Robert L Gottlieb, et al. (+6)
384 [GO] 2021―Sep―29 Corrigendum to: Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates Rita Jaafar, Sarah Aherfi, Nathalie Wurtz, Clio Grimaldier, Van Thuan Hoang, Philippe Colson, et al. (+2)
385 [GO] 2021―Sep―22 Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies Omar Hasan Ali, David Bomze, Lorenz Risch, Silvio D Brugger, Matthias Paprotny, Myriam Weber, et al. (+13)
386 [GO] 2021―Sep―21 WHO guidance to support HIV care models during the Covid-19 era Nathan Ford, Marco Vitoria, Meg Doherty
387 [GO] 2021―Sep―21 Safety and immunogenicity of a recombinant adenovirus type-5-vectored COVID-19 vaccine with a homologous prime-boost regimen in healthy participants aged 6 years and above: a randomised, double-blind, placebo-controlled, phase 2b trial Fengcai Zhu, Pengfei Jin, Tao Zhu, Wenjuan Wang, Huayue Ye, Hongxing Pan, et al. (+10)
388 [GO] 2021―Sep―21 Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters Charles B Stauft, Million Tegenge, Surender Khurana, Youri Lee, Prabhuanand Selvaraj, Hana Golding, et al. (+2)
389 [GO] 2021―Sep―20 Prior infection and age impacts antibody persistence after SARS-CoV-2 mRNA vaccine Elizabeth Fraley, Cas LeMaster, Santosh Khanal, Dithi Banerjee, Tomi Pastinen, Elin Grundberg, et al. (+2)
390 [GO] 2021―Sep―20 Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis Charles Whittaker, Oliver J Watson, Carlos Alvarez-Moreno, Nasikarn Angkasekwinai, Adhiratha Boonyasiri, Luis Carlos Triana, et al. (+47)
391 [GO] 2021―Sep―17 Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters Jasper Fuk-Woo Chan, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Kenn Ka-Heng Chik, Jessica Oi-Ling Tsang, Zijiao Zou, et al. (+21)
392 [GO] 2021―Sep―16 Outcome heterogeneity in COVID-19 patients receiving tocilizumab Man Man Niu, Yue Cao, Rui Xue Li, Guo Zhen Fan, Peng Hu
393 [GO] 2021―Sep―15 Is COVID-19 Less Deadly Now? -- Trends of In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States Rena C Moon, Rachel H Mackey, Zhun Cao, Seth Emont, Laura L Schott, Julie Gayle, et al. (+2)
394 [GO] 2021―Sep―13 Randomized study of rivaroxaban vs. placebo on disease progression and symptoms resolution in high-risk adults with mild COVID-19 Jintanat Ananworanich, Robin Mogg, Michael W Dunne, Mohamed Bassyouni, Consuela Vera David, Erika Gonzalez, et al. (+5)
395 [GO] 2021―Sep―10 Reinfections are more frequent than currently considered in countries with high incidence of COVID-19 cases due to stringent definitions Luis Pampa-Espinoza, Javier Silva-Valencia, Manuel Fernández, Carlos Padilla-Rojas, Lely Solari
396 [GO] 2021―Sep―09 Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study Joshua A Barocas, Alexandra Savinkina, Sara Lodi, Rachel L Epstein, Tara C Bouton, Heather Sperring, et al. (+5)
397 [GO] 2021―Sep―08 False COVID-19 cases due to contamination by inactivated virus vaccine Kelvin Kai-Wang To, Xin Li, David Christopher Lung, Jonathan Daniel Ip, Wan-Mui Chan, Allen Wing-Ho Chu, et al. (+12)
398 [GO] 2021―Sep―06 Severity of SARS-CoV-2 alpha variant (B.1.1.7) in England Daniel J Grint, Kevin Wing, Catherine Houlihan, Hamish P Gibbs, Stephen J W Evans, Elizabeth Williamson, et al. (+31)
399 [GO] 2021―Sep―02 Evolution of COVID-19 symptoms during the first 12 months after illness onset Elke Wynberg, Hugo D G van Willigen, Maartje Dijkstra, Anders Boyd, Neeltje A Kootstra, Joost G van den Aardweg, et al. (+7)
400 [GO] 2021―Sep―02 Rapid emergence and spread of SARS-CoV-2 gamma (P.1) variant in Haiti Massimiliano S Tagliamonte, Carla Mavian, Kayvan Zainabadi, Melanie N Cash, John A Lednicky, Brittany Rife Magalis, et al. (+8)
401 [GO] 2021―Sep―02 Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave Jumari Snyman, Shi-Hsia Hwa, Robert Krause, Daniel Muema, Tarylee Reddy, Yashica Ganga, et al. (+4)
402 [GO] 2021―Sep―02 Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021 Kenneth A Feder, Ami Patel, Venkata R Vepachedu, Catherine Dominguez, Eric N Keller, Liore Klein, et al. (+11)
403 [GO] 2021―Sep―01 Health Care Personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization Jana Shaw, Samantha Hanley, Telisa Stewart, Daniel A Salmon, Christine Ortiz, Paula M Trief, et al. (+4)
404 [GO] 2021―Aug―31 Latino Household Transmission of SARS-CoV-2 Diego A Martinez, Eili Y Klein, Cassandra Parent, Diana Prieto, Benjamin F Bigelow, Ronald E Saxton, Kathleen R Page
405 [GO] 2021―Aug―30 Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Q, Canada Sara Carazo, Denis Talbot, Nicole Boulianne, Marc Brisson, Rodica Gilca, Geneviève Deceuninck, et al. (+10)
406 [GO] 2021―Aug―28 Estimating the latent period of coronavirus disease 2019 (COVID-19) Hualei Xin, Yu Li, Peng Wu, Zhili Li, Eric H Y Lau, Ying Qin, et al. (+4)
407 [GO] 2021―Aug―28 It’s hard to measure success while caring for surges in COVID-19 hospitalizations Lindsey Gottlieb, Scott K Fridkin
408 [GO] 2021―Aug―28 Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis? Kirk U Knowlton
409 [GO] 2021―Aug―28 SARS-CoV-2 Reinfection: A Case Series from a 12-Month Longitudinal Occupational Cohort Christina D Mack, Caroline Tai, Robby Sikka, Yonatan H Grad, Lisa L Maragakis, Nathan D Grubaugh, et al. (+8)
410 [GO] 2021―Aug―21 Undetected and relatively sustained SARS-CoV-2 circulation worldwide during the year 2019 Stefano Petti
411 [GO] 2021―Aug―21 Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta) Sean Wei Xiang Ong, Calvin J Chiew, Li Wei Ang, Tze-Minn Mak, Lin Cui, Matthias Paul H S Toh, et al. (+10)
412 [GO] 2021―Aug―20 COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease Shivakumar Narayanan, Joel V Chua, John W Baddley
413 [GO] 2021―Aug―20 Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered with dexamethasone Carlos K H Wong, Kristy T K Lau, Ivan C H Au, Xi Xiong, Matthew S H Chung, Eric H Y Lau, Benjamin J Cowling
414 [GO] 2021―Aug―17 Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model Can Li, Yanxia Chen, Yan Zhao, David Christopher Lung, Zhanhong Ye, Wenchen Song, et al. (+13)
415 [GO] 2021―Aug―17 Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization Jonathan Fintzi, Tyler Bonnett, Daniel A Sweeney, Nikhil A Huprikar, Anuradha Ganesan, Maria G Frank, et al. (+4)
416 [GO] 2021―Aug―17 Post-vaccination COVID-19: A case-control study and genomic analysis of 119 breakthrough infections in partially vaccinated individuals Ioannis Baltas, Florencia A T Boshier, Charlotte A Williams, Nadua Bayzid, Marius Cotic, José Afonso Guerra-Assunção, et al. (+7)
417 [GO] 2021―Aug―17 Incidence, Clinical Characteristics, and Risk Factors of SARS-CoV-2 Infection among Pregnant Individuals in the United States Fatimah S Dawood, Michael Varner, Alan Tita, Gabriella Newes-Adeyi, Cynthia Gyamfi-Bannerman, Ashley Battarbee, et al. (+17)
418 [GO] 2021―Aug―17 Clinical spectrum of SARS-CoV-2 infection and protection from symptomatic re-infection Hannah E Maier, Guillermina Kuan, Saira Saborio, Fausto Andres Bustos Carrillo, Miguel Plazaola, Carlos Barilla, et al. (+13)
419 [GO] 2021―Aug―17 Pre-Hospital Administration of Remdesivir during a SARS-CoV-2 Outbreak in a Skilled Nursing Facility Megan A Dunay, Sarah L McClain, Rick L Holloway, Sarah L W Norris, Talie Bendixsen Randall, Caitlin E Mohr, et al. (+3)
420 [GO] 2021―Aug―13 Twelve-month systemic consequences of COVID-19 in patients discharged from hospital: a prospective cohort study in Wuhan, China Tingting Liu, Di Wu, Weiming Yan, Xiaojing Wang, Xiaoyun Zhang, Ke Ma, et al. (+21)
421 [GO] 2021―Aug―11 Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2 Chloé Dimeglio, Fabrice Herin, Isabelle Da-Silva, Isabelle Jougla, Claire Pradere, Marion Porcheron, et al. (+3)
422 [GO] 2021―Aug―11 Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color Carla Cerami, Zachary R Popkin-Hall, Tyler Rapp, Kathleen Tompkins, Haoming Zhang, Meredith S Muller, et al. (+17)
423 [GO] 2021―Aug―11 Incidence, clinical presentation, relapses and outcome of SARS-CoV-2 infection in patients treated with anti-CD20 monoclonal antibodies Jorge Calderón-Parra, Elena Múñez-Rubio, Ana Fernández-Cruz, María Cristina García Sánchez, Esther Maderuelo-González, Marcos López-Dosil, et al. (+4)
424 [GO] 2021―Aug―10 Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data Catharine I Paules, Shannon K Gallagher, Rekha R Rapaka, Richard T Davey, Sarah B Doernberg, Robert Grossberg, et al. (+10)
425 [GO] 2021―Aug―09 SARS-CoV-2 Viremia is Associated with COVID-19 Severity and Predicts Clinical Outcomes Jana L Jacobs, William Bain, Asma Naqvi, Brittany Staines, Priscila M S Castanha, Haopu Yang, et al. (+21)
426 [GO] 2021―Aug―09 Improvements in SARS-CoV-2 Testing Cascade in the US: Data from Serial Cross-sectional Assessments Steven J Clipman, Amy Wesolowski, Shruti H Mehta, Sarah Cobey, Derek A T Cummings, Sunil S Solomon
427 [GO] 2021―Aug―08 The Impact of COVID-19 on Healthcare-Associated Infections Meghan A Baker, Kenneth E Sands, Susan S Huang, Ken Kleinman, Edward J Septimus, Neha Varma, et al. (+15)
428 [GO] 2021―Aug―06 Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing Kristen K Coleman, Douglas Jie Wen Tay, Kai Sen Tan, Sean Wei Xiang Ong, Than The Son, Ming Hui Koh, et al. (+9)
429 [GO] 2021―Aug―05 Suspected SARS-CoV-2 Reinfections: Incidence, Predictors, and Healthcare Use among Patients at 238 U.S. Healthcare Facilities, June 1, 2020- February 28, 2021 Alexander Lawandi, Sarah Warner, Junfeng Sun, Cumhur Y Demirkale, Robert L Danner, Michael Klompas, et al. (+6)
430 [GO] 2021―Aug―05 Effect of ivermectin in the treatment of COVID-19: A trial sequential analysis highlighted the requirement of additional randomized controlled trials Sunali Padhi, Abhijit Pati, Aditya K Panda
431 [GO] 2021―Aug―05 Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for the treatment of coronavirus disease Masahiro Banno, Yasushi Tsujimoto, Masahiro Ishikane
432 [GO] 2021―Aug―04 Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States Mark W Tenforde, Manish M Patel, Adit A Ginde, David J Douin, H Keipp Talbot, Jonathan D Casey, et al. (+51)
433 [GO] 2021―Aug―02 Improving Pandemic Response: Employing Mathematical Modeling to Confront COVID-19 Matthew Biggerstaff, Rachel B Slayton, Michael A Johansson, Jay C Butler
434 [GO] 2021―Aug―02 Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (β) in an elderly nursing home Slim Fourati, Benoit Bailly, Anne Le Bouter, Luc Guilpain, Christophe Rodriguez, Jean-Michel Pawlotsky
435 [GO] 2021―Jul―28 Risk of Healthcare-Associated Transmission of SARS-CoV-2 in Hospitalized Cancer Patients Karin Chow, Anoshe Aslam, Tara McClure, Jessica Singh, Jacquelyn Burns, Tracy McMillen, et al. (+6)
436 [GO] 2021―Jul―27 Epidemiology and risk of COVID-19 among travelers at airport and port quarantine stations across Japan: a nationwide descriptive analysis and an individually matched case-control study Motoyuki Tsuboi, Masahiko Hachiya, Hiroshi Ohtsu, Hidechika Akashi, Chiaki Miyoshi, Tamami Umeda
437 [GO] 2021―Jul―26 Leveraging a preexisting global infectious disease network for local decision-making during a pandemic Jocelyn J Herstein, John J Lowe, Timo Wolf, Shawn Vasoo, Yee Sin Leo, BumSik Chin, et al. (+3)
438 [GO] 2021―Jul―23 COVID-19 Outbreak Associated with a Fitness Center - Minnesota, September-November 2020 Tara Suhs, Daniel Gerlach, Jacob Garfin, Alexandra Lorentz, Melanie Firestone, Meghan Sherden, et al. (+10)
439 [GO] 2021―Jul―23 Atypical severe organizing pneumonia following COVID-19 in an immunocompromised teenager Harriet Corvol, Aurelia Alimi, Blandine Prevost, Aurélie Schnuriger, Hubert Ducou Le Pointe, Jérome Rambaud, Marie-Dominique Tabone
440 [GO] 2021―Jul―23 Impact of SARS-CoV-2 variant-associated RBD mutations on the susceptibility to serum antibodies elicited by COVID-19 infection or vaccination Lin-Lei Chen, Lu Lu, Charlotte Yee-Ki Choi, Jian-Piao Cai, Hoi-Wah Tsoi, Allen Wing-Ho Chu, et al. (+14)
441 [GO] 2021―Jul―23 Neutralizing antibodies against SARS-CoV-2 variants induced by natural infection or vaccination: a systematic review and pooled meta-analysis Xinhua Chen, Zhiyuan Chen, Andrew S Azman, Ruijia Sun, Wanying Lu, Nan Zheng, et al. (+9)
442 [GO] 2021―Jul―21 Effects of treatment of COVID-19 with convalescent plasma in 25 B-cell depleted patients Arvind Gharbharan, Corine H GeurtsvanKessel, Carlijn C E Jordans, Marc Blaauw, Marjolein van der Klift, Robert-Jan Hassing, et al. (+11)
443 [GO] 2021―Jul―20 Prevention of COVID-19 by mRNA-based vaccines within the general population of California Kristin L Andrejko, Jake Pry, Jennifer F Myers, Nicholas P Jewell, John Openshaw, James Watt, et al. (+2)
444 [GO] 2021―Jul―15 The Value of Medical Registries and Observational Studies Early in Pandemics: The COVID-19 Experience Somaya Albhaisi, Richard P Wenzel
445 [GO] 2021―Jul―15 An Update on SARS-CoV-2 Diversity in the United States National Capital Region: Evolution of Novel and Variants of Concern C Paul Morris, Chun Huai Luo, Adannaya Amadi, Matthew Schwartz, Nicholas Gallagher, Stuart C Ray, et al. (+2)
446 [GO] 2021―Jul―14 Clinical improvement, outcomes, antiviral activity, and costs associated with early treatment with remdesivir for patients with COVID-19 Carlos K H Wong, Kristy T K Lau, Ivan C H Au, Xi Xiong, Eric H Y Lau, Benjamin J Cowling
447 [GO] 2021―Jul―14 Candidemia and Severe COVID-19 - Which Risk Factors are Modifiable? Todd McCarty
448 [GO] 2021―Jul―13 Deliberation, Dissent, and Distrust: Understanding distinct drivers of COVID-19 vaccine hesitancy in the United States Khai Hoan Tram, Sahar Saeed, Cory Bradley, Branson Fox, Ingrid Eshun-Wilson, Aaloke Mody, Elvin Geng
449 [GO] 2021―Jul―13 Evaluating Vaccine Efficacy Against SARS-CoV-2 Infection Dan-Yu Lin, Yu Gu, Donglin Zeng, Holly E Janes, Peter B Gilbert
450 [GO] 2021―Jul―09 Sequential Dengue and Covid-19. A case of viral Dr. Jekyll or Mr. Hyde? Jaime R Torres
451 [GO] 2021―Jul―08 Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival Upasana Das Adhikari, George Eng, Mara Farcasanu, Laura E Avena, Manish C Choudhary, Virginia A Triant, et al. (+18)
452 [GO] 2021―Jul―08 SARS-CoV-2 cumulative incidence, United States, August-December 2020 Patrick Sean Sullivan, Aaron J Siegler, Kayoko Shioda, Eric W Hall, Heather Bradley, Travis Sanchez, et al. (+7)
453 [GO] 2021―Jul―08 Single-dose mRNA vaccine effectiveness against SARS-CoV-2, including Alpha and Gamma variants: a test-negative design in adults 70 years and older in British Columbia, Canada Danuta M Skowronski, Solmaz Setayeshgar, Macy Zou, Natalie Prystajecky, John R Tyson, Eleni Galanis, et al. (+9)
454 [GO] 2021―Jul―07 COVID-19 Outbreak Associated with a SARS-CoV-2 P.1 Lineage in a Long-Term Care Home after Implementation of a Vaccination Program - Ontario, April-May 2021 Chantal Williams, Dana Al-Bargash, Celeste Macalintal, Rebecca Stuart, Anu Seth, Julienne Latham, et al. (+9)
455 [GO] 2021―Jul―02 Long-Term Persistence of Spike Antibody and Predictive Modeling of Antibody Dynamics Following Infection with SARS-CoV-2 Louis Grandjean, Anja Saso, Arturo Torres Ortiz, Tanya Lam, James Hatcher, Rosie Thistlethwayte, et al. (+11)
456 [GO] 2021―Jul―01 Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study Jessica Seeßle, Tim Waterboer, Theresa Hippchen, Julia Simon, Marietta Kirchner, Adeline Lim, et al. (+2)
457 [GO] 2021―Jul―01 An observational cohort study on the incidence of SARS-CoV-2 infection and B.1.1.7 variant infection in healthcare workers by antibody and vaccination status Sheila F Lumley, Gillian Rodger, Bede Constantinides, Nicholas Sanderson, Kevin K Chau, Teresa L Street, et al. (+31)
458 [GO] 2021―Jun―29 Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study Issaka Sagara, John Woodford, Mamady Kone, Mahamadoun Hamady Assadou, Abdoulaye Katile, Oumar Attaher, et al. (+12)
459 [GO] 2021―Jun―26 Erratum to: Stop COVID Cohort: An Observational Study of 3480 Patients Admitted to the Sechenov University Hospital Network in Moscow City for Suspected Coronavirus Disease 2019 (COVID-19) Infection Anna Berbenyuk, Polina Bobkova, Semyon Bordyugov, Aleksandra Borisenko, Ekaterina Bugaiskaya, Olesya Druzhkova, et al. (+29)
460 [GO] 2021―Jun―25 Ivermectin for the treatment of COVID-19: A systematic review and meta-analysis of randomized controlled trials Yuani M Roman, Paula Alejandra Burela, Vinay Pasupuleti, Alejandro Piscoya, Jose E Vidal, Adrian V Hernandez
461 [GO] 2021―Jun―25 Characterization of SARS-CoV-2 infection clusters based on integrated genomic surveillance, outbreak analysis and contact tracing in an urban setting Andreas Walker, Torsten Houwaart, Patrick Finzer, Lutz Ehlkes, Alona Tyshaieva, Maximilian Damagnez, et al. (+19)
462 [GO] 2021―Jun―25 Extensive SARS-CoV-2 transmission associated with low mortality in Kinshasa, Democratic Republic of Congo. For how long? Robert Colebunders, Chris Kenyon
463 [GO] 2021―Jun―23 Variants of concern are overrepresented among post-vaccination breakthrough infections of SARS-CoV-2 in Washington State Abbye E McEwen, Seth Cohen, Chloe Bryson-Cahn, Catherine Liu, Steven A Pergam, John Lynch, et al. (+15)
464 [GO] 2021―Jun―22 Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience John Paul Verderese, Maria Stepanova, Brian Lam, Andrei Racila, Andrej Kolacevski, David Allen, et al. (+12)
465 [GO] 2021―Jun―22 Chronic asymptomatic SARS-CoV-2 infection in the immunocompromised patient: new challenges and urgent needs Lorenzo Lodi, Maria Moriondo, Alessandra Pucci, Laura Pisano, Silvia Ricci, Giuseppe Indolfi, Chiara Azzari
466 [GO] 2021―Jun―22 Poor Antibody Response after Two Doses of SARS-CoV-2 vaccine in Transplant Recipients Alessandra Mazzola, Eve Todesco, Sarah Drouin, Fanny Hazan, Stéphane Marot, Dominique Thabut, et al. (+5)
467 [GO] 2021―Jun―21 Comprehensive evaluation of the impact of sociodemographic inequalities on adverse outcomes and excess mortality during the COVID-19 pandemic in Mexico City Neftali Eduardo Antonio-Villa, Luisa Fernandez-Chirino, Julio Pisanty-Alatorre, Javier Mancilla-Galindo, Ashuin Kammar-García, Arsenio Vargas-Vázquez, et al. (+10)
468 [GO] 2021―Jun―21 Strong SARS-CoV-2-neutralizing antibody response of previously-infected healthcare workers given one dose of mRNA vaccine Chloé Dimeglio, Fabrice Herin, Isabelle Da-Silva, Marion Porcheron, Guillaume Martin-Blondel, Marcel Miedougé, Jacques Izopet
469 [GO] 2021―Jun―17 The landscape of candidemia during the COVID-19 pandemic Emma E Seagle, Brendan R Jackson, Shawn R Lockhart, Ourania Georgacopoulos, Natalie S Nunnally, Jeremy Roland, et al. (+14)
470 [GO] 2021―Jun―17 The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center Abraar Karan, Michael Klompas, Robert Tucker, Meghan Baker, Vineeta Vaidya, Chanu Rhee
471 [GO] 2021―Jun―17 Children and SARS-CoV-2 transmission: a step closer to better understanding and evidence-based interventions? Danilo Buonsenso, Piero Valentini
472 [GO] 2021―Jun―16 Post-vaccination SARS-CoV-2 infections and incidence of presumptive B.1.427/B.1.429 variant among healthcare personnel at a northern California academic medical center Karen B Jacobson, Benjamin A Pinsky, Maria E Montez Rath, Hannah Wang, Jacob A Miller, Mehdi Skhiri, et al. (+6)
473 [GO] 2021―Jun―15 The risk of symptomatic infection during a second COVID-19 wave, in SARS-CoV-2 seropositive individuals Mattia Manica, Serena Pancheri, Piero Poletti, Giulia Giovanazzi, Giorgio Guzzetta, Filippo Trentini, et al. (+6)
474 [GO] 2021―Jun―14 Humoral and cellular immune responses against SARS-CoV-2 variants and human coronaviruses after single BNT162b2 vaccination Metodi V Stankov, Anne Cossmann, Agnes Bonifacius, Alexandra Dopfer-Jablonka, Gema Morillas Ramos, Nina Gödecke, et al. (+15)
475 [GO] 2021―Jun―10 The SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity Simon D Pollett, Stephanie A Richard, Anthony C Fries, Mark P Simons, Katrin Mende, Tahaniyat Lalani, et al. (+15)
476 [GO] 2021―Jun―08 The Effect of Neutropenia and Filgrastim (G-CSF) in Cancer Patients With COVID-19 Infection Allen W Zhang, Sejal Morjaria, Anna Kaltsas, Tobias M Hohl, Rekha Parameswaran, Dhruvkumar Patel, et al. (+7)
477 [GO] 2021―Jun―08 Universal Use of N95s in Healthcare Settings when Community Covid-19 Rates are High Michael Klompas, Chanu Rhee, Meghan Baker
478 [GO] 2021―Jun―08 Improved survival among hospitalized patients with COVID-19 treated with remdesivir and dexamethasone. A nationwide population-based cohort study Thomas Benfield, Jacob Bodilsen, Christian Brieghel, Zitta Barrella Harboe, Marie Helleberg, Claire Holm, et al. (+25)
479 [GO] 2021―Jun―08 Use of U.S. Blood Donors for National Serosurveillance of SARS-CoV-2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program Mars Stone, Clara Di Germanio, David J Wright, Hasan Sulaeman, Honey Dave, Rebecca V Fink, et al. (+13)
480 [GO] 2021―Jun―04 High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey Antoine N Nkuba, Sheila M Makiala, Emilande Guichet, Paul M Tshiminyi, Yannick M Bazitama, Marc K Yambayamba, et al. (+17)
481 [GO] 2021―Jun―04 Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes Rebecca Kahn, Inga Holmdahl, Sujan Reddy, John Jernigan, Michael J Mina, Rachel B Slayton
482 [GO] 2021―Jun―04 Reporting of Infectious Diseases in the United States During the COVID-19 Pandemic Matthew A Crane, Aleksandra Popovic, Rohan Panaparambil, Andrew I Stolbach, John A Romley, Khalil G Ghanem
483 [GO] 2021―Jun―03 Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients with COVID-19 Jeffrey D Jenks, Saima Aslam, Lucy E Horton, Nancy Law, Ajay Bharti, Cathy Logan, et al. (+3)
484 [GO] 2021―Jun―03 Adverse Outcomes Associated with SARS-CoV-2 variant B.1.351 Infection in Vaccinated Residents of a Long Term Care Home, Ontario, Canada Ahmed Vanker, Allison McGeer, Gray O’Byrne, Ellen C R Snyder, David A Salisbury, Jennifer L Guthrie, et al. (+3)
485 [GO] 2021―Jun―03 Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 SARS-CoV2 Vaccine (Moderna) in a Cohort of Hospital Employees Mark A Jacobson, Adam Zakaria, Zaw Maung, Colin Hart, Tim McCalmont, Marlys Fassett, Erin Amerson
486 [GO] 2021―Jun―02 The potential declining efficacy of the ChAdOx1 nCoV-19 vaccine(AZD1222) on inoculators with NSAIDs intake Hsin-Fu Yeh
487 [GO] 2021―May―29 Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators H Keipp Talbot, Emily T Martin, Manjusha Gaglani, Donald B Middleton, Shekhar Ghamande, Fernanda P Silveira, et al. (+46)
488 [GO] 2021―May―27 Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers Stéphane Marot, Isabelle Malet, Valentin Leducq, Basma Abdi, Elisa Teyssou, Cathia Soulie, et al. (+9)
489 [GO] 2021―May―27 Provider Satisfaction with Infectious Diseases Telemedicine Consults for Hospitalized Patients During the COVID-19 Pandemic Joseph E Canterino, Kaicheng Wang, Marjorie Golden
490 [GO] 2021―May―27 Outpatient Treatment of SARS-CoV-2 Infection to Prevent COVID-19 Progression Myron S Cohen, David A Wohl, William A Fischer, David J Smith, Joseph J Eron
491 [GO] 2021―May―26 Risk Factors for Death Among the First 80 543 COVID-19 Cases in China: Relationships Between Age, Underlying Disease, Case Severity, and Region Yanping Zhang, Wei Luo, Qun Li, Xijie Wang, Jin Chen, Qinfeng Song, et al. (+27)
492 [GO] 2021―May―25 Risk of reinfection after seroconversion to SARS-CoV-2: A population-based propensity-score matched cohort study Antonio Leidi, Flora Koegler, Roxane Dumont, Richard Dubos, María-Eugenia Zaballa, Giovanni Piumatti, et al. (+10)
493 [GO] 2021―May―24 Disparities in COVID-19 outcomes for African Americans: more studies are warranted Shiva Mehravaran, Hussien Ahmed, Yun-Chi Chen
494 [GO] 2021―May―24 Serial intervals and case isolation delays for COVID-19: a systematic review and meta-analysis Sheikh Taslim Ali, Amy Yeung, Songwei Shan, Lin Wang, Huizhi Gao, Zhanwei Du, et al. (+4)
495 [GO] 2021―May―05 Risk Factors For Infection And Health Impacts Of The Covid-19 Pandemic In People With Autoimmune Diseases Kathryn C Fitzgerald, Christopher A Mecoli, Morgan Douglas, Samantha Harris, Berna Aravidis, Jemima Albayda, et al. (+28)
496 [GO] 2021―May―05 Role of epithelial-endothelial cell interaction in the pathogenesis of SARS-CoV-2 infection Kenrie Pui-Yan Hui, Man-Chun Cheung, Ka-Ling Lai, Ka-Chun Ng, John Chi-Wang Ho, Malik Peiris, et al. (+2)
497 [GO] 2021―May―04 Interacting Epidemics in Amazonian Brazil: Prior Dengue Infection Associated with Increased COVID-19 Risk in a Population-Based Cohort Study Vanessa C Nicolete, Priscila T Rodrigues, Igor C Johansen, Rodrigo M Corder, Juliana Tonini, Marly A Cardoso, et al. (+6)
498 [GO] 2021―May―04 Combination therapy with tocilizumab and dexamethasone cost-effectively reduces Coronavirus disease 2019 mortality Pranay Sinha, Benjamin P Linas
499 [GO] 2021―Apr―27 Pre-market development times for innovative vaccines - to what extent are the COVID-19 vaccines outliers? Reed F Beall, Aaron S Kesselheim, Aidan Hollis
500 [GO] 2021―Apr―23 Re-infection with SARS-CoV-2 in Patients Undergoing Serial Laboratory Testing Adnan I Qureshi, William I Baskett, Wei Huang, Iryna Lobanova, S Hasan Naqvi, Chi-Ren Shyu
501 [GO] 2021―Apr―23 Substantial decline in invasive pneumococcal disease (IPD) during COVID-19 pandemic in Hong Kong Jade L L Teng, Kenny M N Fok, Ken P K Lin, Elaine Chan, Yuanchao Ma, Susanna K P Lau, Patrick C Y Woo
502 [GO] 2021―Apr―23 SARS-CoV-2 Sequence Characteristics of COVID-19 Persistence and Reinfection Manish C Choudhary, Charles R Crain, Xueting Qiu, William Hanage, Jonathan Z Li
503 [GO] 2021―Apr―23 Vaccinated and convalescent donor-derived SARS-CoV-2-specific T cells as adoptive immunotherapy for high-risk COVID-19 patients Penelope-Georgia Papayanni, Dimitrios Chasiotis, Kiriakos Koukoulias, Aphrodite Georgakopoulou, Anastasia Iatrou, Eleni Gavriilaki, et al. (+15)
504 [GO] 2021―Apr―23 Household exposure to SARS-CoV-2 and association with COVID-19 severity: a Danish nationwide cohort study Marcella M Broccia, Victoria Elizabeth V E, de Knegt, Elisabeth Helen Anna E H A, Mills, Amalie Lykkemark A L Møller, et al. (+17)
505 [GO] 2021―Apr―23 Effectiveness of mRNA COVID-19 vaccines against SARS-CoV-2 infection in a cohort of healthcare personnel Melanie D Swift, Laura E Breeher, Aaron J Tande, Christopher P Tommaso, Caitlin M Hainy, Haitao Chu, et al. (+3)
506 [GO] 2021―Apr―23 Disease severity and durability of the SARS-CoV-2 antibody response: A view through the lens of the second year of the pandemic Liise-anne Pirofski
507 [GO] 2021―Apr―22 Assess Ventilation When Determining Safe Distancing in Schools to Control COVID-19 Transmission Richard M Lynch, Elissa Favata, Michael Gochfeld
508 [GO] 2021―Apr―16 SARS-CoV-2 transmission in a Georgia school district - United States, December 2020-January 2021 Jenna R Gettings, Jeremy A W Gold, Anne Kimball, Kaitlin Forsberg, Colleen Scott, Anna Uehara, et al. (+44)
509 [GO] 2021―Apr―07 Ultra-sensitive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection for the Diagnosis of Coronavirus Disease 2019 (COVID-19) in Upper Respiratory Samples Hannah Wang, Catherine A Hogan, Michelle Verghese, Daniel Solis, Mamdouh Sibai, ChunHong Huang, et al. (+3)
510 [GO] 2021―Mar―30 Estimation of secondary household attack rates for emergent spike L452R SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco James Peng, Jamin Liu, Sabrina A Mann, Anthea M Mitchell, Matthew T Laurie, Sara Sunshine, et al. (+23)
511 [GO] 2021―Mar―29 Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) among Health Care Workers-Zambia, July 2020 Sombo Fwoloshi, Jonas Z Hines, Danielle T Barradas, Samuel Yingst, Mpanji Siwingwa, Lameck Chirwa, et al. (+23)
512 [GO] 2021―Mar―24 Assessing asymptomatic, pre-symptomatic and symptomatic transmission risk of SARS-CoV-2 Peng Wu, Fengfeng Liu, Zhaorui Chang, Yun Lin, Minrui Ren, Canjun Zheng, et al. (+16)
513 [GO] 2021―Mar―24 Associations between measures of social distancing and SARS-CoV-2 seropositivity: a nationwide population-based study in the Netherlands Eric R A Vos, Michiel van Boven, Gerco den Hartog, Jantien A Backer, Don Klinkenberg, Cheyenne C E van Hagen, et al. (+5)
514 [GO] 2021―Mar―23 The essential role of DSMBs in ensuring the ethics of global vaccine trials to address COVID-19 Lisa Eckstein, Annette Rid, Dorcas Kamuya, Seema K Shah
515 [GO] 2021―Mar―19 Corrigendum to: A Case of 2019 Novel Coronavirus in a Pregnant Woman With Preterm Delivery
516 [GO] 2021―Mar―17 Changing Epidemiology of Respiratory Syncytial Virus in Australia - delayed re-emergence in Victoria compared to WA/NSW after prolonged lock-down for COVID-19 Sarah McNab, Lien Anh Ha Do, Vanessa Clifford, Nigel W Crawford, Andrew Daley, Kim Mulholland, et al. (+5)
517 [GO] 2021―Mar―16 National Changes in Outpatient Systemic Antibiotic Use During the Coronavirus Disease 2019 Pandemic in Australia Janet K Sluggett, Yen H Dinh, Steven L Wesselingh, Maria C Inacio, Gillian E Caughey
518 [GO] 2021―Mar―16 Antibody Dynamics, Seroreversion, and Persistence After SARS-CoV-2: Another Answer Gregory A Poland
519 [GO] 2021―Mar―12 Reinfection Rates among Patients who Previously Tested Positive for COVID-19: a Retrospective Cohort Study Megan M Sheehan, Anita J Reddy, Michael B Rothberg
520 [GO] 2021―Mar―10 Transmission of SARS-CoV-2 infection among children in summer schools applying stringent control measures in Barcelona, Spain Iolanda Jordan, Mariona Fernandez de Sevilla, Victoria Fumado, Quique Bassat, Elisenda Bonet-Carne, Claudia Fortuny, et al. (+29)
521 [GO] 2021―Mar―09 Effectiveness of three versus six feet of physical distancing for controlling spread of COVID-19 among primary and secondary students and staff: A retrospective, state-wide cohort study Polly van den Berg, Elissa M Schechter-Perkins, Rebecca S Jack, Isabella Epshtein, Richard Nelson, Emily Oster, Westyn Branch-Elliman
522 [GO] 2021―Mar―09 Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening Aaron J Tande, Benjamin D Pollock, Nilay D Shah, Gianrico Farrugia, Abinash Virk, Melanie Swift, et al. (+3)
523 [GO] 2021―Mar―09 Trends in Prescribing of Antibiotics and Drugs Investigated for COVID-19 Treatment in U.S. Nursing Home Residents During the COVID-19 Pandemic Katryna A Gouin, Stephen Creasy, Mary Beckerson, Martha Wdowicki, Lauri A Hicks, Jennifer N Lind, et al. (+3)
524 [GO] 2021―Mar―09 Evaluating the Long-Term Efficacy of COVID-19 Vaccines Dan-Yu Lin, Donglin Zeng, Peter B Gilbert
525 [GO] 2021―Mar―09 Transmission of SARS-CoV-2 from asymptomatic and presymptomatic individuals in healthcare settings despite medical masks and eye protection Michael Klompas, Meghan A Baker, Diane Griesbach, Robert Tucker, Glen R Gallagher, Andrew S Lang, et al. (+5)
526 [GO] 2021―Mar―09 Household SARS-CoV-2 transmission and children: a network prospective study Antoni Soriano-Arandes, Anna Gatell, Pepe Serrano, Mireia Biosca, Ferran Campillo, Ramon Capdevila, et al. (+111)
527 [GO] 2021―Mar―08 COVID-19 Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients Nitipong Permpalung, Teresa Po-Yu Chiang, Allan B Massie, Sean X Zhang, Robin K Avery, Saman Nematollahi, et al. (+3)
528 [GO] 2021―Mar―08 SARS-CoV-2 Episode 2? A sequel nobody wants to see Anne Piantadosi
529 [GO] 2021―Feb―23 Reduced Vitamin K Status and Coronavirus Disease 2019: An Epiphenomenon of Impaired Kidney Function? Dion Groothof, Adrian Post, Reinold O B Gans, Stephan J L Bakker
530 [GO] 2021―Feb―23 Difference in SARS-CoV-2 attack rate between children and adults may reflect bias Zoë Hyde
531 [GO] 2021―Feb―15 Plasma metabolomic profiling of patients recovered from COVID-19 with pulmonary sequelae 3 months after discharge Juanjuan Xu, Mei Zhou, Ping Luo, Zhengrong Yin, Sufei Wang, Tingting Liao, et al. (+8)
532 [GO] 2021―Feb―11 Indirect HIV morbidity and mortality due to COVID-19 Natasha Bell, Margherita Bracchi, Alessia Dalla Pria, Mark Nelson, Marta Boffito
533 [GO] 2021―Feb―10 Severe reinfection with South African SARS-CoV-2 variant 501Y.V2: A case report Noémie Zucman, Fabrice Uhel, Diane Descamps, Damien Roux, Jean-Damien Ricard
534 [GO] 2021―Feb―04 The Impact of State Mask-Wearing Requirements on the Growth of COVID-19 Cases in the United States Peter F Rebeiro, David M Aronoff, M Kevin Smith
535 [GO] 2021―Feb―03 Thrombosis and COVID-19: Controversies and (Tentative) Conclusions Jean M Connors, Toshiaki Iba, Rajesh T Gandhi
536 [GO] 2021―Feb―03 Understanding Drivers of COVID-19 Vaccine Hesitancy Among Blacks Florence Momplaisir, Norrisa Haynes, Hervette Nkwihoreze, Maria Nelson, Rachel M Werner, John Jemmott
537 [GO] 2021―Feb―03 SARS-CoV-2 setting-specific transmission rates: a systematic review and meta-analysis Hayley A Thompson, Andria Mousa, Amy Dighe, Han Fu, Alberto Arnedo-Pena, Peter Barrett, et al. (+18)
538 [GO] 2021―Jan―28 The Olympiad of SARS-CoV-2 vaccinology: Fundamentals to Complement Technical Frontiers Robert L Gottlieb, Cedric W Spak
539 [GO] 2021―Jan―27 The impact of vaccination on COVID-19 outbreaks in the United States Seyed M Moghadas, Thomas N Vilches, Kevin Zhang, Chad R Wells, Affan Shoukat, Burton H Singer, et al. (+5)
540 [GO] 2021―Jan―27 COVID-19 symptoms and SARS-CoV-2 antibody positivity in a large survey of first responders and healthcare personnel, May-July 2020 Lara J Akinbami, Lyle R Petersen, Samira Sami, Nga Vuong, Susan L Lukacs, Lisa Mackey, et al. (+2)
541 [GO] 2021―Jan―25 Antioxidant therapy in COVID-19: The crucial role of early treatment and antioxidant typology Domenico Lapenna
542 [GO] 2021―Jan―25 Intractable COVID-19 and Prolonged SARS-CoV-2 Replication in a CAR-T-cell Therapy Recipient: A Case Study Matthew K Hensley, William G Bain, Jana Jacobs, Sham Nambulli, Urvi Parikh, Anthony Cillo, et al. (+27)
543 [GO] 2021―Jan―17 Evaluation of SARS-CoV-2 transmission mitigation strategies on a university campus using an agent-based network model Ravi Goyal, John Hotchkiss, Robert T Schooley, Victor De Gruttola, Natasha K Martin
544 [GO] 2021―Jan―15 Population-based Estimates of COVID-19-like Illness, COVID-19 Illness, and Rates of Case Ascertainment, Hospitalizations, and Deaths - Non-Institutionalized New York City Residents, March-April 2020 Karen A Alroy, Aldo Crossa, Christine Dominianni, Jessica Sell, Katherine Bartley, Michael Sanderson, et al. (+10)
545 [GO] 2021―Jan―15 Airborne Transmission of SARS-CoV-2: What We Know Jonathan M Samet, Kimberly Prather, Georges Benjamin, Seema Lakdawala, John-Martin Lowe, Arthur Reingold, et al. (+2)
546 [GO] 2021―Jan―02 Prospective Longitudinal Serosurvey of Health Care Workers in the First Wave of the SARS-CoV-2 Pandemic in a Quaternary Care Hospital in Munich, Germany Tobias Weinberger, Julius Steffen, Andreas Osterman, Tonina T Mueller, Maximilian Muenchhoff, Paul R Wratil, et al. (+9)
547 [GO] 2021―Jan―01 SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses Andrea Pilotto, Stefano Masciocchi, Irene Volonghi, Valeria De Giuli, Francesca Caprioli, Sara Mariotto, et al. (+18)
548 [GO] 2021―Jan―01 SARS-CoV-2 immunity and reinfection Jennifer Dan, Sanjay Mehta
549 [GO] 2020―Dec―21 Suppression of SARS-CoV-2 after a second wave in Victoria, Australia Michelle L Giles, Euan M Wallace, Charles Alpren, Nicole Brady, Simon Crouch, Finn Romanes, et al. (+2)
550 [GO] 2020―Dec―18 Impact of Sex and Metabolic Comorbidities on COVID-19 Mortality Risk Across Age Groups: 66,646 Inpatients Across 613 U.S. Hospitals Katherine E Goodman, Laurence S Magder, Jonathan D Baghdadi, Lisa Pineles, Andrea R Levine, Eli N Perencevich, Anthony D Harris
551 [GO] 2020―Dec―18 Reinfection with SARS-CoV-2: Implications for Vaccines Jeffrey I Cohen, Peter D Burbelo
552 [GO] 2020―Dec―15 HIV care models during the COVID-19 era Giovanni Guaraldi, Jovana Milic, Esteban Martinez, Adeeba Kamarulzaman, Cristina Mussini, Laura Waters, et al. (+4)
553 [GO] 2020―Dec―15 A tale of two studies: Study design and our understanding of SARS-CoV-2 seroprevalence Ross M Boyce, Bonnie E Shook-Sa, Allison E Aiello
554 [GO] 2020―Dec―10 Differential household attack rates mirror the ability to control Covid-19 Alex R Cook, Borame L Dickens, Annelies Wilder-Smith
555 [GO] 2020―Dec―10 Compiling Observational Research During a Pandemic: A Necessary Bridge Rebekah W Moehring, Thomas L Holland
556 [GO] 2020―Dec―08 Paradoxes and uncertainties of immunomodulatory treatments in the fight against COVID-19 Laurent Kaiser, Diem-Lan Vu-Cantero, Christiane S Eberhardt
557 [GO] 2020―Dec―05 Co-infection, SARS-CoV-2 and influenza: an evolving puzzle Sara Covin, George W Rutherford
558 [GO] 2020―Dec―02 Viral cultures for COVID-19 infectious potential assessment - a systematic review T Jefferson, E A Spencer, J Brassey, C Heneghan
559 [GO] 2020―Dec―02 Effects of human behaviour changes during the COVID-19 pandemic on influenza spread in Hong Kong Nan Zhang, Wei Jia, Hao Lei, Peihua Wang, Pengcheng Zhao, Yong Guo, et al. (+7)
560 [GO] 2020―Dec―02 Determining the infectious potential of individuals with positive RT-PCR SARS-CoV-2 tests Peter Doshi, John H Powers
561 [GO] 2020―Dec―01 Characteristics of Adults aged 18-49 Years without Underlying Conditions Hospitalized with Laboratory-Confirmed COVID-19 in the United States, COVID-NET - March-August 2020 Daniel Owusu, Lindsay Kim, Alissa O’Halloran, Michael Whitaker, Alexandra M Piasecki, Arthur Reingold, et al. (+17)
562 [GO] 2020―Dec―01 Improving surveillance estimates of COVID-19 incidence in the United States Eli S Rosenberg, Heather M Bradley
563 [GO] 2020―Dec―01 Dose-response effects of hydroxychloroquine on prophylaxis against SARS-CoV-2 / COVID-19 infection Fabricio S Neves
564 [GO] 2020―Dec―01 Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection Daniel Poston, Yiska Weisblum, Helen Wise, Kate Templeton, Sara Jenks, Theodora Hatziioannou, Paul Bieniasz
565 [GO] 2020―Dec―01 Is there an association between SARS-CoV-2 and Streptococcus pneumoniae? Leigh M Howard
566 [GO] 2020―Nov―30 A practical and economic approach for assessing potential SARS-CoV-2 transmission risk in COVID-19 patients John A Lednicky
567 [GO] 2020―Nov―27 COVID-19 infection among people with HIV in New York City: A population-level analysis of linked surveillance data Sarah L Braunstein, Rachael Lazar, Amanda Wahnich, Demetre C Daskalakis, Oni J Blackstock
568 [GO] 2020―Nov―26 The COVID-19 Pan-Syndemic - will we ever learn? Srivatsan Padmanabhan
569 [GO] 2020―Nov―23 Estimated incidence of COVID-19 illness and hospitalization - United States, February-September, 2020 Heather Reese, A Danielle Iuliano, Neha N Patel, Shikha Garg, Lindsay Kim, Benjamin J Silk, et al. (+3)
570 [GO] 2020―Nov―20 Comprehensive health assessment three months after recovery from acute COVID-19 Bram van den Borst, Jeannette B Peters, Monique Brink, Yvonne Schoon, Chantal P Bleeker-Rovers, Henk Schers, et al. (+8)
571 [GO] 2020―Nov―19 Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019 Jee-Soo Lee, So Yeon Kim, Taek Soo Kim, Ki Ho Hong, Nam-Hee Ryoo, Jaehyeon Lee, et al. (+15)
572 [GO] 2020―Nov―18 A High Percentage of People with HIV on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following COVID-19 Michael J Peluso, Sonia Bakkour, Michael P Busch, Steven G Deeks, Timothy J Henrich
573 [GO] 2020―Nov―17 SARS-CoV-2 Antibody Testing: Important but Imperfect Jack T Stapleton
574 [GO] 2020―Nov―12 COVID-19 disease spectrum in children - first insights from Africa Ben J Marais
575 [GO] 2020―Nov―10 Establishing a New Normal for Hospital Care: A Whole of Hospital Approach to COVID-19 Brandon X Lum, Eugene H Liu, Sophia Archuleta, Jyoti Somani, Natasha Bagdasarian, Catherine S Koh, et al. (+4)
576 [GO] 2020―Nov―10 Susceptibility to Sars-COV-2 Infection Among Children And Adults: A Seroprevalence Study of Family Households in the Barcelona Metropolitan Region, Spain Pedro Brotons, Cristian Launes, Elena Buetas, Vicky Fumado, Desiree Henares, Mariona Fernandez de Sevilla, et al. (+10)
577 [GO] 2020―Nov―06 Persons with HIV and the COVID-19 Pandemic: A Viral Synergy of Biology and Sociology Lauren F Collins
578 [GO] 2020―Nov―06 Hydroxychloroquine for Prevention of SARS-CoV-2 Infection: challenges to trial conduct during the global pandemic Jason D Goldman
579 [GO] 2020―Nov―04 Prevalence of IgG against SARS-CoV-2 and evaluation of a rapid MEDsan IgG test in children seeking medical care Klara M Posfay-Barbe, Diego O Andrey, Julien Virzi, Patrick Cohen, Fiona Pigny, Ana R Goncalves, et al. (+6)
580 [GO] 2020―Nov―04 The Effect of SARS-CoV-2 Mitigation Strategies on Seasonal Respiratory Viruses: A Tale of Two Large Metropolitan Centers in the United States Amy C Sherman, Ahmed Babiker, Andrew J Sieben, Alexander Pyden, James Steinberg, Colleen S Kraft, et al. (+2)
581 [GO] 2020―Nov―01 Beyond the 405 and the 5: Geographic variations and factors associated with SARS-CoV-2 positivity rates in Los Angeles County Tara Vijayan, Michael Shin, Paul C Adamson, Christina Harris, Teresa Seeman, Keith C Norris, David Goodman-Meza
582 [GO] 2020―Oct―29 Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls Andrea Mastrangelo, Bruno Nicolò Germinario, Marica Ferrante, Claudia Frangi, Raffaele Li Voti, Camilla Muccini, et al. (+37)
583 [GO] 2020―Oct―27 The Low Case Fatality Rate of COVID-19 in Hong Kong Could Be Deceptive Christian HOFFMANN, Eva WOLF
584 [GO] 2020―Oct―27 Response to the COVID-19 pandemic among people experiencing homelessness in congregant living settings in San Diego, CA Hanna Marquez, Christian Ramers, Adam Northrup, Aaron Tam, Jie Liu, Sarah Rojas, et al. (+6)
585 [GO] 2020―Oct―27 Dose-response Relation Deduced for Coronaviruses from COVID-19, SARS and MERS Meta-analysis Results and its Application for Infection Risk Assessment of Aerosol Transmission Xiaole Zhang, Jing Wang
586 [GO] 2020―Oct―27 Unravelling the modes of transmission of SARS-CoV-2 during a nursing home outbreak: looking beyond the church super-spread event Helene A C M Voeten, Reina S Sikkema, Marjolein Damen, Bas B Oude Munnink, Carla Arends, Ellen Stobberingh, et al. (+3)
587 [GO] 2020―Oct―27 Isolation or De-isolation: Measuring the Infectivity of SARS-CoV-2? Hung-Chih Yang
588 [GO] 2020―Oct―23 COVID-19 - Lessons Learned and Questions Remaining Ferric C Fang, Constance A Benson, Carlos del Rio, Kathryn M Edwards, Vance G Fowler, Jr., et al. (+10)
589 [GO] 2020―Oct―23 COVID-19 and preventative medicine for HIV infected children Lorato Anderson, Miguela Caniza
590 [GO] 2020―Oct―23 A concern regarding estimated sensitivities and specificities of nasopharyngeal and saliva specimens for SARS-CoV-2 infection Kentaro Iwata, Kenichi Yoshimura
591 [GO] 2020―Oct―21 Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study Anna Maria Geretti, Alexander J Stockdale, Sophie H Kelly, Muge Cevik, Simon Collins, Laura Waters, et al. (+8)
592 [GO] 2020―Oct―20 Biomarker Research and Development for Coronavirus Disease 2019 (COVID-19): European Medical Research Infrastructures Call for Global Coordination Emanuela Oldoni, Alain van Gool, Laura García Bermejo, Andreas Scherer, Michaela Th Mayrhofer, Francesco Florindi, et al. (+6)
593 [GO] 2020―Oct―20 Specific re-distribution of SARS-CoV-2 variants in the respiratory system and intestinal tract Pengcheng Du, Chuan Song, Rui Li, Yangzi Song, Jiarui Li, Nan Ding, et al. (+12)
594 [GO] 2020―Oct―16 Favipiravir as an antiviral agent in COVID-19: same script, different cast? Nicolas Dauby
595 [GO] 2020―Oct―16 Self-Collected Oral Fluid and Nasal Swab Specimens Demonstrate Comparable Sensitivity to Clinician-Collected Nasopharyngeal Swab Specimens for the Detection of SARS-CoV-2 N Kojima, F Turner, V Slepnev, A Bacelar, L Deming, S Kodeboyina, J D Klausner
596 [GO] 2020―Oct―15 Candida auris: a latent threat to critically ill patients with COVID-19 Jose Y Rodriguez, Patrice Le Pape, Olga Lopez, Kelin Esquea, Anny L Labiosa, Carlos Alvarez-Moreno
597 [GO] 2020―Oct―15 Candidaemia in COVID-19, a link to disease pathology or increased clinical pressures? P Lewis White, Rishi Dhillon, Brendan Healy, Matthew P Wise, Matthijs Backs
598 [GO] 2020―Oct―15 Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden Ville N Pimenoff, Miriam Elfström, Iacopo Baussano, Mikael Björnstedt, Joakim Dillner
599 [GO] 2020―Oct―15 Transmission of SARS-CoV-2 via Contaminated Surfaces: What is to be Done? Craig S Conover
600 [GO] 2020―Oct―15 Hospital transfers across U.S. regions to address the “space” shortage in a pandemic: a public good George L Anesi
601 [GO] 2020―Oct―14 An overlooked role for fecal transmission of SARS-CoV-2? Justin Lessler
602 [GO] 2020―Oct―13 The inherent problems with the generalizability of the CALL score: towards reliable clinical prediction models for COVID-19 Takashi Yoshioka, Satoshi Funada, Yan Luo
603 [GO] 2020―Oct―13 Hydroxychloroquine as pre-exposure prophylaxis for COVID-19 in healthcare workers: a randomized trial Radha Rajasingham, Ananta S Bangdiwala, Melanie R Nicol, Caleb P Skipper, Katelyn A Pastick, Margaret L Axelrod, et al. (+16)
604 [GO] 2020―Oct―12 Survival analysis of treatment efficacy in comparative COVID-19 studies Zachary R McCaw, Lu Tian, Dae Hyun Kim, A Russell Localio, Lee-Jen Wei
605 [GO] 2020―Oct―12 Longitudinal Profile of Laboratory Parameters and Their Application in the Prediction for Fatal Outcome Among Patients Infected With SARS-CoV-2: A Retrospective Cohort Study Hao-Long Zeng, Qing-Bin Lu, Qing Yang, Xu Wang, Dao-Yuan Yue, Lei-Ke Zhang, et al. (+3)
606 [GO] 2020―Oct―10 Improving Antimicrobial Stewardship in Critically-Ill Patients with COVID-19 Daniel R Stevenson, Manpreet Sahemey, Joaquim Cevallos Morales, Juan Martín-Lázaro, Ruaridh Buchanan, Robert Serafino Wani
607 [GO] 2020―Oct―10 Sewage as a Possible Transmission Vehicle During a Coronavirus Disease 2019 Outbreak in a Densely populated Community: Guangzhou, China, April 2020 Jun Yuan, Zongqiu Chen, Chenghua Gong, Hui Liu, Baisheng Li, Kuibiao Li, et al. (+10)
608 [GO] 2020―Oct―08 The Impact of Social Distancing for SARS-CoV-2 on Respiratory Syncytial Virus and Influenza Burden Kathryn M Edwards
609 [GO] 2020―Oct―07 Learning more about what can make COVID-19 deadly: Insights from the Atlanta Metropolitan Area Brian D McCauley, Juan M Ortega-Legaspi
610 [GO] 2020―Oct―07 Convalescent plasma for patients with severe COVID-19: a matched cohort study Ralph Rogers, Fadi Shehadeh, Evangelia K Mylona, Josiah Rich, Marguerite Neill, Francine Touzard-Romo, et al. (+6)
611 [GO] 2020―Oct―07 Interferon-gamma release assay for accurate detection of SARS-CoV-2 T cell response Kanagavel Murugesan, Prasanna Jagannathan, Tho D Pham, Suchitra Pandey, Hector F Bonilla, Karen Jacobson, et al. (+7)
612 [GO] 2020―Oct―07 Inter-Region Transfers for Pandemic Surges Kenneth A Michelson, Chris A Rees, Jayshree Sarathy, Paige VonAchen, Michael Wornow, Michael C Monuteaux, Mark I Neuman
613 [GO] 2020―Oct―06 StopCOVID cohort: An observational study of 3,480 patients admitted to the Sechenov University hospital network in Moscow city for suspected COVID-19 infection Daniel Munblit, Nikita A Nekliudov, Polina Bugaeva, Oleg Blyuss, Maria Kislova, Ekaterina Listovskaya, et al. (+22)
614 [GO] 2020―Oct―06 Re-infection with SARS-CoV-2: What Goes Around May Come Back Around Arthur Y Kim, Rajesh T Gandhi
615 [GO] 2020―Oct―01 Survival of SARS-CoV-2 and influenza virus on the human skin: Importance of hand hygiene in COVID-19 Ryohei Hirose, Hiroshi Ikegaya, Yuji Naito, Naoto Watanabe, Takuma Yoshida, Risa Bandou, et al. (+3)
616 [GO] 2020―Oct―01 SARS-CoV-2 seroprevalence survey among 17,971 healthcare and administrative personnel at hospitals, pre-hospital services, and specialist practitioners in the Central Denmark Region Sanne Jespersen, Susan Mikkelsen, Thomas Greve, Kathrine Agergård Kaspersen, Martin Tolstrup, Jens Kjærgaard Boldsen, et al. (+8)
617 [GO] 2020―Sep―29 Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies Omar Hasan Ali, David Bomze, Lorenz Risch, Silvio D Brugger, Matthias Paprotny, Myriam Weber, et al. (+13)
618 [GO] 2020―Sep―28 COVID-19 Disparities: A call for equity in health outcomes and clinical research Benjamin P Linas, Chinazo O Cunningham
619 [GO] 2020―Sep―28 ABO Blood Group Correlations With COVID-19: Cohort Choice Makes A Difference Daniele Focosi, Maria Carla Iorio, Maria Lanza
620 [GO] 2020―Sep―28 The natural history of SARS-CoV-2 infection: a composite but incomplete picture Jaiprasath Sachithanandham, Chloe L Thio, Ashwin Balagopal
621 [GO] 2020―Sep―25 Clinical epidemiology of hospitalized patients with COVID-19 in Japan: Report of the COVID-19 REGISTRY JAPAN Nobuaki Matsunaga, Kayoko Hayakawa, Mari Terada, Hiroshi Ohtsu, Yusuke Asai, Shinya Tsuzuki, et al. (+15)
622 [GO] 2020―Sep―25 Health-care workers with COVID-19 living in Mexico City: clinical characterization and related outcomes Neftali Eduardo Antonio-Villa, Omar Yaxmehen Bello-Chavolla, Arsenio Vargas-Vázquez, Carlos A Fermín-Martínez, Alejandro Márquez-Salinas, Jessica Paola Bahena-López
623 [GO] 2020―Sep―25 Correlation between 3790 qPCR positives samples and positive cell cultures including 1941 SARS-CoV-2 isolates Rita Jaafar, Sarah Aherfi, Nathalie Wurtz, Clio Grimaldier, Van Thuan Hoang, Philippe Colson, et al. (+2)
624 [GO] 2020―Sep―25 Mass screening of asymptomatic persons for SARS-CoV-2 using saliva Isao Yokota, Peter Y Shane, Kazufumi Okada, Yoko Unoki, Yichi Yang, Tasuku Inao, et al. (+7)
625 [GO] 2020―Sep―24 Assessment of the Haemophagocytic lymphohistiocytosis HScore in patients with COVID-19 Kristina E N Clark, William D Nevin, Tabitha Mahungu, Helen Lachmann, Animesh Singh
626 [GO] 2020―Sep―23 Lessons Learned from the Re-emergent COVID-19 Cases in Areas of Long Reported No Community Transmission Yasmine Ibrahim, Akshay Raut, Joseph Varney, Anmol Sidhu, Vinh Dong, Tien Huy Nguyen
627 [GO] 2020―Sep―22 Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with COVID-19 Brendan R Jackson, Jeremy A W Gold, Pavithra Natarajan, John Rossow, Robyn Neblett Fanfair, Juliana da Silva, et al. (+23)
628 [GO] 2020―Sep―22 Menopause status and COVID-19 Felice Gersh, Carl J Lavie, James H O’Keefe
629 [GO] 2020―Sep―22 Serum antibody profile of a patient with COVID-19 reinfection Kelvin Kai-Wang To, Ivan Fan-Ngai Hung, Kwok-Hung Chan, Shuofeng Yuan, Wing-Kin To, Dominic Ngai-Chong Tsang, et al. (+4)
630 [GO] 2020―Sep―21 Double-blind, randomized, placebo-controlled trial with N-acetylcysteine for treatment of severe acute respiratory syndrome caused by COVID-19 Julio Cesar Garcia de Alencar, Claudia de Lucena Moreira, Alicia Dudy Müller, Cleuber Esteves Chaves, Marina Akemi Fukuhara, Elizabeth Aparecida da Silva, et al. (+10)
631 [GO] 2020―Sep―21 Decreased mortality in COVID-19 patients treated with Tocilizumab: a rapid systematic review and meta-analysis of observational studies Jishnu Malgie, Jan W Schoones, Bart G Pijls
632 [GO] 2020―Sep―21 Asymptomatic reinfection in two healthcare workers from India with genetically distinct SARS-CoV-2 Vivek Gupta, Rahul C Bhoyar, Abhinav Jain, Saurabh Srivastava, Rashmi Upadhayay, Mohamed Imran, et al. (+8)
633 [GO] 2020―Sep―21 SARS-CoV-2 transmission dynamics should inform policy Muge Cevik, Julia L Marcus, Caroline Buckee, Tara C Smith
634 [GO] 2020―Sep―17 The Impact of Sociodemographic Factors, Comorbidities and Physiologic Response on 30-day Mortality in COVID-19 Patients in Metropolitan Detroit Joseph Miller, Raef A Fadel, Amy Tang, Giuseppe Perrotta, Erica Herc, Sandeep Soman, et al. (+6)
635 [GO] 2020―Sep―17 3D Printing in Medicine: COVID-19 Testing with 3D Printed Nasopharyngeal Swabs Frank J Rybicki
636 [GO] 2020―Sep―17 Risk Factors for COVID-19-associated hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System Jean Y Ko, Melissa L Danielson, Machell Town, Gordana Derado, Kurt J Greenlund, Pam Daily Kirley, et al. (+16)
637 [GO] 2020―Sep―17 Corticosteroid-related in-hospital hyperglycemia: does it negate mortality benefits in COVID-19? Chia Siang Kow, Syed Shahzad Hasan
638 [GO] 2020―Sep―17 A Case of Early Re-infection with SARS-CoV-2 Derek Larson, Sterling L Brodniak, Logan J Voegtly, Regina Z Cer, Lindsay A Glang, Francisco J Malagon, et al. (+6)
639 [GO] 2020―Sep―17 Clinical Impact, Costs, and Cost-Effectiveness of Expanded SARS-CoV-2 Testing in Massachusetts Anne M Neilan, Elena Losina, Audrey C Bangs, Clare Flanagan, Christopher Panella, G Ege Eskibozkurt, et al. (+11)
640 [GO] 2020―Sep―17 Whole-genome sequencing to track SARS-CoV-2 transmission in nosocomial outbreaks Mary Lucey, Guerrino Macori, Niamh Mullane, Una Sutton-Fitzpatrick, Gabriel Gonzalez, Suzie Coughlan, et al. (+4)
641 [GO] 2020―Sep―17 Infant Outcomes Following Maternal Infection with SARS-CoV-2: First Report from the PRIORITY Study Valerie J Flaherman, Yalda Afshar, John Boscardin, Roberta L Keller, Anne Mardy, Mary K Prahl, et al. (+8)
642 [GO] 2020―Sep―16 SARS-CoV-2 spreads to lymph nodes and strongly expands CD4+ TEMRA cells in a patient with mild COVID-19 Ernesto Roldán-Santiago, Amparo Benito-Berlinches, Laura Martínez-García, Carmen Quereda, Eulalia Rodríguez-Martín, Pilar Pérez-Elías, et al. (+8)
643 [GO] 2020―Sep―16 Warp Speed for COVID-19 Vaccines: Why are Children Stuck in Neutral? Evan J Anderson, James D Campbell, C Buddy Creech, Robert Frenck, Satoshi Kamidani, Flor M Munoz, et al. (+2)
644 [GO] 2020―Sep―16 American Politics and the Spread of SARS-CoV-2 Jason H Wasfy
645 [GO] 2020―Sep―16 Carving out a niche for SARS-CoV-2 plasma RNA testing Benjamin A Pinsky, Catherine A Hogan
646 [GO] 2020―Sep―15 Lung ultrasonography for risk stratification in patients with COVID-19: a prospective observational cohort study Thomas Brahier, Jean-Yves Meuwly, Olivier Pantet, Marie-Josée Brochu Vez, Hélène Gerhard Donnet, Mary-Anne Hartley, et al. (+2)
647 [GO] 2020―Sep―13 A Psychological Perspective on the Association between Critical Care Resource Availability and Emotional Wellness during the COVID-19 Pandemic Nadine J Kaslow, DeJuan T White, Sarah C Cook
648 [GO] 2020―Sep―12 Viral genomics to inform infection control response in occupational COVID-19 transmission Naomi C A Whyler, Norelle L Sherry, Courtney R Lane, Torsten Seemann, Patiyan Andersson, Michelle Sait, et al. (+4)
649 [GO] 2020―Sep―12 Saliva is not a useful diagnostic specimen in children with Coronavirus Disease 2019 Chia Yin Chong, Kai-Qian Kam, Jiahui Li, Matthias Maiwald, Liat Hui Loo, Karen Donceras Nadua, et al. (+3)
650 [GO] 2020―Sep―11 Tuberculosis Elimination in the Era of COVID-19: A Moving Target Navisha Dookie, Nesri Padayatchi, Kogieleum Naidoo
651 [GO] 2020―Sep―11 Systematically mapping clinical features of infections with classical endemic human coronaviruses Pengfei Li, Aqsa Ikram, Maikel P Peppelenbosch, Zhongren Ma, Qiuwei Pan
652 [GO] 2020―Sep―11 Kinetics of SARS-CoV-2 Antibody Avidity Maturation and Association with Disease Severity Yiqi Ruben Luo, Indrani Chakraborty, Cassandra Yun, Alan H B Wu, Kara L Lynch
653 [GO] 2020―Sep―10 Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19:Serologic Testing Kimberly E Hanson, Angela M Caliendo, Cesar A Arias, Janet A Englund, Mary K Hayden, Mark J Lee, et al. (+11)
654 [GO] 2020―Sep―09 Structural vulnerability to COVID-19 among Latinx communities in the United States Valeria D Cantos, Paulina A Rebolledo
655 [GO] 2020―Sep―09 Social Disadvantage, Politics, and SARS-CoV-2 Trends: A County-Level Analysis of United States Data Ahmad Mourad, Nicholas A Turner, Arthur W Baker, Nwora Lance Okeke, Shanti Narayanasamy, Robert Rolfe, et al. (+3)
656 [GO] 2020―Sep―08 3D Printed Alternative to the Standard Synthetic Flocked Nasopharyngeal Swabs Used for COVID-19 testing Summer J Decker, Todd A Goldstein, Jonathan M Ford, Michael N Teng, Robert S Pugliese, Gregory J Berry, et al. (+16)
657 [GO] 2020―Sep―07 Detection of SARS-CoV-2 RNA in Blood of Patients with COVID-19: What Does It Mean? Jana L Jacobs, John W Mellors
658 [GO] 2020―Sep―04 COVID-19 and HIV spotlight the U.S. imperative for permanent affordable housing Elise D Riley, Matthew D Hickey, Elizabeth Imbert, Angelo A Clemenzi-Allen, Monica Gandhi
659 [GO] 2020―Sep―04 Common pediatric respiratory infectious diseases may serve as an early predictor for SARS-CoV-2 new wave of infections David Dawei Yang, Naïm Ouldali, Vincent Gajdos, Roxane Thomas-Sertillanges, Loganayagi Vasante, David Skurnik, François Angoulvant
660 [GO] 2020―Sep―04 Reconsidering assumptions of adolescent and young adult SARS-CoV-2 transmission dynamics Vincent Guilamo-Ramos, Adam Benzekri, Marco Thimm-Kaiser, Andrew Hidalgo, David C Perlman
661 [GO] 2020―Sep―02 SARS-CoV-2 RNA in plasma is associated with ICU admission and mortality in patients hospitalized with COVID-19 Christian Prebensen, Peder L My hre, Christine Jonassen, Anbjørg Rangberg, Anita Blomfeldt, My Svensson, et al. (+2)
662 [GO] 2020―Sep―02 Invasive Fungal Disease complicating COVID-19: when it rains it pours Martin Hoenigl
663 [GO] 2020―Sep―01 No One Likes a Stick up Their Nose: Making the Case for Saliva-Based Testing for COVID-19 Farhana Ali, Daniel A Sweeney
664 [GO] 2020―Sep―01 Rapid real-time tracking of non-pharmaceutical interventions and their association with SARS-CoV-2 positivity: The COVID-19 Pandemic Pulse Study Steven J Clipman, Amy P Wesolowski, Dustin G Gibson, Smisha Agarwal, Anastasia S Lambrou, Gregory D Kirk, et al. (+3)
665 [GO] 2020―Sep―01 Healthcare professionals’ perceptions of critical care resource availability and factors associated with mental well-being during COVID-19: Results from a US survey Monisha Sharma, Claire J Creutzfeldt, Ariane Lewis, Pratik V Patel, Christiane Hartog, Gemi E Jannotta, et al. (+6)
666 [GO] 2020―Sep―01 Risk factors for SARS-CoV-2 detection in blood of critically ill patients Niccolò Buetti, Juliette Patrier, Quentin Le Hingrat, Ambre Loiodice, Lila Bouadma, Benoit Visseaux, Jean-François Timsit
667 [GO] 2020―Sep―01 Symptomatic SARS-CoV-2 reinfection by a phylogenetically distinct strain Jan Van Elslande, Pieter Vermeersch, Kris Vandervoort, Tony Wawina-Bokalanga, Bert Vanmechelen, Elke Wollants, et al. (+5)
668 [GO] 2020―Sep―01 SARS-CoV-2 surveillance in decedents in a large, urban medical examiner’s office Andrew F Brouwer, Jeffrey L Myers, Emily T Martin, Kristine E Konopka, Adam S Lauring, Marisa C Eisenberg, et al. (+4)
669 [GO] 2020―Aug―29 COVID-19: First data from Africa W D Francois Venter, Jeremy Nel
670 [GO] 2020―Aug―26 Reduced vitamin K status as a potentially modifiable risk factor of severe COVID-19 Anton S M Dofferhoff, Ianthe Piscaer, Leon J Schurgers, Margot P J Visser, Jody M W van den Ouweland, Pim A de Jong, et al. (+11)
671 [GO] 2020―Aug―24 COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing Kelvin Kai-Wang To, Ivan Fan-Ngai Hung, Jonathan Daniel Ip, Allen Wing-Ho Chu, Wan-Mui Chan, Anthony Raymond Tam, et al. (+14)
672 [GO] 2020―Aug―24 Methylprednisolone for COVID-19: Was Benjamin Rush prescient? Jeffrey L Lennox
673 [GO] 2020―Aug―20 How Do Presenting Symptoms and Outcomes Differ by Race/Ethnicity Among Hospitalized Patients with COVID-19 Infection? Experience in Massachusetts Thomas R McCarty, Kelly E Hathorn, Walker D Redd, Nicolette J Rodriguez, Joyce C Zhou, Ahmad Najdat Bazarbashi, et al. (+6)
674 [GO] 2020―Aug―19 Empiric Antibacterial Therapy and Community-onset Bacterial Co-infection in Patients Hospitalized with COVID-19: A Multi-Hospital Cohort Study Valerie M Vaughn, Tejal Gandhi, Lindsay A Petty, Payal K Patel, Hallie C Prescott, Anurag N Malani, et al. (+4)
675 [GO] 2020―Aug―18 Prevalence of SARS-CoV-2 asymptomatic infections in two large academic health systems in Wisconsin Frida Rivera, Nasia Safdar, Nathan Ledeboer, Grace Schaack, Derrick J Chen, L Silvia Munoz-Price
676 [GO] 2020―Aug―17 The challenge of managing COVID-19 associated pulmonary aspergillosis Roger J Brüggemann, Frank L van de Veerdonk, Paul E Verweij
677 [GO] 2020―Aug―17 Evaluating the Efficacy of Therapies in COVID-19 Patients Dan-Yu Lin, Donglin Zeng, Joseph J Eron
678 [GO] 2020―Aug―14 Insights on COVID-19 epidemiology from a historic cruise ship quarantine Takuya Yamagishi, Yohei Doi
679 [GO] 2020―Aug―13 Baricitinib: Impact on COVID-19 coagulopathy? Sarah C J Jorgensen, Lisa Burry, Christopher L Y Tse, Linda D Dresser
680 [GO] 2020―Aug―13 Response to Correspondence: Baricitinib - Impact on COVID-19 Coagulopathy? Jorgensen et. al. Boghuma K Titanji, Monica M Farley, Raymond F Schinazi, Vincent C Marconi
681 [GO] 2020―Aug―13 Response to Correspondence: Baricitinib as Treatment of COVID-19 Friend or Foe of the Pancreas? Cerda-Contreras et.al Boghuma K Titanji, Monica M Farley, Raymond F Schinazi, Vincent C Marconi
682 [GO] 2020―Aug―13 Baricitinib as treatment for COVID-19: friend or foe of the pancreas? Christopher Cerda-Contreras, Laura Nuzzolo-Shihadeh, Adrián Camacho-Ortiz, Eduardo Perez-Alba
683 [GO] 2020―Aug―13 Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses Yaniv Lustig, Shlomit Keler, Rachel Kolodny, Nir Ben-Tal, Danit Atias-Varon, Ekaterina Shlush, et al. (+6)
684 [GO] 2020―Aug―10 COVID-19, organ transplantation, and the nuances of immunomodulation: lessons learned and what comes next Ghady Haidar
685 [GO] 2020―Aug―10 Gut microbiota and COVID-19: A superfluous diagnostic biomarker or therapeutic target? Emily Klann, Shannan Rich, Volker Mai
686 [GO] 2020―Aug―10 Influenza vaccination: an ally to mitigate influenza-associated risks during the coronavirus pandemics Francisca González-Rubio, Ignatios Ioakeim-Skoufa, Beatriz Poblador-Plou, Antonio Gimeno-Miguel, Alexandra Prados-Torres
687 [GO] 2020―Aug―10 Untangling SARS-CoV-2 epidemic control - lessons from Vietnam Frank G Cobelens, Vanessa C Harris
688 [GO] 2020―Aug―07 COVID-19 and Children: Adding Another Piece to the Puzzle Elizabeth H Ristagno, Kristina A Bryant
689 [GO] 2020―Aug―07 AVIFAVIR for Treatment of Patients with Moderate COVID-19: Interim Results of a Phase II/III Multicenter Randomized Clinical Trial Andrey A Ivashchenko, Kirill A Dmitriev, Natalia V Vostokova, Valeria N Azarova, Andrew A Blinow, Alina N Egorova, et al. (+15)
690 [GO] 2020―Aug―06 What should be the ideal definite COVID-19 case definition? Oguz Resat Sipahi
691 [GO] 2020―Aug―06 Posterior oropharyngeal salivafor the detection of SARS-CoV-2 Marie Pierre Otto, Chrystelle Darles, Elodie Valero, Patrick Benner, Fabien Dutasta, Frédéric Janvier
692 [GO] 2020―Aug―06 Cerebrospinal fluid features in SARS-CoV-2 RT-PCR positive patients Mathilde Bellon, Cecilia Schweblin, Nathalie Lambeng, Pascal Cherpillod, Jessica Vazquez, Patrice H Lalive, et al. (+2)
693 [GO] 2020―Aug―05 Alveolar SARS-CoV-2 viral load is tightly correlated with severity in COVID-19 ARDS Mathieu Blot, Marine Jacquier, Catherine Manoha, Lionel Piroth, Pierre-Emmanuel Charles
694 [GO] 2020―Aug―04 Unique SARS-CoV-2 clusters causing a large COVID-19 outbreak in Hong Kong Kelvin Kai-Wang To, Wan-Mui Chan, Jonathan Daniel Ip, Allen Wing-Ho Chu, Anthony Raymond Tam, Raymond Liu, et al. (+13)
695 [GO] 2020―Aug―04 Evaluation of COVID-19 RT-qPCR tests in multi-sample pools Atul Gang, Jaya Gang
696 [GO] 2020―Aug―03 SARS-CoV-2 viral load in the upper respiratory tract of children and adults with early acute COVID-19 Stéphanie Baggio, Arnaud G L’Huillier, Sabine Yerly, Mathilde Bellon, Noémie Wagner, Marie Rohr, et al. (+6)
697 [GO] 2020―Aug―03 Why contact tracing efforts have failed to curb COVID-19 transmission in much of the U.S Eva Clark, Elizabeth Y Chiao, E Susan Amirian
698 [GO] 2020―Aug―03 Comparing nasopharyngeal swab and early morning saliva for the identification of SARS-CoV-2 Mohan Rao, Fairuz A Rashid, Fashihah S A H Sabri, Nur Nadia Jamil, Rozainanee Zain, Rohaidah Hashim, et al. (+4)
699 [GO] 2020―Jul―31 Coronavirus Disease 2019 (COVID-19) Outbreak in a San Francisco Homeless Shelter Elizabeth Imbert, Patrick M Kinley, Ashley Scarborough, Caroline Cawley, Madeline Sankaran, Sarah N Cox, et al. (+4)
700 [GO] 2020―Jul―31 To Toci or Not to Toci for COVID-19: Is That Still the Question? Guang-Shing Cheng, Joshua A Hill
701 [GO] 2020―Jul―31 The Multidimensional Challenge of Treating COVID-19: Remdesivir is a Foot in the Door Rajesh T Gandhi
702 [GO] 2020―Jul―31 The first 100 days of SARS-CoV-2 control in Vietnam Quang Thai Pham, Maia A Rabaa, Huy Luong Duong, Quang Tan Dang, Dai Quang Tran, Ha-Linh Quach, et al. (+13)
703 [GO] 2020―Jul―31 Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection Kai Wang, Quan-Xin Long, Hai-Jun Deng, Jie Hu, Qing-Zhu Gao, Gui-Ji Zhang, et al. (+6)
704 [GO] 2020―Jul―24 Infectious Diseases Society of America Guidelines on Infection Prevention for Health Care Personnel Caring for Patients with Suspected or Known COVID-19 John B Lynch, Perica Davitkov, Deverick J Anderson, Adarsh Bhimraj, Vincent Chi-Chung  Cheng, Judith Guzman-Cottrill, et al. (+12)
705 [GO] 2020―Jul―24 Diagnosing SARS-CoV-2 Related Multisystem Inflammatory Syndrome in Children (MIS-C): Focus on the Gastrointestinal Tract and the Myocardium Anne H Rowley
706 [GO] 2020―Jul―22 Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care Susan A Olender, Katherine K Perez, Alan S Go, Bindu Balani, Eboni G Price-Haywood, Nirav S Shah, et al. (+27)
707 [GO] 2020―Jul―20 Potential Influence of Menstrual Status and Sex Hormones on female SARS-CoV-2 Infection: A Cross-sectional Study from Multicentre in Wuhan, China Ting Ding, Jinjin Zhang, Tian Wang, Pengfei Cui, Zhe Chen, Jingjing Jiang, et al. (+11)
708 [GO] 2020―Jul―17 Pan-Family Assays for Rapid Viral Screening: Reducing Delays in Public Health Responses During Pandemics Michael Erlichster, Gursharan Chana, Daniela Zantomio, Benjamin Goudey, Efstratios Skafidas
709 [GO] 2020―Jul―16 Systematic testing for influenza and COVID-19 among patients with respiratory illness Brendan Flannery, Jennifer K Meece, John V Williams, Emily T Martin, Manjusha Gaglani, Michael L Jackson, H Keipp Talbot
710 [GO] 2020―Jul―16 Lessons from Mass-Testing for COVID-19 in Long Term Care Facilities for the Elderly in San Francisco Janice K Louie, Hyman M Scott, Amie DuBois, Natalya Sturtz, Wendy Lu, Juliet Stoltey, et al. (+6)
711 [GO] 2020―Jul―16 Mitigation of a COVID-19 Outbreak in a Nursing Home Through Serial Testing of Residents and Staff Daniel J Escobar, Maria Lanzi, Pouné Saberi, Ruby Love, Darren R Linkin, John J Kelly, et al. (+4)
712 [GO] 2020―Jul―15 Response System for and Epidemiological Features of COVID-19 in Gyeongsangnam-do Province in South Korea Yu Mi Wi, Su Jin Lim, Si-Ho Kim, Seungjin Lim, Su Jin Lee, Byung-Han Ryu, et al. (+6)
713 [GO] 2020―Jul―14 Risk Factors for Intensive Care Unit Admission and In-hospital Mortality among Hospitalized Adults Identified through the U.S. Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET) Lindsay Kim, Shikha Garg, Alissa O’Halloran, Michael Whitaker, Huong Pham, Evan J Anderson, et al. (+20)
714 [GO] 2020―Jul―13 Excess soluble fms-like tyrosine kinase 1 correlates with endothelial dysfunction and organ failure in critically ill COVID-19 patients Vincent Dupont, Lukshe Kanagaratnam, Antoine Goury, Gaël Poitevin, Mathieu Bard, Gauthier Julien, et al. (+5)
715 [GO] 2020―Jul―13 SARS-CoV-2 infects and damages the mature and immature olfactory sensory neurons of hamsters Anna Jinxia Zhang, Andrew Chak-Yiu Lee, Hin Chu, Jasper Fuk-Woo Chan, Zhimeng Fan, Can Li, et al. (+10)
716 [GO] 2020―Jul―10 Tocilizumab for treatment of mechanically ventilated patients with COVID-19 Emily C Somers, Gregory A Eschenauer, Jonathan P Troost, Jonathan L Golob, Tejal N Gandhi, Lu Wang, et al. (+16)
717 [GO] 2020―Jul―08 Personalized therapy approach for hospitalized patients with COVID-19 Carolina Garcia-Vidal, Estela Moreno-García, Marta Hernández-Meneses, Pedro Puerta-Alcalde, Mariana Chumbita, Nicole Garcia-Pouton, et al. (+11)
718 [GO] 2020―Jul―08 The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States Julius M Wilder
719 [GO] 2020―Jul―08 Natural transmission of bat-like SARS-CoV-2PRRA variants in COVID-19 patients Yik Chun Wong, Siu Ying Lau, Kelvin Kai Wang To, Bobo Wing Yee Mok, Xin Li, Pui Wang, et al. (+9)
720 [GO] 2020―Jul―08 Development and Validation of a Nomogram for Assessing Survival in Patients with COVID-19 Pneumonia Yi-Min Dong, Jia Sun, Yi-Xin Li, Qian Chen, Qing-Quan Liu, Zhou Sun, et al. (+11)
721 [GO] 2020―Jul―08 The practical challenges of making clinical use of the quantitative value for SARS-CoV-2 viral load across several dynamics Amy J Mathers
722 [GO] 2020―Jul―07 SARS-CoV-2 antibody prevalence in blood in a large school community subject to a Covid-19 outbreak: a cross-sectional study Juan Pablo Torres, Cecilia Piñera, Verónica De La Maza, Anne J Lagomarcino, Daniela Simian, Bárbara Torres, et al. (+3)
723 [GO] 2020―Jul―07 Microbiota and Covid-19. Which came first, the chicken or the egg? Maria Antonietta Marcialis, Flaminia Bardanzellu, Vassilios Fanos
724 [GO] 2020―Jul―07 Risk Factors for Healthcare Personnel Infection with Endemic Coronaviruses (HKU1, OC43, NL63, 229E): Results from the Respiratory Protection Effectiveness Clinical Trial (ResPECT) Derek A T Cummings, Lewis J Radonovich, Geoffrey J Gorse, Charlotte A Gaydos, Mary T Bessesen, Alexandria C Brown, et al. (+10)
725 [GO] 2020―Jul―07 Rapid Emergence of SARS-CoV-2 in the Greater New York Metropolitan Area: Geolocation, Demographics, Positivity Rates, and Hospitalization for 46,793 Persons Tested by Northwell Health Samuel B Reichberg, Partha P Mitra, Aya Haghamad, Girish Ramrattan, James M Crawford, Gregory J Berry, et al. (+7)
726 [GO] 2020―Jul―07 When hospitals Harm: Multi-modal entry of SARS-CoV-2 into inpatient healthcare Scott R Curry, Cassandra D Salgado
727 [GO] 2020―Jul―03 It is Time to Address Airborne Transmission of COVID-19 Lidia Morawska, Donald K Milton
728 [GO] 2020―Jul―03 Simple ‘Rule-of-6’ predicts severe COVID-19 disease Borame Sue Lee Dickens, Jue Tao Lim, Jere Wenn Low, Chun Kiat Lee, Yinxiaohe Sun, Haziq Bin Mohamad Nasir, et al. (+6)
729 [GO] 2020―Jul―02 The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing ICU capacity Brooke E Nichols, Lise Jamieson, Sabrina R C Zhang, Gabriella A Rao, Sheetal Silal, Juliet R C Pulliam, et al. (+2)
730 [GO] 2020―Jul―02 Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for COVID-19 Patients - Nashville, Tennessee William B Stubblefield, H Keipp Talbot, Leora Feldstein, Mark W Tenforde, Mohammed Ata Ur Rasheed, Lisa Mills, et al. (+12)
731 [GO] 2020―Jul―02 Commentary: Rapid Testing of Healthcare Employees for COVID-19: What Can We Learn from the Seattle Experience? Kristina A Bryant, Pam Isaacs
732 [GO] 2020―Jul―02 Evaluating use cases for human challenge trials in accelerating SARS-CoV-2 vaccine development Linh Chi Nguyen, Christopher W Bakerlee, T Greg McKelvey, Sophie M Rose, Alexander J Norman, Nicholas Joseph, et al. (+8)
733 [GO] 2020―Jun―29 Immune modulation in COVID-19: Strategic considerations for personalized therapeutic intervention Mark W Hall, Ila Joshi, Luis Leal, Eng Eong Ooi
734 [GO] 2020―Jun―27 Rapid Reorganization of an Academic Infectious Diseases Program During the COVID-19 Pandemic in Detroit: A Novel Unit-Based Group Rounding Model Amit Vahia, Zohra S Chaudhry, Linda Kaljee, Tommy Parraga-Acosta, Smitha Gudipati, Gina Maki, et al. (+15)
735 [GO] 2020―Jun―27 Community Acquired Co-infection in COVID-19: A Retrospective Observational Experience Christopher J Lehmann, Mai T Pho, David Pitrak, Jessica P Ridgway, Natasha N Pettit
736 [GO] 2020―Jun―27 Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019 Reed Magleby, Lars F Westblade, Alex Trzebucki, Matthew S Simon, Mangala Rajan, Joel Park, et al. (+3)
737 [GO] 2020―Jun―27 Pneumocystis Jirovecii Pneumonia and SARS-CoV-2 Co-Infection in newly diagnosed HIV-1 infection Sebastian Mang, Dominic Kaddu-Mulindwa, Carlos Metz, André Becker, Frederik Seiler, Sigrun Smola, et al. (+6)
738 [GO] 2020―Jun―25 Early Results from SARS-CoV-2 PCR testing of Healthcare Workers at an Academic Medical Center in New York City Arielle R Nagler, Eric R Goldberg, Maria E Aguero-Rosenfeld, Joan Cangiarella, Gary Kalkut, Carolyn Rooke Monahan, Robert J Cerfolio
739 [GO] 2020―Jun―24 COVID-19 in Immunocompromised Hosts: What We Know So Far Monica Fung,, Jennifer M Babik
740 [GO] 2020―Jun―23 Distribution of Transmission Potential during Non-Severe COVID-19 Illness Nabin K Shrestha, Francisco Marco Canosa, Amy S Nowacki, Gary W Procop, Sherilynn Vogel, Thomas G Fraser, et al. (+3)
741 [GO] 2020―Jun―23 Social distancing alters the clinical course of COVID-19 in young adults: A comparative cohort study Michel Bielecki, Roland Züst, Denise Siegrist, Daniele Meyerhofer, Giovanni Andrea Gerardo Crameri, Zeno Giovanni Stanga, et al. (+3)
742 [GO] 2020―Jun―23 COVID-19 pharmacologic treatments for children: research priorities and approach to pediatric studies Anthony J Garcia-Prats, Nicole Salazar-Austin, James H Conway, Kendra Radtke, Sylvia M LaCourse, Elizabeth Maleche-Obimbo, et al. (+3)
743 [GO] 2020―Jun―23 Investigating the sex differences in COVID-19: Another step forward, but many unanswered questions Philip Yang, Annette M Esper
744 [GO] 2020―Jun―23 Novel coronavirus 2019 transmission risk in educational settings Chee Fu Yung, Kai-qian Kam, Karen Donceras Nadua, Chia Yin Chong, Natalie Woon Hui Tan, Jiahui Li, et al. (+4)
745 [GO] 2020―Jun―23 SARS-CoV-2 infection in healthcare personnel with high-risk occupational exposure: evaluation of seven-day exclusion from work policy Helena C Maltezou, Xanthi Dedoukou, Maria Tseroni, Evi Tsonou, Vasileios Raftopoulos, Kalliopi Papadima, et al. (+5)
746 [GO] 2020―Jun―22 Use of Baricitinib in Patients with Moderate and Severe COVID-19 Boghuma K Titanji, Monica M Farley, Ashish Mehta, Randi Connor-Schuler, Abeer Moanna, Sushma K Cribbs, et al. (+7)
747 [GO] 2020―Jun―22 Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients in New York City Keith Sigel, Talia Swartz, Eddye Golden, Ishan Paranjpe, Sulaiman Somani, Felix Richter, et al. (+17)
748 [GO] 2020―Jun―22 Drug-induced liver injury in a COVID-19 patient: potential interaction of remdesivir with P-glycoprotein inhibitors Emiel Leegwater, Anne Strik, Erik B Wilms, Liesbeth B E Bosma, David M Burger, Thomas H Ottens, Cees van Nieuwkoop
749 [GO] 2020―Jun―22 Comparing Nasopharyngeal and Mid-Turbinate Nasal Swab Testing for the Identification of SARS-CoV-2 Swetha Pinninti, Connie Trieu, Sunil K Pati, Misty Latting, Joshua Cooper, Maria C Seleme, et al. (+4)
750 [GO] 2020―Jun―19 THE RIGHT TIME FOR STEROIDS IN COVID-19 Ana Fernández Cruz, Belén Ruiz-Antorán, Elena Múñez Rubio, Aránzazu Sancho López, Alejandro Callejas Díaz, Cristina Avendaño-Solá, Antonio Ramos Martínez
751 [GO] 2020―Jun―19 Managing COVID-19 spread with voluntary public-health measures: Sweden as a case study for pandemic control Shina C L Kamerlin, Peter M Kasson
752 [GO] 2020―Jun―19 Asymptomatic transmission and the infection fatality risk for COVID-19: Implications for school reopening Sten H Vermund, Virginia E Pitzer
753 [GO] 2020―Jun―19 Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Alainna J Jamal, Mohammad Mozafarihashjin, Eric Coomes, Jeff Powis, Angel X Li, Aimee Paterson, et al. (+13)
754 [GO] 2020―Jun―19 Posterior oropharyngeal saliva for the detection of SARS-CoV-2 Sally Cheuk, Ying WONG, Herman TSE, Hon Kei SIU, Tsz Shan KWONG, Man Yee Chu, et al. (+9)
755 [GO] 2020―Jun―19 Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors Christian Erikstrup, Christoffer Egeberg Hother, Ole Birger Vestager Pedersen, Kåre Mølbak, Robert Leo Skov, Dorte Kinggaard Holm, et al. (+16)
756 [GO] 2020―Jun―18 Loss of Taste and Smell as Distinguishing Symptoms of COVID-19 Patrick Dawson, Elizabeth M Rabold, Rebecca L Laws, Erin E Conners, Radhika Gharpure, Sherry Yin, et al. (+9)
757 [GO] 2020―Jun―18 Breastmilk and COVID-19: What Do We Know? David W Kimberlin, Karen M Puopolo
758 [GO] 2020―Jun―17 Social distancing measures: evidence of interruption of seasonal influenza activity and early lessons of the SARS-CoV-2 pandemic Andrew D Wiese, Jordan Everson, Carlos G Grijalva
759 [GO] 2020―Jun―16 High-dose but not low-dose corticosteroids potentially delay viral shedding of patients with COVID-19 Sijia Li, Zhigang Hu, Xinyu Song
760 [GO] 2020―Jun―16 COVID-19 and the RAAS George O A Naik
761 [GO] 2020―Jun―16 The Disproportionate Impact of COVID-19 on Racial and Ethnic Minorities in the United States Don Bambino Geno Tai, Aditya Shah, Chyke A Doubeni, Irene G Sia, Mark L Wieland
762 [GO] 2020―Jun―16 Clinical Presentation and Outcomes of Pregnant Women with COVID-19: A Systematic Review and Meta-Analysis Reem Matar, Layan Alrahmani, Nasser Monzer, Labib G Debiane, Elie Berbari, Jawad Fares, et al. (+2)
763 [GO] 2020―Jun―15 Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital Hannah M Rickman, Tommy Rampling, Karen Shaw, Gema Martinez-Garcia, Leila Hail, Pietro Coen, et al. (+4)
764 [GO] 2020―Jun―15 Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia Stanley C Jordan, Phillip Zakowski, Hai P Tran, Ethan A Smith, Cyril Gaultier, Gregory Marks, et al. (+13)
765 [GO] 2020―Jun―13 Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19 Kimberly E Hanson, Angela M Caliendo, Cesar A Arias, Janet A Englund, Mark J Lee, Mark Loeb, et al. (+10)
766 [GO] 2020―Jun―12 Performance of oropharyngeal swab testing compared to nasopharyngeal swab testing for diagnosis of COVID-19 -United States, January-February 2020 Monita R Patel, Darin Carroll, Emily Ussery, Hilary Whitham, Christopher A Elkins, Judith Noble-Wang, et al. (+8)
767 [GO] 2020―Jun―12 Asymptomatic and symptomatic SARS-CoV-2 infections in close contacts of COVID-19 patients: a seroepidemiological study Hong-Jun Zhang, Ying-Ying Su, Shi-Lin Xu, Guo-Qing Chen, Chang-Cheng Li, Ren-Jie Jiang, et al. (+5)
768 [GO] 2020―Jun―08 Contact tracing: Essential to the public health response and our understanding of the epidemiology of COVID-19 Keri N Althoff, Sally B Coburn, Denis Nash
769 [GO] 2020―Jun―07 Pregnancy and Pandemic Disease Karen Palmore Beckerman
770 [GO] 2020―Jun―05 Pandemic Planning in Homeless Shelters: A pilot study of a COVID-19 testing and support program to mitigate the risk of COVID-19 outbreaks in congregate settings Claire Bodkin, Vaibhav Mokashi, Kerry Beal, Jill Wiwcharuk, Robin Lennox, Dale Guenter, et al. (+2)
771 [GO] 2020―Jun―05 COVID-19 : Pacific Islands challenges Simon Poignant, Laure Baudouin, Marc Vinclair, Sandrine Mons
772 [GO] 2020―Jun―05 The Laboratory Diagnosis of COVID-19-- Frequently-Asked Questions Ferric C Fang, Samia N Naccache, Alexander L Greninger
773 [GO] 2020―Jun―04 Can the SARS-CoV-2 PCR Cycle Threshold Value and Time from Symptom Onset to Testing Predict Infectivity? Matthew J Binnicker
774 [GO] 2020―Jun―03 Alterations of the Gut Microbiota in Patients with COVID-19 or H1N1 Influenza Silan Gu, Yanfei Chen, Zhengjie Wu, Yunbo Chen, Hainv Gao, Longxian Lv, et al. (+15)
775 [GO] 2020―Jun―03 Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients Dustin R Long, Saurabh Gombar, Catherine A Hogan, Alexander L Greninger, Vikas O’Reilly Shah, Chloe Bryson-Cahn, et al. (+9)
776 [GO] 2020―Jun―03 On setting expectations for a SARS-CoV-2 Vaccine David H Canaday, Stefan Gravenstein
777 [GO] 2020―Jun―02 Neutralizing Antibodies Responses to SARS-CoV-2 in COVID-19 Inpatients and Convalescent Patients Xiaoli Wang, Xianghua Guo, Qianqian Xin, Yang Pan, Yaling Hu, Jing Li, et al. (+3)
778 [GO] 2020―Jun―02 COVID-19 pandemic: Impact caused by school closure and national lockdown on pediatric visits and admissions for viral and non-viral infections, a time series analysis François Angoulvant, Naïm Ouldali, David Dawei Yang, Mathilde Filser, Vincent Gajdos, Alexis Rybak, et al. (+7)
779 [GO] 2020―Jun―02 The natural history and transmission potential of asymptomatic SARS-CoV-2 infection Nguyen Van Vinh Chau, Vo Thanh Lam, Nguyen Thanh Dung, Lam Minh Yen, Ngo Ngoc Quang Minh, Le Manh Hung, et al. (+21)
780 [GO] 2020―Jun―02 The Importance of Advancing SARS-CoV-2 Vaccines in Children Carol M Kao, Walter A Orenstein, Evan J Anderson
781 [GO] 2020―May―29 The CALL score for predicting outcomes in patients with COVID-19 Elisa Grifoni, Alice Valoriani, Francesco Cei, Vieri Vannucchi, Federico Moroni, Lorenzo Pelagatti, et al. (+3)
782 [GO] 2020―May―29 Age-dependent gender differences of COVID-19 in mainland China: comparative study Jie Qian, Lin Zhao, Run-Ze Ye, Xiu-Jun Li, Yuan-Li Liu
783 [GO] 2020―May―29 COVID-19 outbreaks in U.S. immigrant detention centers: the urgent need to adopt CDC guidelines for prevention and evaluation John James Openshaw, Mark A Travassos
784 [GO] 2020―May―29 Household COVID-19 Prevalence Emmanuel Mandonnet, Jean-Michel Molina
785 [GO] 2020―May―29 From Easing Lockdowns to Scaling-Up Community-Based COVID-19 Screening, Testing, and Contact Tracing in Africa - Shared Approaches, Innovations, and Challenges to Minimize Morbidity and Mortality Jean B Nachega, Ashraf Grimwood, Hassan Mahomed, Geoffrey Fatti, Wolfgang Preiser, Oscar Kallay, et al. (+13)
786 [GO] 2020―May―29 Diligent medical activities of a publicly designated medical institution for infectious diseases pave the way for overcoming COVID-19: A positive message to people working at the cutting edge Tatsuya Nagano, Jun Arii, Mitsuhiro Nishimura, Naofumi Yoshida, Keiji Iida, Yoshihiro Nishimura, Yasuko Mori
787 [GO] 2020―May―29 Dose Optimization of Hydroxychloroquine for COVID-19: Do Blood Concentrations Matter? Matthew M Ippolito, Charles Flexner
788 [GO] 2020―May―29 COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies John Gourtsoyannis
789 [GO] 2020―May―29 It’s True Even in a Pandemic: Children are Not Merely Little Adults C Buddy Creech
790 [GO] 2020―May―28 Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19) Patrick C K Tam, Kathleen M Ly, Max L Kernich, Nicola Spurrier, Diana Lawrence, David L Gordon, Emily C Tucker
791 [GO] 2020―May―28 Seroconversion rate and diagnostic accuracy of serological tests for COVID-19 Bharathnag Nagappa, Yamini Marimuthu
792 [GO] 2020―May―28 Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19) Jasper Fuk-Woo Chan, Shuofeng Yuan, Anna Jinxia Zhang, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Andrew Chak-Yiu Lee, et al. (+13)
793 [GO] 2020―May―28 Monitoring COVID-19 through Trends in Influenza-like Illness and Laboratory-confirmed Influenza and COVID-19 - New York State, excluding New York City, January 1 - April 12, 2020 Eli S Rosenberg, Eric W Hall, Elizabeth M Rosenthal, Angela M Maxted, Donna L Gowie, Elizabeth M Dufort, et al. (+5)
794 [GO] 2020―May―28 Predictors for Severe COVID-19 Infection Ashish Bhargava, Elisa Akagi Fukushima, Miriam Levine, Wei Zhao, Farah Tanveer, Susanna M Szpunar, Louis Saravolatz
795 [GO] 2020―May―28 What is the role of SARS-CoV-2 PCR testing in discontinuation of transmission-based precautions for COVID-19 patients? Bahaa Abu Raya, David M Goldfarb, Manish Sadarangani
796 [GO] 2020―May―28 Clinical Outcomes of COVID-19 with Evidence-Based Supportive Care Derek T Larson, John H Sherner, Kia M Gallagher, Cynthia L Judy, Madison B Paul, Alexandra M Mahoney, Peter J Weina
797 [GO] 2020―May―28 Low prevalence of SARS-CoV-2 among pregnant and postpartum patients with universal screening in Seattle, Washington Sylvia M LaCourse, Alisa Kachikis, Michela Blain, LaVone E Simmons, James A Mays, Amber D Pattison, et al. (+25)
798 [GO] 2020―May―28 Towards a better case fatality estimate for SARS-CoV-2 during the early phase of the United States outbreak Jeremy Samuel Faust
799 [GO] 2020―May―28 A Conceptual Discussion about R0 of SARS-COV-2 in Healthcare Settings Laura TEMIME, Marie-Paule GUSTIN, Audrey DUVAL, Niccolò BUETTI, Pascal CRÉPEY, Didier GUILLEMOT, et al. (+5)
800 [GO] 2020―May―28 Maximum Daily Temperature, Precipitation, Ultra-Violet Light and Rates of Transmission of SARS-Cov-2 in the United States Shiv T Sehra, Justin D Salciccioli, Douglas J Wiebe, Shelby Fundin, Joshua F Baker
801 [GO] 2020―May―28 Impact of Public Health Interventions on Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Korea Hyunju Lee, Heeyoung Lee, Kyoung-Ho Song, Eu Suk Kim, Jeong Su Park, Jongtak Jung, et al. (+4)
802 [GO] 2020―May―27 Hospitalized patients with COVID-19 and HIV: a case series Kate Childs, Frank A Post, Claire Norcross, Zoë Ottaway, Elizabeth Hamlyn, Killian Quinn, et al. (+2)
803 [GO] 2020―May―26 Metatranscriptomic Characterization of COVID-19 Identified A Host Transcriptional Classifier Associated With Immune Signaling Haocheng Zhang, Jing-Wen Ai, Wenjiao Yang, Xian Zhou, Fusheng He, Shumei Xie, et al. (+9)
804 [GO] 2020―May―26 Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies Hanalise V Huff, Avantika Singh
805 [GO] 2020―May―26 Importance of Pediatric Inclusion in COVID-19 Therapeutic Trials Vanessa N Raabe, Jennifer Lighter, Arthur L Caplan, Adam J Ratner
806 [GO] 2020―May―25 Alterations in smell or taste - Classic COVID-19? Jason A Trubiano, Sara Vogrin, Jason C Kwong, Natasha Homes
807 [GO] 2020―May―25 The Urgent Need for Medicare Reimbursement for Home Infusion Antibiotics amidst a Pandemic Amber C Streifel, Monica K Sikka
808 [GO] 2020―May―22 Prognostic value of C-reactive protein in patients with COVID-19 Xiaomin Luo, Wei Zhou, Xiaojie Yan, Tangxi Guo, Benchao Wang, Hongxia Xia, et al. (+6)
809 [GO] 2020―May―22 Chronological Changes of Viral Shedding in Adult Inpatients with COVID-19 in Wuhan, China Jing-Tao Huang, Ruo-Xi Ran, Zhi-Hua Lv, Li-Na Feng, Chen-Yang Ran, Yong-Qing Tong, et al. (+10)
810 [GO] 2020―May―22 Whole nucleocapsid protein of SARS-CoV-2 may cause false positive results in serological assays Yutaro Yamaoka, Sundararaj S Jeremiah, Kei Miyakawa, Ryo Saji, Mototsugu Nishii, Ichiro Takeuchi, Akihide Ryo
811 [GO] 2020―May―21 Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington Frederick S Buckner, Denise J McCulloch, Vidya Atluri, Michela Blain, Sarah A McGuffin, Arun K Nalla, et al. (+8)
812 [GO] 2020―May―21 Renin-angiotensin-aldosterone system inhibitors impact on COVID-19 mortality: What’s next for ACE2? Ankit B Patel, Ashish Verma
813 [GO] 2020―May―21 Predicting infectious SARS-CoV-2 from diagnostic samples Jared Bullard, Kerry Dust, Duane Funk, James E Strong, David Alexander, Lauren Garnett, et al. (+9)
814 [GO] 2020―May―21 Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection Roberto Gnavi, Moreno Demaria, Roberta Picariello, Marco Dalmasso, Fulvio Ricceri, Giuseppe Costa
815 [GO] 2020―May―20 Thymosin alpha 1 (Tα1) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells Yueping Liu, Yue Pang, Zhenhong Hu, Ming Wu, Chenhui Wang, Zeqing Feng, et al. (+10)
816 [GO] 2020―May―20 Associations of Early COVID-19 Cases in San Francisco with Domestic and International Travel Wei Gu, Xianding Deng, Kevin Reyes, Elaine Hsu, Candace Wang, Alicia Sotomayor-Gonzalez, et al. (+4)
817 [GO] 2020―May―20 Connecting hydroxychloroquine in vitro antiviral activity to in vivo concentration for prediction of antiviral effect: a critical step in treating COVID-19 patients Jianghong Fan, Xinyuan Zhang, Jiang Liu, Yuching Yang, Nan Zheng, Qi Liu, et al. (+5)
818 [GO] 2020―May―20 Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study Sun-Young Jung, Jae Chol Choi, Seung-Hun You, Won-Young Kim
819 [GO] 2020―May―20 Influenza vaccine does not increase the risk of coronavirus or other non-influenza respiratory viruses: retrospective analysis from Canada, 2010-11 to 2016-17 Danuta M Skowronski, Macy Zou, Quinten Clarke, Catharine Chambers, James A Dickinson, Suzana Sabaiduc, et al. (+9)
820 [GO] 2020―May―20 Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China Yubo Wang, Jin Tong, Yalan Qin, Ting Xie, Jianghua Li, Jianrong Li, et al. (+5)
821 [GO] 2020―May―19 To Interpret the SARS-CoV-2 Test, Consider the Cycle Threshold Value Michael R Tom, Michael J Mina
822 [GO] 2020―May―19 Where is the implementation science? An opportunity to apply principles during the COVID19 pandemic Stephanie Parks Taylor, Marc A Kowalkowski, Rinad S Beidas
823 [GO] 2020―May―18 Higher solar irradiance is associated with a lower incidence of COVID-19 Mar Guasp, Carlos Laredo, Xabier Urra
824 [GO] 2020―May―18 Symptomatic Infants have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease than Older Children Philip Zachariah, Katia C Halabi, Candace L Johnson, Susan Whitter, Jorge Sepulveda, Daniel A Green
825 [GO] 2020―May―15 Early Short Course Corticosteroids in Hospitalized Patients with COVID-19 Raef Fadel, Austin R Morrison, Amit Vahia, Zachary R Smith, Zohra Chaudhry, Pallavi Bhargava, et al. (+4)
826 [GO] 2020―May―15 COVID-19: The New Caledonia experience Jad Kerbaj, Cecile Cazorla, Thierry De Greslan, Mathieu Serie, Ann-Claire Gourinat, Benoit Marot
827 [GO] 2020―May―15 Reduction of coronavirus burden with mass azithromycin distribution Thuy Doan, Armin Hinterwirth, Ahmed M Arzika, Lee Worden, Cindi Chen, Lina Zhong, et al. (+3)
828 [GO] 2020―May―12 An inflammatory profile correlates with decreased frequency of cytotoxic cells in COVID-19 Veronica Bordoni, Alessandra Sacchi, Eleonora Cimini, Stefania Notari, Germana Grassi, Eleonora Tartaglia, et al. (+16)
829 [GO] 2020―May―12 Clinical features and outcomes of HIV patients with coronavirus disease 2019 Cristina Gervasoni, Paola Meraviglia, Agostino Riva, Andrea Giacomelli, Letizia Oreni, Davide Minisci, et al. (+3)
830 [GO] 2020―May―12 Social media and the new world of scientific communication during the COVID19 pandemic S Pollett, C Rivers
831 [GO] 2020―May―11 Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis John J Y Zhang, Keng Siang Lee, Li Wei Ang, Yee Sin Leo, Barnaby Edward Young
832 [GO] 2020―May―08 Monologue of a physician who tested persistently positive for COVID-19 Bing Qu, Jing Yang
833 [GO] 2020―May―08 COVID-19 Clinical Trial Oversight at a Major Academic Medical Center: Approach of the Michigan Medicine COVID-19 Clinical Trial Committees Kayte Spector-Bagdady, Peter D R Higgins, Anna S Lok
834 [GO] 2020―May―07 SARS-CoV-2 (COVID-19): What do we know about children? A systematic review Nisha S Mehta, Oliver T Mytton, Edward W S Mullins, Tom A Fowler, Catherine L Falconer, Orla B Murphy, et al. (+4)
835 [GO] 2020―May―07 Hydroxychloroquine in COVID-19 patients: what still needs to be known about the kinetics G Martin-Blondel, S Ruiz, M Murris, S Faguer, V Duhalde, F Eyvrard, et al. (+13)
836 [GO] 2020―May―07 The Effects of Pregnancy on Women with COVID-19: Maternal and Infant Outcomes David A Schwartz
837 [GO] 2020―May―07 The SARS-CoV-2 epidemic in Zimbabwe: Quo vadis? Leolin Katsidzira, Lenon Gwaunza, James G Hakim
838 [GO] 2020―May―07 Household Transmission of SARS-CoV-2, Zhuhai, China, 2020 Jian Wu, Yiying Huang, Changli Tu, Chunping Bi, Zhigang Chen, Liyun Luo, et al. (+9)
839 [GO] 2020―May―05 Lessons from COVID-19 in children: Key hypotheses to guide preventative and therapeutic strategies Tulika Singh, Sarah M Heston, Stephanie N Langel, Maria Blasi, Jillian H Hurst, Genevieve G Fouda, et al. (+2)
840 [GO] 2020―May―05 Association of higher body mass index (BMI) with severe coronavirus disease 2019 (COVID-19) in younger patients Sean Wei Xiang Ong, Barnaby Edward Young, Yee-Sin Leo, David Chien Lye
841 [GO] 2020―May―05 COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State-March 2020 Eli S Rosenberg, Elizabeth M Dufort, Debra S Blog, Eric W Hall, Dina Hoefer, Bryon P Backenson, et al. (+6)
842 [GO] 2020―May―02 Risk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, China Ling Hu, Shaoqiu Chen, Yuanyuan Fu, Zitong Gao, Hui Long, Jian-ming Wang, et al. (+14)
843 [GO] 2020―May―01 Clinical and laboratory predictors of in-hospital mortality in patients with COVID-19: a cohort study in Wuhan, China Kun Wang, Peiyuan Zuo, Yuwei Liu, Meng Zhang, Xiaofang Zhao, Songpu Xie, et al. (+3)
844 [GO] 2020―Apr―30 Bacterial and fungal co-infection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing Timothy M Rawson, Luke S P Moore, Nina Zhu, Nishanthy Ranganathan, Keira Skolimowska, Mark Gilchrist, et al. (+3)
845 [GO] 2020―Apr―30 Role of serology in the COVID-19 pandemic Sean Stowell, Jeannette Guarner
846 [GO] 2020―Apr―30 Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection Rongqing Zhao, Maohua Li, Hao Song, Jianxin Chen, Wenlin Ren, Yingmei Feng, et al. (+23)
847 [GO] 2020―Apr―30 Evaluation of COVID-19 RT-qPCR test in multi-sample pools Idan Yelin, Noga Aharony, Einat Shaer Tamar, Amir Argoetti, Esther Messer, Dina Berenbaum, et al. (+10)
848 [GO] 2020―Apr―30 Still much to learn about the diagnostic role of SARS-CoV-2 antibody detection Simona Di Giambenedetto, Arturo Ciccullo, Brunella Posteraro, Francesca Lombardi, Alberto Borghetti, Maurizio Sanguinetti
849 [GO] 2020―Apr―29 Olfactory and Gustatory Dysfunction in Coronavirus Disease 19 (COVID-19) Jan C Luers, Alexander C Rokohl, Niklas Loreck, Philomena A Wawer Matos, Max Augustin, Felix Dewald, et al. (+3)
850 [GO] 2020―Apr―29 Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is? Farhana Ali, Daniel A Sweeney
851 [GO] 2020―Apr―29 COVID-19, superinfections and antimicrobial development: What can we expect? Cornelius J Clancy, M Hong Nguyen
852 [GO] 2020―Apr―24 Interactive web-based graphs of novel coronavirus COVID-19 cases and deaths per population by country Masashi Idogawa, Shoichiro Tange, Hiroshi Nakase, Takashi Tokino
853 [GO] 2020―Apr―24 Working schedule, sleep quality and susceptibility to COVID-19 in healthcare workers Michael Belingheri, Maria Emilia Paladino, Michele Augusto Riva
854 [GO] 2020―Apr―24 Contact tracing for COVID-19: An opportunity to reduce health disparities and End the HIV/AIDS Epidemic in the US Bohdan Nosyk, Wendy S Armstrong, Carlos del Rio
855 [GO] 2020―Apr―23 Clinical impact of renin-angiotensin system inhibitors on in-hospital mortality of patients with hypertension hospitalized for COVID-19 Sara Tedeschi, Maddalena Giannella, Michele Bartoletti, Filippo Trapani, Marina Tadolini, Claudio Borghi, Pierluigi Viale
856 [GO] 2020―Apr―23 Early risk factors for the duration of SARS-CoV-2 viral positivity in COVID-19 patients Aifen Lin, Ze-Bao He, Sheng Zhang, Jian-Gang Zhang, Xia Zhang, Wei-Hua Yan
857 [GO] 2020―Apr―23 Access by English and Non-English Speakers Is Needed to COVID-19 Clinical Trials Mamta K Jain, Nancy Rollins, Raksha Jain
858 [GO] 2020―Apr―23 Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Jiuxin Qu, Chi Wu, Xiaoyong Li, Guobin Zhang, Zhaofang Jiang, Xiaohe Li, et al. (+2)
859 [GO] 2020―Apr―23 First reported nosocomial outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a pediatric dialysis unit Vera Schwierzeck, Jens Christian König, Joachim Kühn, Alexander Mellmann, Carlos Luis Correa-Martínez, Heymut Omran, et al. (+3)
860 [GO] 2020―Apr―22 Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Adarsh Bhimraj, Rebecca L Morgan, Amy Hirsch Shumaker, Valery Lavergne, Lindsey Baden, Vincent Chi-Chung Cheng, et al. (+9)
861 [GO] 2020―Apr―21 A case series of children with Coronavirus Disease 2019: what have we learned? Jasper Fuk-Woo Chan, Kelvin Kai-Wang To, Kwok-Yung Yuen
862 [GO] 2020―Apr―20 Responding to the COVID-19 outbreak in Singapore: Staff Protection and Staff Temperature and Sickness Surveillance Systems Htet Lin Htun, Dwee Wee Lim, Win Mar Kyaw, Wan-Ning Janis Loh, Lay Tin Lee, Brenda Ang, Angela Chow
863 [GO] 2020―Apr―18 Down-regulated gene expression spectrum and immune responses changed during the disease progression in COVID-19 patients Yabo Ouyang, Jiming Yin, Wenjing Wang, Hongbo Shi, Ying Shi, Bin Xu, et al. (+7)
864 [GO] 2020―Apr―17 Antibody Detection and Dynamic Characteristics in Patients with COVID-19 Fei Xiang, Xiaorong Wang, Xinliang He, Zhenghong Peng, Bohan Yang, Jianchu Zhang, et al. (+7)
865 [GO] 2020―Apr―17 Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients Ai Tang Xiao, Yi Xin Tong, Sheng Zhang
866 [GO] 2020―Apr―17 Population movement, city closure in Wuhan and geographical expansion of the 2019-nCoV pneumonia infection in China in January 2020 Kun Liu, Siqi Ai, Shuxuan Song, Guanghu Zhu, Fei Tian, Huan Li, et al. (+6)
867 [GO] 2020―Apr―17 Testing for SARS-CoV-2: Can We Stop at Two? Tau Hong Lee, Ray Junhao Lin, Raymond T P Lin, Timothy Barkham, Pooja Rao, Yee-Sin Leo, et al. (+2)
868 [GO] 2020―Apr―16 The characteristics of household transmission of COVID-19 Wei Li, Bo Zhang, Jianhua Lu, Shihua Liu, Zhiqiang Chang, Peng Cao, et al. (+5)
869 [GO] 2020―Apr―16 After Covid-19 Richard P Wenzel
870 [GO] 2020―Apr―16 Weak Induction of Interferon Expression by SARS-CoV-2 Supports Clinical Trials of Interferon Lambda to Treat Early COVID-19 Thomas R O’Brien, David L Thomas, Sarah S Jackson, Ludmila Prokunina-Olsson, Raymond P Donnelly, Rune Hartmann
871 [GO] 2020―Apr―16 The duration of viral shedding of discharged patients with severe COVID-19 Bo Zhou, Jianqing She, Yadan Wang, Xiancang Ma
872 [GO] 2020―Apr―16 SARS-CoV-2 infection (COVID-19) in febrile infants without respiratory distress Michal Paret, Jennifer Lighter, Rebecca Pellett Madan, Vanessa N Raabe, Gail F Shust, Adam J Ratner
873 [GO] 2020―Apr―16 Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients Xiaohua Chen, Binghong Zhao, Yueming Qu, Yurou Chen, Jie Xiong, Yong Feng, et al. (+6)
874 [GO] 2020―Apr―16 Albert Camus’ ‘The COVID-19 Plague’ Revisited Carlos Franco-Paredes
875 [GO] 2020―Apr―15 Comment of the potential risks of sexual and vertical transmission of Covid-19 infection Laura Scorzolini, Angela Corpolongo, Concetta Castilletti, Eleonora Lalle, Andrea Mariano, Emanuele Nicastri
876 [GO] 2020―Apr―15 Sequential analysis of viral load in a neonate and her mother infected with SARS-CoV-2 Mi Seon Han, Moon-Woo Seong, Eun Young Heo, Ji Hong Park, Namhee Kim, Sue Shin, et al. (+3)
877 [GO] 2020―Apr―14 A Tool to Early Predict Severe Corona Virus Disease 2019 (COVID-19) : A Multicenter Study using the Risk Nomogram in Wuhan and Guangdong, China Jiao Gong, Jingyi Ou, Xueping Qiu, Yusheng Jie, Yaqiong Chen, Lianxiong Yuan, et al. (+6)
878 [GO] 2020―Apr―14 Importance of inclusion of pregnant and breastfeeding women in COVID-19 therapeutic trials Sylvia M LaCourse, Grace John-Stewart, Kristina M Adams Waldorf
879 [GO] 2020―Apr―10 The changing patter of COVID-19 in China: A tempo-geographic analysis of the SARS-CoV-2 epidemic T Weiming, L Huipeng, M Gifty, W Zaisheng, C Weibin, W Dan, Y Rongbin
880 [GO] 2020―Apr―10 Nonpharmaceutical interventions and epidemic intensity during the 2019 novel coronavirus disease pandemic Gang Qin, Lei Zhang, Cheng-Jun Yu
881 [GO] 2020―Apr―09 Generalizability of COVID-19 Clinical Prediction Models Shubhada Hooli, Carina King
882 [GO] 2020―Apr―09 Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020 Kostas Danis, Olivier Epaulard, Thomas Bénet, Alexandre Gaymard, Séphora Campoy, Elisabeth Bothelo-Nevers, et al. (+83)
883 [GO] 2020―Apr―09 Good IgA bad IgG in SARS-CoV-2 infection? Marie C Béné, Marcelo de Carvalho, Marion Eveillard, Yannick Lebri
884 [GO] 2020―Apr―08 Comparative replication and immune activation profiles of SARS-CoV-2 and SARS-CoV in human lungs: an ex vivo study with implications for the pathogenesis of COVID-19 Hin Chu, Jasper Fuk-Woo Chan, Yixin Wang, Terrence Tsz-Tai Yuen, Yue Chai, Yuxin Hou, et al. (+15)
885 [GO] 2020―Apr―08 Asymptomatic and Presymptomatic Infectors: Hidden Sources of COVID-19 Disease Guanjian Li, Weiran Li, Xiaojin He, Yunxia Cao
886 [GO] 2020―Apr―08 Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission Jennifer Lighter, Michael Phillips, Sarah Hochman, Stephanie Sterling, Diane Johnson, Fritz Francois, Anna Stachel
887 [GO] 2020―Apr―08 Predictors of refractory Coronavirus disease (COVID-19) pneumonia Bahaa Abu-Raya
888 [GO] 2020―Apr―08 Prediction for Progression Risk in Patients with COVID-19 Pneumonia: the CALL Score Dong Ji, Dawei Zhang, Jing Xu, Zhu Chen, Tieniu Yang, Peng Zhao, et al. (+7)
889 [GO] 2020―Apr―08 Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV Juanjuan Zhao, Xuejiao Liao, Haiyan Wang, Lanlan Wei, Mingzhao Xing, Lei Liu, Zheng Zhang
890 [GO] 2020―Apr―08 Effect of throat washings on detection of 2019 novel coronavirus Wen-Liang Guo, Qian Jiang, Feng Ye, Shao-Qiang Li, Cheng Hong, Li-Yan Chen, Shi-Yue Li
891 [GO] 2020―Apr―07 Inquiring into Benefits of Independent Activation of Non-Classical Renin-Angiotensin System in the Clinical Prognosis and Reduction of COVID-19 mortality Luis Miguel Álvarez-Aragón, Antonio Luis Cuesta-Muñoz, Inmaculada Álvarez-López
892 [GO] 2020―Apr―07 PCR Assays Turned Positive in 25 Discharged COVID-19 Patients Jing Yuan, Shanglong Kou, Yanhua Liang, JianFeng Zeng, Yanchao Pan, Lei Liu
893 [GO] 2020―Apr―04 Towards Optimization of Hydroxychloroquine Dosing in Intensive Care Unit COVID-19 Patients Sophie Perinel, Manon Launay, Élisabeth Botelho-Nevers, Éric Diconne, Aurore Louf-Durier, Raphaël Lachand, et al. (+5)
894 [GO] 2020―Apr―03 Care for the psychological status of frontline medical staff fighting against COVID-19 Jing Huang, Fangkun Liu, Ziwei Teng, Jindong Chen, Jingping Zhao, Xiaoping Wang, Renrong Wu
895 [GO] 2020―Apr―03 Lockdown contained the spread of 2019 novel coronavirus disease in Huangshi city, China: Early epidemiological findings Tuo Ji, Hai-Lian Chen, Jing Xu, Ling-Ning Wu, Jie-Jia Li, Kai Chen, Gang Qin
896 [GO] 2020―Apr―02 New measures for COVID-19 response: a lesson from the Wenzhou experience Linhui Ruan, Min Wen, Qingrun Zeng, Chengshui Chen, Shengwei Huang, Su Yang, et al. (+9)
897 [GO] 2020―Apr―01 SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection Lin Qiu, Xia Liu, Meng Xiao, Jing Xie, Wei Cao, Zhengyin Liu, et al. (+4)
898 [GO] 2020―Apr―01 First Mildly Ill, Non-Hospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States - Maricopa County, Arizona, 2020 Sarah E Scott, Karen Zabel, Jennifer Collins, Katherine C Hobbs, Melissa J Kretschmer, Mitchell Lach, et al. (+17)
899 [GO] 2020―Apr―01 Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan Makoto Saito, Eisuke Adachi, Seiya Yamayoshi, Michiko Koga, Kiyoko Iwatsuki-Horimoto, Yoshihiro Kawaoka, Hiroshi Yotsuyanagi
900 [GO] 2020―Mar―31 The COVID-19 pandemic: we are all in this together Florence Momplaisir
901 [GO] 2020―Mar―27 The Late Arrival of COVID-19 in Africa - Mitigating Pan-Continental Spread Jean B Nachega, Moussa Seydi, Alimuddin Zumla
902 [GO] 2020―Mar―27 Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 Juanjuan Zhao, Quan Yuan, Haiyan Wang, Wei Liu, Xuejiao Liao, Yingying Su, et al. (+19)
903 [GO] 2020―Mar―27 Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea Joseph P Dudley, Nam Taek Lee
904 [GO] 2020―Mar―27 Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients Fengting Yu, Liting Yan, Nan Wang, Siyuan Yang, Linghang Wang, Yunxia Tang, et al. (+9)
905 [GO] 2020―Mar―26 Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility Jasper Fuk-Woo Chan, Anna Jinxia Zhang, Shuofeng Yuan, Vincent Kwok-Man Poon, Chris Chung-Sing Chan, Andrew Chak-Yiu Lee, et al. (+18)
906 [GO] 2020―Mar―26 Spotlight on Jails: COVID-19 Mitigation Policies Needed Now Alysse G Wurcel, Emily Dauria, Nicholas Zaller, Ank Nijhawan, Curt Beckwith, Kathryn Nowotny, Lauren Brinkley-Rubinstein
907 [GO] 2020―Mar―24 Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System-a Call for Epidemiologic Investigations Thomas C Hanff, Michael O Harhay, Tyler S Brown, Jordana B Cohen, Amir M Mohareb
908 [GO] 2020―Mar―24 The first locally acquired novel case of 2019-nCoV infection in a healthcare worker in the Paris area Elise Klement, Nagisa Godefroy, Sonia Burrel, Dimitri Kornblum, Gentiane Monsel, Alexandre Bleibtreu, et al. (+5)
909 [GO] 2020―Mar―24 Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study Andrea Giacomelli, Laura Pezzati, Federico Conti, Dario Bernacchia, Matteo Siano, Letizia Oreni, et al. (+6)
910 [GO] 2020―Mar―21 Epidemiological and Clinical Predictors of COVID-19 Yinxiaohe Sun, Vanessa Koh, Kalisvar Marimuthu, Oon Tek Ng, Barnaby Young, Shawn Vasoo, et al. (+7)
911 [GO] 2020―Mar―21 Could chloroquine /hydroxychloroquine be harmful in Coronavirus Disease 2019 (COVID-19) treatment? Maurizio Guastalegname, Alfredo Vallone
912 [GO] 2020―Mar―20 A COVID-19 Transmission within a family cluster by presymptomatic infectors in China Guoqing Qian, Naibin Yang, Ada Hoi Yan Ma, Liping Wang, Guoxiang Li, Xueqin Chen, Xiaomin Chen
913 [GO] 2020―Mar―19 Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19) Li Guo, Lili Ren, Siyuan Yang, Meng Xiao, De Chang, Fan Yang, et al. (+16)
914 [GO] 2020―Mar―12 Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China Zhongliang Wang, Bohan Yang, Qianwen Li, Lu Wen, Ruiguang Zhang
915 [GO] 2020―Mar―11 A case report of neonatal COVID-19 infection in China Shaoshuai Wang, Lili Guo, Ling Chen, Weiyong Liu, Yong Cao, Jingyi Zhang, Ling Feng
916 [GO] 2020―Mar―11 Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China Pingzheng Mo, Yuanyuan Xing, Yu Xiao, Liping Deng, Qiu Zhao, Hongling Wang, et al. (+13)
917 [GO] 2020―Mar―10 A comparative study on the clinical features of COVID-19 pneumonia to other pneumonias Dahai Zhao, Feifei Yao, Lijie Wang, Ling Zheng, Yongjun Gao, Jun Ye, et al. (+3)
918 [GO] 2020―Mar―09 Protecting Health Care Workers during the COVID-19 Coronavirus Outbreak -Lessons from Taiwan's SARS response Jonathan Schwartz, Chwan-Chuen King, Muh-Yong Yen
919 [GO] 2020―Mar―09 A Novel Approach for a Novel Pathogen: using a home assessment team to evaluate patients for 2019 novel coronavirus (SARS-CoV-2) Chloe Bryson-Cahn, Jeffrey Duchin, Vanessa A Makarewicz, Meagan Kay, Krista Rietberg, Nathanael Napolitano, et al. (+3)
920 [GO] 2020―Mar―06 “The Art of War” in the Era of Coronavirus Disease 2019 (COVID-19) Daniel N Maxwell, Trish M Perl, James B Cutrell
921 [GO] 2020―Mar―06 Dysregulation of immune response in patients with COVID-19 in Wuhan, China Chuan Qin, Luoqi Zhou, Ziwei Hu, Shuoqi Zhang, Sheng Yang, Yu Tao, et al. (+5)
922 [GO] 2020―Mar―06 In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Xueting Yao, Fei Ye, Miao Zhang, Cheng Cui, Baoying Huang, Peihua Niu, et al. (+9)
923 [GO] 2020―Mar―03 Perinatal Transmission of COVID-19 Associated SARS-CoV-2: Should We Worry? Cuifang Fan, Di Lei, Congcong Fang, Chunyan Li, Ming Wang, Yuling Liu, et al. (+6)
924 [GO] 2020―Mar―03 Diagnosis and Management of First Case of COVID-19 in Canada: Lessons applied from SARS Xavier Marchand-Senécal, Rob Kozak, Samira Mubareka, Natasha Salt, Jonathan B Gubbay, Alireza Eshaghi, et al. (+6)
925 [GO] 2020―Feb―28 2019 novel coronavirus is undergoing active recombination Huiguang Yi
926 [GO] 2020―Feb―27 A glimpse into the origins of genetic diversity in SARS-CoV-2 Joel O Wertheim
927 [GO] 2020―Feb―26 Clinical Characteristics of Imported Cases of COVID-19 in Jiangsu Province: A Multicenter Descriptive Study Jian Wu, Jun Liu, Xinguo Zhao, Chengyuan Liu, Wei Wang, Dawei Wang, et al. (+6)
928 [GO] 2020―Feb―26 A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery Xiaotong Wang, Zhiqiang Zhou, Jianping Zhang, Fengfeng Zhu, Yongyan Tang, Xinghua Shen
929 [GO] 2020―Feb―25 De-isolating COVID-19 Suspect Cases: A Continuing Challenge Jun-Yang Tay, Poh Lian Lim, Kalisvar Marimuthu, Sapna Pradip Sadarangani, Li Min Ling, Brenda Sze Peng Ang, et al. (+3)
930 [GO] 2020―Feb―25 A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load Kai-qian Kam, Chee Fu Yung, Lin Cui, Raymond Lin Tzer Pin, Tze Minn Mak, Matthias Maiwald, et al. (+5)
931 [GO] 2020―Feb―25 Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients Zijie Shen, Yan Xiao, Lu Kang, Wentai Ma, Leisheng Shi, Li Zhang, et al. (+13)
932 [GO] 2020―Feb―25 A Case Series of children with 2019 novel coronavirus infection: clinical and epidemiological features Jiehao Cai, Jing Xu, Daojiong Lin, zhi Yang, Lei Xu, Zhenghai Qu, et al. (+13)
933 [GO] 2020―Feb―10 Consistent detection of 2019 novel coronavirus in saliva Kelvin Kai-Wang To, Owen Tak-Yin Tsang, Cyril Chik-Yan Yip, Kwok-Hung Chan, Tak-Chiu Wu, Jacky M C Chan, et al. (+12)
934 [GO] 2020―Jan―31 Origin and evolution of the 2019 novel coronavirus Liangsheng Zhang, Fu-ming Shen, Fei Chen, Zhenguo Lin
 [1] 

934 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.123 sec